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Abstract  
Introduction: The role of microRNAs (miRs) in articular cartilage is still not well 
established, however many studies have reported the differential expression of a number 
of miRs between healthy and osteoarthritic (OA) articular cartilage. These studies have 
focused on the OA pathology itself without considering the impact of mechanical load, 
which is one of the major risk factors implicated in the loss of cartilage integrity and the 
onset of OA development. Previous studies have already identified a number of 
mechanically-regulated miRs, therefore I hypothesised that (i) physiological and non-
physiological magnitudes of compressive load differentially regulate the expression of 
mechano-sensitive miRs, and (ii) mechanically-regulated miRs differentially expressed in 
response to a non-physiological magnitude of load are implicated in the regulation of 
mechano-sensitive matrix molecule turnover and are involved in OA development.  
Results: Transcriptional assessment of selected mechanically-regulated matrix 
molecules demonstrated that loading regimes of 2.5MPa and 7MPa (1Hz, 15 minutes) 
induced homeostatic and catabolic responses at the gene level respectively, therefore 
they were selected to represent ‘physiological’ and ‘non-physiological’ magnitudes of 
loads which have the potential to induce biosynthetic and degradative protein responses 
if applied for prolonged periods of time. Next generation sequencing (NGS) of articular 
cartilage miRs libraries demonstrated that the alteration in expression of specific miRs 
occurs in a magnitude- and time-dependent manner. However, 24h post-load, according 
to the NGS data, seems to be the most appropriate to observe significant changes in miRs 
levels. Validation of a few miRs, important for cartilage integrity, at 24h post-load 
indicated up-regulation of miR-21-5p, miR-27a-5p, miR-221 and miR-222 and  
down-regulation of miR-483 in response to the ‘non-physiological’ 7MPa magnitude 
(1Hz, 15 minutes) whereas in explants subjected to a ‘physiological’ 2.5MPa magnitude 
(1Hz, 15 minutes) the level of these miRs remained unchanged. Identification of target 
genes of miR-21-5p, miR-221 and miR-222 performed by NGS of RNA extracted from 
primary articular chondrocytes transfected with specific miR inhibitors demonstrated  
a number of differentially expressed genes. qPCR validation of these potential miR target 
genes on RNA collected from cells transfected with functional miR-21-5p, miR-221 and 
miR-222 inhibitors or mimics identified TIMP-3 as a direct target of miR-21-5p, miR-221 
and miR-222, whereas CPEB was targeted by miR-21-5p. 
Conclusion: This current study confirms the reported mechano-regulation of miR-221 
and miR-222, and furthermore demonstrates the novel mechano-regulation of  
miR-21-5p, miR-27a-5p and miR-483 in cartilage explants. This work is the first to identify 
TIMP-3 as a target of miR-21-5p and miR-221/-222, and CPEB3 as a direct target of  
miR-21-5p in primary chondrocytes. An association between the identified differentially-
regulated miRs in response to a non-physiological magnitude of load, with those that are 
expressed in OA cartilage and their regulatory effect on molecules important for cartilage 
integrity, described in this thesis may pioneer future studies aimed at identifying 
cartilage biomarkers of load-induced OA and provide therapeutic potential for OA 
treatment. 
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1.1. Articular cartilage 
Healthy joints undergo normal, pain free movement because the ends of long bones are 
covered by articular cartilage; due to its composition and structure, articular cartilage is 
viscoelastic and dissipates mechanical forces enabling painless, low-friction movement 
of synovial joints (Buckwalter et al., 2005).   
1.1.2. Structure of articular cartilage 
Articular cartilage is an avascular and aneural thin tissue (Buckwalter et al., 2005), in 
which the organisation and structure of the cells (chondrocytes) and extracellular matrix 
(ECM) confers its functional properties. The thickness of cartilage between different 
species differ; it has been reported that the average thickness of human knee cartilage 
is 2.2 - 2.5mm, whereas the animal equivalents range from 0.3mm for rabbit,  
0.4 - 0.5mm for sheep, 0.6 - 1.3mm for dog, 0.7 - 1.5mm for goat and 1.5 - 2mm for 
horse (Frisbie et al., 2006). The mature articular cartilage is divided into four zones: 
superficial, middle, deep and calcified cartilage (Figure 1.1) (Pearle et al., 2005, Bhosale 
and Richardson, 2008). 
1.1.2.1. Superficial zone 
The lamina splendens was first observed by MacConaill et al. using phase contrast 
microscopy (MacConaill, 1951), and its existence confirmed using transmission electron 
microscopy (TEM) (Ghadially, 1983) and scanning electron microscopy (SEM) (Clark, 
1985). Lamina splendens - the outermost layer of the superficial zone is acellular 
(Teshima et al., 1995) and collagen types I, II and III in this layer are arranged in fine 
fibrils which are often observed in bundles (Fujioka et al., 2013); this differs to their 
organisation in the deep zone where the fibrils are thicker and rarely aggregated into 
bundles (Duance, 1983). The other important difference is the presence of a high 
concentration of type I collagen in the lamina splendens, which is absent in the deeper 
zone of mature mammalian cartilage (Duance, 1983). The lamina splendens also 
comprises lubricin (alternatively known as Superficial Zone Protein (SZP) or proteoglycan 
4 (PRG4)) which is synthesised by the superficial zone chondrocytes and secreted to the 
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surface (Klein et al., 2003). Lubricin, together with hyaluronan serve a primary function 
in joint boundary lubrication (Jones et al., 2007). It provides low friction by repelling one 
cartilage surface from another based on strong repulsive charges (Waller et al., 2013, 
Jay and Waller, 2014). 
The superficial zone is the thinnest zone of articular cartilage and is made from fine, 
tightly packed, collagen fibrils oriented parallel to the surface (mainly types II and IX 
collagen) (Pearle et al., 2005, Wardale and Duance, 1993). It consists of a layer of 
flattened chondrocytes oriented parallel to the surface (Buckwalter et al., 2005). This 
zone is characterised by a high concentration of water and collagen fibrils and a low 
concentration of proteoglycans with respect to the deeper zone (Buckwalter et al., 
2005). The collagen orientation resists tensile/shear forces imposed on cartilage by 
everyday joint movement (Bhosale and Richardson, 2008). Apart from the mechanical 
properties of packed collagen fibrils, they also act as a filter for molecules and control 
the movement of macromolecules in and out of cartilage (Buckwalter et al., 2005). 
1.1.2.2. Mid zone 
The mid zone  is several times thicker than the superficial zone and represents 40 – 60% 
of the total cartilage volume in humans (Buckwalter et al., 2005). The spheroidal shaped, 
randomly organised chondrocytes have more synthetic organelles (Golgi membranes 
and endoplasmic reticulum) than cells in the zone above, therefore in comparison to the 
superficial zone, the ECM contains more proteoglycan and thicker collagen fibrils 
(Buckwalter et al., 2005); these collagen fibrils are arranged into arcade-like structures 
and are referred to as Benninghoff arcades (Benninghoff, 1925, Eyre, 2002). The matrix 
composition of the mid zone provides cartilage with the first line of resistance against 
compressive load (Buckwalter et al., 2005).  
1.1.2.3. Deep zone 
The spherical chondrocytes are arranged in columns parallel to the collagen fibrils and 
perpendicular to the joint surface (Buckwalter et al., 2005); these deep zone cells 
synthesise the highest concentration of collagen and proteoglycans compared to cells in 
the other zones. The deep zone contains the largest diameter collagen fibrils, the highest 
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concentration of proteoglycans and the lowest content of water (Buckwalter et al., 
2005). Due to the perpendicular arrangement of collagen fibrils to the joint surface and 
the swelling pressure derived from the high proteoglycan content, the deep zone 
provides the greatest resistance to compressive forces (Roughley, 2006). 
1.1.2.4. Calcified zone 
In mature animals the tidemark is a visible border between the uncalcified and calcified 
cartilage that is characterised by a low cell density, a calcified matrix and a very low 
metabolic activity (Buckwalter et al., 2005). Most of the cells in this zone have  
a hypertrophic phenotype and synthesise type X collagen (Poole et al., 2001). The 
calcified zone, intermediate in stiffness between the uncalcified cartilage and 
subchondral bone, reduces high stress forces at the cartilage/bone interface. The 
calcified zone plays an integral role in the attachment of the articular cartilage to the 
subchondral bone by fastening the collagen fibrils present in the deep zone to the 
underlying subchondral bone. 
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Figure 1.1. Cross-sectional diagram of mature articular cartilage. Organisation of zones 
(A), collagen framework (B) and chondrocytes (C) in articular cartilage. Adapted from 
(Browne and Branch, 2000). 
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1.1.3. Composition of articular cartilage 
Articular cartilage is composed of a specialised extracellular matrix (ECM) of collagens 
(mainly collagen type II), proteoglycans and non-collagenous proteins (Figure 1.2) 
(Goldring and Marcu, 2009). Chondrocytes form approximately 1% of the total volume 
of human articular cartilage, and are responsible for synthesising and maintaining the 
matrix infrastructure (Buckwalter et al., 2005). The cartilage ECM is responsible for the 
tensile strength and compressive resistance of the tissue to mechanical load (Goldring 
and Marcu, 2012) and it consists of two components: tissue fluid and macromolecules 
that form a framework that gives the tissue its form and structure (Buckwalter et al., 
2005).  
1.1.3.1. Tissue fluid 
The fluid phase is the most abundant component of articular cartilage and is composed 
of water and dissolved gases, metabolites and inorganic ions such as sodium, calcium 
and potassium, to balance the negatively charged proteoglycans. The water phase 
contributes up to 80% of the wet weight of articular cartilage and its volume can change 
depending on the cartilage zone, age and pathological stage of osteoarthritis (Bhosale 
and Richardson, 2008). The volume, concentration and movement of water in articular 
cartilage depend on interactions with structural macromolecules, mainly with 
hyaluronan/proteoglycans. Due to the negative charge of glycosaminoglycans they 
control the fluid’s behaviour and electrolyte concentration (Buckwalter et al., 2005).  
The solid phase of cartilage tissue has a low permeability which causes a pressurisation 
of water in the tissue and plays a large role in load transmission in cartilage (Buckwalter 
et al., 2005). Both the low permeability of the solid phase and the high pressure of the 
fluid phase contribute to the stiffness and viscoelastic properties of articular cartilage 
and allows it to withstand a high load, i.e. many times that of body weight (Buckwalter 
et al., 2005).  
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Figure 1.2. Schematic diagram depicting the organization of ECM molecules in articular 
cartilage. Due to the distance from the cells, the matrix can be divided into three zones: 
pericellular: which is the closest zone to the chondrocyte where ECM components 
interact with cell surface/cell receptors (A), territorial matrix: which is the second zone 
in order from the cell (B) and the inter-territorial zone: which lies furthest in distance 
from the cell (C). Key: CD44 - CD44 molecule, CILP‑1 - cartilage intermediate layer 
protein 1, COMP - cartilage oligomeric matrix protein, CS - chondroitin sulphate, KS - 
keratan sulphate; PRELP - proline‑arginine‑rich end leucine‑rich repeat protein. Adapted 
from (Heinegård and Saxne, 2011). 
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1.1.3.2. Structural macromolecules 
The solid component of articular cartilage is mainly composed of collagen type II fibrils 
and aggregating proteoglycans (Pearle et al., 2005). Other components of cartilage such 
as lipids, phospholipids, non-collagenous proteins and other types of collagen are also 
present, but in a minor proportion (Pearle et al., 2005, Buckwalter et al., 2005). 
1.1.3.3. Collagens   
All collagen molecules contain three parallel polypeptide strands coiled around each 
other forming a triple helix (Ramshaw et al., 1998). Each polypeptide chain consists of 
repeating peptide triplets of Glycine-X-Y. Although X and Y can be any amino acid proline (Pro) 
and hydroxyproline (Hyp) are dominant in these positions (Ramshaw et al., 1998, Shoulders 
and Raines, 2009) The Gly-Pro-Hyp triplet contributes to the maximal stability of the collagen 
triple-helix (Ramshaw et al., 1998, Shoulders and Raines, 2009). 
Collagen type II which constitutes 90-95 % of the collagen in the cartilage ECM forms the 
principal framework with proteoglycans; other types of collagen such as collagen VI, IX, 
X and XI (Buckwalter et al., 2005) and collagen types I and III identified in the superficial 
zone (Eyre, 2002, Fujioka et al., 2013, Wardale and Duance, 1993) are also present in 
articular cartilage. The type II collagen molecule lines up end to end and side to side to 
create microfibrils which are covalently cross-linked to each other to form collagen 
fibrils in association with collagens IX and XI (Figure 1.3) providing strength and stability 
to the articular cartilage (Eyre, 2002, Buckwalter et al., 2005). 
Collagen type VI creates important aggregates in the ECM surrounding the chondrocytes 
termed the pericellular matrix (PCM); this helps the cells to attach to the ECM 
(Buckwalter et al., 2005, Gordon and Hahn, 2010, Poole et al., 1988).  
Type X collagen is produced only by hypertrophic chondrocytes in the calcified zone of 
cartilage (Reichenberger et al., 1991); it is localised within the pericellular environment 
suggesting that it acts as a structural support for hypertrophic chondrocytes and plays  
a role in cartilage mineralisation and endochondral ossification (Gelse et al., 2003, 
Reichenberger et al., 1991).        
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Collagen type IX is cross-linked to the surface of collagen type II fibrils and has an ability 
to create bridges between adjacent collagen fibrils which increases network mechanical 
integrity (Eyre, 2002). Type XI collagen nucleates collagen type II fibrils promoting 
stabilisation of the fibrillar type II collagen network (Buckwalter et al., 2005). 
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Figure 1.3. Potential interactions between collagens type II, IX and XI in a cartilage 
collagen fibril. Collagen IX is covalently linked to the surface of thin cartilage collagen 
fibrils which are constructed from two collagen II microfibrils and two collagen XI 
microfibrils at the core of the fibril, sorrounded by ten microfibrils comprising five 
collagen type II molecules (Holmes and Kadler, 2006, Kadler et al., 2008). Adapted from 
(Kadler et al., 2008).  
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1.1.3.4. Proteoglycans 
Heavily glycosylated proteins that occur in the cartilage ECM belong to the proteoglycan 
family and comprise 10 - 20% wet weight of cartilage (Buckwalter et al., 2005).  
The proteoglycans consist of a protein core to which at least one glycosaminoglycan 
(GAG) chain is covalently attached (Kiani et al., 2002). GAGs protrude from the protein 
core and remain separated from each other because of their negative charge which 
repel each other and other negatively charged molecules, but attract cations 
(Buckwalter et al., 2005). In articular cartilage, two major classes of proteoglycans have 
been found: small non-aggregating leucine rich proteoglycans (SLRPs): e.g. decorin, 
biglycan and fibromodulin, and large aggregating proteoglycan monomers, namely 
aggrecan (Buckwalter et al., 2005). 
1.1.3.4.1. Non-aggregating proteoglycans 
The small leucine-rich proteoglycans (SLRPs) are biologically active components of the 
ECM proteoglycans consisting of one or more GAG chains attached to a protein core that 
is made up of leucine-rich repeats (LRRs) bordered by cysteine-clusters (Douglas et al., 
2006, Iozzo, 1998, Heinegård, 2009). Members of SLRPs are classified based on the 
amount of LRRs and positioning of cysteine-clusters in the protein core, and the type of 
GAG covalently attached (Roughley, 2006). SLRPs that are present in articular cartilage 
can be divided into two distinct classes: class I – decorin and biglycan that possess one 
or two GAG chains, respectively, consisting either chondroitin or dermatan sulphate, 
and class II – fibromodulin that carries several GAG chains (keratan sulphate) (Hedbom 
and Heinegård, 1993).  
SLRPs regulate collagen network organisation by connection through their protein  
core/ GAG chains to collagen which contribute to cartilage integrity and function (Dellett 
et al., 2012). Decorin and biglycan interact with collagen type VI microfibrils through 
their core protein and facilitate interactions with other ECM components, for example 
with matrilin-1 (Heinegård, 2009) which provides further cross-linking to aggrecan or 
alternatively collagen type II fibrils (Wiberg et al., 2003). Recently, evidence of a strong 
interaction of biglycan with collagen type II fibrils was reported (Douglas et al., 2006, 
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Vynios et al., 2001); this suggests that biglycan, similar to decorin and fibromodulin, has 
the capacity to decorate collagen type II fibrils (Buckwalter et al., 2005, Hedbom and 
Heinegård, 1993) and may have a role in organising and stabilising the type II collagen 
framework (Figure 1.2). Moreover, studies have shown the ability of SLRPs to regulate 
some signalling pathways through binding to their ligands, receptors or members of the 
pathway (Dellett et al., 2012). Decorin, biglycan and fibromodulin bind transforming 
growth factor-β (TGF-β) sequestering its activity (Hildebrand et al., 1994), and therefore 
may influence the activity of the TGF-β signalling pathway which is important in the 
regulation of articular chondrocyte metabolism (Swingler et al., 2012). Decorin and 
biglycan are also associated with Wnt-1 induced secreted protein-1 (WISP-1) (Desnoyers 
et al., 2001), known to be up-regulated in OA cartilage, and a component of the 
canonical Wnt signalling pathway regulating both MMPs and aggrecanases expression 
(Blom et al., 2009). Decorin through its protein core is also able to bind and activate the 
insulin-like growth factor 1 (IGF-1) receptor (Schönherr et al., 2005), which is particularly 
important in cartilage homeostasis as IGF-1 is a vital anabolic stimulus activating 
proteoglycan synthesis in articular cartilage (Verschure et al., 1996). 
1.1.3.4.2. Aggrecan 
In articular cartilage, aggrecan is found in multi-molecular aggregates, comprised of 
numerous monomers bound to a hyaluronan molecule (HA) (Figure 1.4) and this 
structure is stabilised by link protein (Kiani et al., 2002). The aggrecan core protein 
consists of three globular domains: G1 and G2, at the N-terminus, and G3 at the  
C-terminus (Aspberg, 2012, Roughley, 2006). The G1 and G2 domains are separated by 
a short interglobular domain (IGD). The G2 and G3 domains are separated by a long 
GAG-attachment region, which is subdivided into a keratan sulphate (KS) domain and 
two chondroitin sulphate (CS) domains (CS1 and CS2) (Aspberg, 2012, Roughley, 2006). 
The aggrecan  monomers are non-covalently bound to HA via the G1 domain and the 
presence of link protein that stabilises this interaction (Figure 1.4) (Aspberg, 2012, 
Roughley, 2006). The very large multi-molecular aggregates of HA - aggrecan are 
trapped within the collagen framework of cartilage (Bhosale and Richardson, 2008). Due 
to their fixed negative charges that attract positive ions they have an ability to draw 
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water into the tissue causing the cartilage swelling pressure which is crucial to the 
biomechanical properties of cartilage, as it provides the tissue with the ability to resist 
compressive load (Huang and Wu, 2008). The biomechanical capability of articular tissue 
is described in more detail in Section 1.3. 
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Figure 1.4. Schematic diagram of multi-molecular aggregate of aggrecan bound to a 
hyaluronan molecule (A) and proteoglycan aggrecan monomer (B). G1, G2, G3 - globular 
domains, IGD - interglobular domain, KS - keratan sulphate domain, CS1, CS2 - 
chondroitin sulphate domains. Adapted from (Huang and Wu, 2008, Pearle et al., 2005). 
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1.1.3.5. Hyaluronan 
Hyaluronic acid (HA) is a non-sulphated glycosaminoglycan synthesised in the cellular 
membrane directly to the ECM (Roughley, 2006). It has a very high affinity to water 
binding therefore it plays a crucial role in water movement and homeostasis. In a water 
rich environment it creates a gel-like solution and together with the collagen type II – 
aggrecan network it provides tissue viscoelasticity which is very important in cartilage 
protection and functionality (Fraser et al., 1997). HA occurs freely or in association with 
matrix or cell surface proteins in the intercellular matrix. It is involved in creating 
aggrecan aggregates which are located between collagen fibrils and which attract water 
into cartilage via osmosis. Moreover, the proteoglycan-collagen type II network 
stabilises the intercellular matrix structure; due to the association with the major 
cellular HA receptor CD44 localised in the plasma membrane it anchors chondrocytes 
into the intercellular matrix  (Fraser et al., 1997, Laurent and Fraser, 1992).  
Intra-articular injection with medium (800kDa) and high (2000-3000kDa) molecular 
mass HA are used to treat osteoarthritis (OA) of the knee; recent studies have reported 
that HA, apart from symptom modifying effects such as relief of joint pain, also represses 
the expression of catabolic molecules in OA cartilage (Yatabe et al., 2009). Binding of 
HA2700 with CD44 in IL-1 stimulated human OA chondrocytes inhibited mRNA and 
protein levels of ADAMTS-4 (Yatabe et al., 2009), whereas HA800 binding to CD44 had  
a protective role via MMP-1, -3 and -13 inhibition in both healthy and IL-1 treated human 
OA chondrocytes (Julovi et al., 2004).  
1.1.3.6. Non-collagenous proteins and glycoproteins 
The ECM of cartilage contains numerous additional matrix glycoproteins. To that class 
of protein belong for example: link protein, cartilage oligomeric matrix protein (COMP), 
matrilins and structural proteins e.g. fibronectin (Roughley, 2001). It is thought that their 
main role is to help organise and maintain the macromolecular structure of the cartilage 
ECM (Buckwalter et al., 2005). 
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Link proteins are involved in creating aggrecan aggregates through conformational 
alterations in the G1 domain of the aggrecan monomer which allows binding to HA 
(Roughley, 2006).  
COMP, also called thrombospondin-5 (TSP-5), interacts with many ECM proteins e.g. 
collagen, matrilins, fibronectin and aggrecan, and one of its main functions is in ECM 
assembly (Acharya et al., 2014). COMP promotes collagen type II fibrillogenesis in 
cartilage as its five domains interact with five collagen type II molecules bringing them 
closer to each other to create a microfibril (Heinegård, 2009). The association of COMP 
with collagen type IX that is located on the collagen type II fibril surface suggests a role 
for COMP as a “bridging molecule” involved in fibril network stabilisation (Acharya et al., 
2014).  
The matrilins are also considered as one of the most important molecules affecting 
matrix assembly. Of the four members of the matrilin family, matrilin-1 and matrilin-3 
are the most abundant in cartilage; they are often referred to as “bridging molecules” 
as they connect indirectly other matrix molecules e.g. COMP and collagen type X (Klatt 
et al., 2011). Matrilin-1 is the only matrilin that has been reported to associate with 
aggrecan (Paulsson and Heinegård, 1979). In turn, matrilin-1, -3, and -4 were localised 
in a complex with decorin and biglycan bound to collagen type VI (Klatt et al., 2011); this 
complex could further bind to aggrecan or collagen type II fibrils either directly or via 
collagen type IX (Klatt et al., 2011).  
Specific mutations in the COMP gene lead to pseudochondroplasia (PSACH) and multiple 
epiphyseal dysplasia (MED), diseases which can also manifest due to mutations in 
marilin-3 or collagen type IX genes (Briggs et al., 2015). Both of these diseases are 
defined by limb dwarfism with normal skull size and are characterised by joint pain, 
stiffness and early OA development (Briggs et al., 2015). Interestingly, COMP mutations 
(d469del, D511Y and G427E) in PSACH chondrocytes showed impaired secretion of 
collagen type IX and matrilin-3, whereas the expression levels of collagen type II and 
aggrecan did not change (Hecht et al., 2005). They also reported destabilisation of 
intercellular matrix structure in PSACH cartilage indicating the importance of COMP, 
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matrilin-3 and collagen IX in maintaining cartilage structure and integrity (Hecht et al., 
2005).  
Fibronectin is a molecule responsible for cell adhesion to the intercellular matrix 
(Acharya et al., 2014). One end of a fibronectin molecule can interact with the cell 
surface directly or through receptors e.g. integrins, whereas the other end binds to 
matrix molecules such as COMP (Acharya et al., 2014), collagen and sulphated 
proteoglycans (Perkins et al., 1979, Martin and Buckwalter, 1998). The abundance of 
fibronectin in human OA cartilage is elevated approximately 10-fold in comparison to 
healthy tissue  (Brown and Jones, 1990). Although, the functional implication of 
fibronectin in OA degradation is unknown (Roughley, 2001), the fibronectin fragments 
are able to promote aggrecan degradation at the well-characterised aggrecanase 
cleavage sites (Homandberg et al., 1997). Therefore it is believed that fibronectin 
fragments present in arthritic cartilage induce expression of inflammatory cytokines, 
e.g. IL-1 that stimulates elevated production of aggrecanases (Homandberg et al., 1997, 
Roughley, 2006). 
1.1.4. Tissue homeostasis 
Chondrocytes are responsible for maintaining tissue homeostasis e.g. composition and 
organisation of the ECM. In healthy tissue they respond to their environment to 
maintain the balance between anabolic and catabolic activity, thereby regulating the 
synthesis and degradation processes of cartilage components (Goldring and Marcu, 
2009). They maintain healthy cartilage by controlling the optimal amount of ECM 
molecules, mainly collagen type II and aggrecan. Cartilage degradation is mediated by 
proteolytic enzymes, such as matrix metalloproteinases and aggrecanases: a disintegrin 
and metalloprotease with thrombospondin motifs (ADAMTS -4 and -5) that degrade the 
main components in cartilage, collagen and proteoglycans respectively (Barter et al., 
2012). 
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1.1.4.1. Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) belong to a family of zinc containing endopeptidases 
and are responsible for tissue turnover and ECM degradation, where substrates include 
collagen, gelatin, matrix glycoproteins and proteoglycans (Verma and Hansch, 2007). 
Most MMPs have a very low activity in normal, healthy tissue. Their expression and 
activity  is regulated by specific factors e.g. inflammatory cytokines, hormones, growth 
factors, mechanical load, cell-cell and cell-ECM interactions, but their activity is strictly 
controlled by tissue inhibitors of metalloproteinases (TIMPs) (Nagase et al., 2006, Verma 
and Hansch, 2007). Thus, the balance between MMPs and TIMPs is crucial to ECM 
homeostasis (Nagase et al., 2006). MMPs are synthesised as pro-enzymes and require 
activation by other proteolytic enzymes (Verma and Hansch, 2007). MMPs are 
composed of 5 homologous domains: 1. Signal peptide which is required for the 
secretion of MMPs into the ECM (Bonnans et al., 2014). 2. Pro-peptide domain to 
maintain the enzyme in an inactive form. This domain contains a cysteine residue which 
binds the Zn2+ site in the catalytic domain to keep the enzyme in a latent form 3. Catalytic 
domain that is required for proteolytic activity. The activation of MMP enzyme is 
conducted by disruption of the cysteine residue - Zn2+ association. This process is called 
a “cysteine switch” and it replaces cysteine with water in connection with Zn2+. 4. Hinge 
region which links the catalytic and hemopexin domain, 5. Hemopexin domain which is 
responsible for interactions with substrates and confers enzyme specificity (Murphy et 
al., 2002, Snoek-van Beurden and Von den Hoff, 2005) (Figure 1.5). Some MMPs have 
additional domains, such as transmembrane or cytoplasmic domains (Snoek-van 
Beurden and Von den Hoff, 2005). Based on the domain arrangement, substrate 
specificity and sequence similarity, MMPs have been divided into six subfamilies (Table 
1.1). 
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Figure 1.5. Schematic diagram of domain structure of MMPs. Key: SP - signal peptide, 
pro - pro-peptide domain, Cys – cysteine residue, Zn2+ - zinc ion, HExxH - Zn2+ binding 
motif, HR - hinge region. Adapted from (Gong et al., 2014). 
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Table 1.1. Members of the human matrix metalloproteinase family (Snoek-van Beurden 
and Von den Hoff, 2005). Key:  - MMPs involved in cartilage matrix degradation in OA 
(Troeberg and Nagase, 2012). 
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1.1.4.2. Aggrecanases 
The principal aggrecanases present in articular cartilage are aggrecanase-1 and 
aggrecanase-2 called ADAMTS-4 and ADAMTS-5, respectively (Caterson et al., 2000). 
Both of these are multi-domain metalloproteinases which consist of a signal sequence, 
pro-domain, catalytic domain, disintegrin-like domain, spacer domain, thrombospondin 
motifs (TSP) and sub-motifs which help to regulate enzyme activity and substrate 
specificity (Huang and Wu, 2008). ADAMTS-4 and ADAMTS-5 are the shortest members 
of the ADAMTS family because they have only one or two TSP motifs, respectively 
(Figure 1.6) (Nagase et al., 2006). They are synthesised as zymogens and before they are 
secreted into the ECM, furin cleaves the furin recognition sequence localised in the pro-
domains of ADAMTS-4 and -5 resulting in their activation (Verma and Hansch, 2007). 
The ancillary domains of both ADAMTSs have a crucial role in directing these enzymes 
to the cell surface, ECM and their substrates, whereas the cysteine rich domain and 
spacer domain are essential for these enzymes interaction with the GAGs on aggrecan 
(Verma and Hansch, 2007).  
ADAMTS-4 and ADAMTS-5 are involved in controlling aggrecan turnover in the cartilage 
ECM (Caterson et al., 2000, Caterson et al., 1999). The critical site of cleavage by 
ADAMTS-4 and -5 occurs within the aggrecan IGD domain, between G1 and G2 (Figure 
1.7); this releases the negatively charged GAG containing domain from the aggregate 
that is critical in maintaining the high osmotic pressure, hence hydration state of the 
tissue essential to resist compressive mechanical loads. The presence of GAGs (occurring 
after cleavage of the Glu373-Ala374 in IGD domain) in the synovial fluid of patients with 
OA indicates that this cleavage site mediates aggrecan degradation and can drive 
pathology in articular cartilage (Huang and Wu, 2008). However, the  
Glu373-Ala374 bond is not the only cleavage site of these enzymes (Huang and Wu, 2008). 
ADAMTS-4 and -5 also cleave aggrecan at four other sites that are located between the 
G2 and G3 domain (Figure 1.7) (Nagase and Kashiwagi, 2003, Huang and Wu, 2008, 
Caterson et al., 2000). 
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Figure 1.6. Schematic diagram of ADAMTS-4 (A) and ADAMTS-5 (B) structure. The 
protease domain is responsible for the enzyme’s transformation from a zymogen into 
its active form and hence it’s enzymatic activity. The ancillary domain affects the 
enzymatic specificity of these ADAMTSs (Verma and Hansch, 2007). Key:  
TSP - thrombospondin type I domain. Adapted from (Verma and Hansch, 2007). 
 
 
Figure 1.7. Aggrecanase cleavage sites for human (orange) and bovine (black) aggrecan 
core protein. Numbers above the boxes indicate the preferred order of enzymatic 
cleavage. Modified image from (Huang and Wu, 2008). 
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1.1.4.3. Tissue inhibitors of metalloproteinases 
The activity of metalloproteinases can be controlled and regulated by endogenous 
inhibitors (Lipka and Boratynski, 2008). Tissue inhibitor of metalloproteinases (TIMPs) is 
the main group of regulators and comprise four inhibitors including TIMP-1, TIMP-2, 
TIMP-3 and TIMP-4 (Snoek-van Beurden and Von den Hoff, 2005). TIMPs comprise 2 
subdomains: N-terminal and C-terminal. The N-terminal subdomain binds to the 
catalytic site of MMPs and inhibits their activity through removing water bound to the 
Zn2+ in the catalytic domain and displacing it with cysteine residues belonging to the  
N-terminal domain of TIMP (Brew and Nagase, 2010). TIMPs inhibit all MMPs tested to 
date, however the efficiency of inhibition varies with each TIMP. Interestingly, TIMP-3 is 
bound to GAGs and is considered to be a better inhibitor of aggrecanases (ADAMTS-4 
and -5) than MMPs (Visse and Nagase, 2003, Lipka and Boratynski, 2008).  
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1.2. Osteoarthritis  
In healthy cartilage, anabolic and catabolic activities of chondrocytes are balanced; 
however, there are several factors which can disturb this homeostasis and limit the 
ability of the cells to maintain tissue homeostasis, thereby contributing to the 
development and progression of articular cartilage degeneration e.g. osteoarthritis 
(OA). Several risk factors that contribute to the development of OA include ageing, 
abnormal mechanical stress, joint injury, obesity, inflammation and genetic 
predisposition. OA is characterised by progressive loss of articular cartilage and bone 
remodelling inducing osteophyte formation (Lorenz and Richter, 2006). The typical 
feature of OA is tissue degradation which results in a progressive loss of the structure 
and function of articular cartilage. The progressive loss of cartilage can be divided into 
three stages (Figure 1.8).  As a first step in OA, the surface loses its smoothness and  
some changes to the cartilage surface are noticeable, and aggrecan levels decrease 
(Lorenz and Richter, 2006).  There is a higher concentration of water in the ECM, tissue 
permeability increases resulting in a significantly lower hydrostatic pressure. Decreased 
hydrostatic pressure in the ECM causes a reduction in the compressive stiffness of the 
tissue (Pearle et al., 2005). The next stage, that can last several years, is the further loss 
of proteoglycans and the formation of chondrocyte clusters surrounded by newly 
synthesised matrix molecules which are produced to attempt to repair the damage. 
However, chondrocytes are not able to adequately renew the tissue, therefore the third 
and last stage of OA is the complete loss of cartilage tissue (Lorenz and Richter, 2006).  
 
 
       
 
 
 
 
25 
 
 
 
 
 
 
Figure 1.8. Representative toluidine blue stained sections of healthy and OA cartilage 
regions from the femoral condyle of human OA knee joint. Healthy area with smooth 
articular cartilage surface (a). Section from an early stage of OA (fibrillated area) showing 
dense staining for proteoglycans in the mid zone, where chondrocytes remain active (b). 
Section from the late stage of OA showing a degraded articular cartilage surface, loss of 
proteoglycan staining and chondrocyte clusters (c) (Venkatesan et al., 2012). 
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1.2.1. OA cartilage turnover 
OA results from an imbalance of anabolic and catabolic activities with increased 
expression and activation of proteolytic enzymes such as the MMPs and ADAMTSs that 
degrade the main components in cartilage: collagen and proteoglycans respectively 
(Goldring and Marcu 2009a). Collagenase-1, -2, -3 (MMP-1, -8, -13), stromelysin-1 
(MMP-3) and membrane type I (MT1) MMP (MMP-14) are all involved in collagen 
degradation in OA (Goldring and Marcu, 2009). MMP-3 activates pro-collagenases (pro-
MMP- 1, -13) and pro-gelatinases (pro-MMP-9, -2) (Ramos-DeSimone et al., 1999, 
Johnson et al., 2011); MMP-14 synthesised by chondrocytes activates pro-MMP-13 
which in turn activates pro-MMP-9 (Goldring and Marcu, 2009). Some MMPs such as 
MMP-3, -7, -8 and -14 have an ability to degrade proteoglycans, but ADAMTS-4 and-5 
are thought to be the principal aggrecan degrading enzymes (Goldring and Marcu, 
2009). Some studies have shown that abnormal mechanical load, inflammatory 
cytokines, genetic and epigenetic alterations (e.g. microRNAs (miRs)) can increase 
expression and activity of catabolic enzymes, affecting chondrocyte viability and ECM 
breakdown (Barter et al., 2012, Blain et al., 2001, Goldring and Marcu, 2012, Thomas et 
al., 2011). All MMPs, but also ADAMTS-4 and -5, that are involved in cartilage 
turnover/degradation are regulated by the specific endogenous protein inhibitors TIMPs 
in a 1:1 stoichiometry (Visse and Nagase, 2003), therefore disruption of this balance may 
lead to OA development. TIMP-1, -2, -3 and -4 inhibit the activity of all MMPs, but with 
different affinities for different MMPs (Murphy, 2011); TIMP-1 interacts the most 
effectively with MMP-1, -3, -7 and -9, whereas TIMP-2 presents a preference for 
inhibition of MMP-2, however TIMP-2 can also act as an activator of pro-MMP-2 (Brew 
and Nagase, 2010, Murphy, 2011, Bourboulia and Stetler-Stevenson, 2010). TIMP-3, 
apart from its preference to inhibit MMP-2 and -9, also represses ADAMTS-4 and -5 
(Brew and Nagase, 2010, Murphy, 2011, Bourboulia and Stetler-Stevenson, 2010).  
In turn, TIMP-4 preferentially inhibits MMP-14 (Brew and Nagase, 2010, Murphy, 2011, 
Bourboulia and Stetler-Stevenson, 2010). TIMP-1 and TIMP-4 are also capable of binding 
to pro-MMP-9 and pro-MMP-2 respectively and prevent their activation, whereas  
TIMP-3 plays an inhibitor role by association with both of these inactive forms of MMPs 
(Bourboulia and Stetler-Stevenson, 2010). 
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1.3. Mechanical load 
Mechanical load is one of the most important factors that affects cartilage structure and 
function through chondrocyte stimulation  (Buckwalter et al., 2005). At the joint level 
articular cartilage is mostly exposed to compressive load; however, there are also other 
mechanical stimuli such as tension and shear that occur in cartilage as a result of 
everyday movement which affects the cellular response and induces deformation, fluid 
flow, hydrostatic pressure, osmotic pressure, ion concentration changes and pH 
alteration in tissue (Figure 1.9) (Lee et al., 2005a).  
Cartilage has unique viscoelastic properties that enable its deformation when the joint 
is exposed to mechanical load and reduces the magnitude of compression applied to the 
bone (Buckwalter et al., 2005). The biomechanical properties of the cartilage is 
facilitated by one of the most abundant components of the ECM which are the 
proteoglycans (Buschmann et al., 1995). According to the principle of the Donnan effect, 
negatively charged GAGs, to maintain cartilage electro-neutrality, attract positively 
charged ions (mainly Ca2+ and Na+) (Prydz, 2015). This process results in electro-
neutrality but also in a large difference in the ionic concentration between the cartilage 
matrix and surrounding tissues. The increased cation concentration in the cartilage ECM 
creates an internal osmotic pressure in the tissue, also referred to as the Donnan 
osmotic pressure (Wilson et al., 2005). The higher concentration of ions within the 
cartilage ECM compared to the outside of the tissue is followed by water influx, ECM 
swelling and expansion resisted by the collagen fibril network, therefore collagen is 
subjected to a “pre-stress” even if the external load is not applied (Lai et al., 1991). When 
the cartilage is exposed to mechanical compression, the water is expelled from the 
cartilage increasing the osmotic pressure and limiting the degree of compression; but 
when the load is removed, water molecules are re-imbibed into the tissue and restore 
the structure of cartilage to what it was before the load (Buckwalter et al., 2005, 
Buschmann et al., 1995). Moderate mechanical load is essential to maintain cartilage 
homeostasis as it induces chondrocytes to balance the synthesis of molecules that are 
involved in anabolic/catabolic cell processes. Abnormal joint loading which is 
characterised by either over-load or insufficient load has been reported to disrupt the 
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homeostatic production of molecules by chondrocytes and cause cartilage degeneration 
which contributes to OA development.  
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Figure 1.9. Illustration of different types of load to which articular cartilage in the joint 
is exposed to and the accompanying physical and biochemical alterations in response to 
everyday movement. Adapted from (Al-Sabah, 2014, PhD thesis). 
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Many studies have been performed to investigate the effect of mechanical forces on 
articular cartilage homeostasis. In vitro studies have been conducted to observe the 
chondrocyte’s response to biomechanical signals without any interaction with other 
surrounding joint tissues e.g. bone, synovium. For this kind of experiment, either a cell 
culture system (monolayer or 3D) or articular cartilage explants have been utilised. Also, 
in vivo studies have been performed to determine the effect of load on the whole joint. 
In vitro studies have demonstrated that chondrocytes are mechano-responsive to 
compressive, shear and tensile loads (Das et al., 2008, Huang et al., 2007, Urban, 1994, 
Ramage et al., 2009, Blain, 2007, Thomas et al., 2011). In vivo studies have shown that 
moderate mechanical loading like walking and jogging is necessary to maintain healthy 
cartilage, while over- or insufficiently loaded articular cartilage can activate catabolic 
enzymes and promote cartilage degradation (Bader et al., 2011).  
Chondrocyte activity is stimulated by mechanical and biochemical signals that can 
induce a wide range of metabolic responses in articular cartilage (Buckwalter et al., 
2005, Griffin and Guilak, 2005). Depending on the type of loading, mechanical load may 
have both degenerative and biosynthetic roles in cartilage metabolism and homeostasis. 
Normal mechanical load, such as walking and moderate exercise stimulates 
chondrocytes to produce collagen and aggrecan enabling the maintenance of normal 
cartilage integrity. Abnormal, non-physiological loading, such as insufficient or over load 
may lead to loss of proteoglycans, destruction of the collagen network and inhibition of 
matrix protein synthesis which can drive the development of OA. Different joints and 
different types of physical activities are associated with different mechanical forces 
(Ramage et al., 2009). Articular cartilage is mainly loaded in compression; however, 
chondrocytes also perceive hydrostatic pressure generated by shear and tensile strain 
(Blain, 2007, Lee et al., 2005c). Changes in amplitude, frequency and duration of loading 
have significant effects on cell activity and ECM synthesis, and also affects the 
production of molecules leading to cartilage breakdown (Urban, 1994). 
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1.3.1. In vivo studies 
Abnormal joint loading such as immobilisation has been reported to affect collagen-
proteoglycan network components of articular cartilage decreasing its biomechanical 
properties and increasing the risk of pathology. 
Early in vivo sheep studies performed by Caterson et al. reported the necessity of mechanical 
load to maintain cartilage homeostasis (Caterson and Lowther, 1978). A 4-week 
immobilisation period of one of the sheep forelegs resulted in a decrease in cartilage 
proteoglycan molecular weight in the non-weight bearing ankle joint; in contrast, the articular 
cartilage of the loaded joint in the contralateral leg presented a significant increase in 
proteoglycan molecular weight (Caterson and Lowther, 1978). 
Palmoski et al. further confirmed the importance of mechanical load on cartilage homeostasis 
(Palmoski et al., 1979, Palmoski and Brandt, 1981). Immobilisation of adult canine joints 
by casting the limb led to decreased proteoglycan synthesis in cartilage as soon as 6 days 
after immobilisation, whereas after 3 weeks alterations in proteoglycan aggregation 
were observed (aggregates of proteoglycans were smaller); 2 weeks of reloading of 
these joints immobilised for 6 weeks restored proteoglycan aggregates to their normal 
size (Palmoski et al., 1979). Furthermore, it was found that knee joint cartilage unloaded 
for 6 weeks was characterised by increased water content and reduced tissue thickness 
(Palmoski and Brandt, 1981).  
In turn, a study performed on young dogs where the hind limb was immobilised for  
11 weeks demonstrated no effect on proteoglycan synthesis but a decreased 
concentration of GAGs in the uncalcified (mainly superficial) zones of knee articular 
cartilage (Kiviranta et al., 1987, Haapala et al., 1999, Jortikka et al., 1997). Interestingly, 
the cartilage of the contralateral leg presented a 25-35% increase in GAG concentration 
(Kiviranta et al., 1987). The collagen fibril network did not show a significant alteration 
in response to joint immobilisation, however there was a reduction of collagen cross-
links resulting in decreased stiffness of cartilage (Haapala et al., 1999).  
In the human hip joint, light and moderate activities such as walking have been 
estimated to apply pressures in the range of 0.1 - 4MPa (Ramage et al., 2009, Urban, 
1994). Under more strenuous activities such as jumping the peak stress of load may 
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reach 20MPa, whereas the contact pressure of body weight during standing i.e. static 
compression has been measured as 1MPa (Ramage et al., 2009, Urban, 1994).  
In vivo studies conducted on hamsters and rodents have shown that moderate load 
bearing exercise maintains cartilage homeostasis (Bader et al., 2011). In the study of 
Otterness et al., housed hamsters that had undergone 3 months daily wheel running 
exercise (6-12 km per day) had smooth, healthy cartilage, whereas the cartilage of 
hamsters that had 3 months of sedentary activity was fibrillated. This study also 
demonstrated a lower content and synthesis of proteoglycans in the group of inactive 
hamsters (Otterness et al., 1998).  
Histological assessment of the knee joints of Wistar rats which ran excessively i.e. 30 km 
in the wheel within six weeks, demonstrated a moderate severity of OA; transcriptional 
analysis showed increased expression of MMP-3 compared to non-exercising animals 
(Pap et al., 1998).  
1.3.2. In vitro studies 
In vitro studies on the effect of mechanical forces on chondrocytes have been conducted 
either on chondrocyte cultures (monolayer or 3D) or cartilage tissue explants, and both 
have demonstrated the influence of loading regimes on the synthesis of ECM 
components (Fitzgerald et al., 2008). Static compression inhibits synthesis of 
proteoglycans and proteins whereas dynamic compression (depending on frequency, 
amplitude and loading time) can be either degenerative or biosynthetic (Urban, 1994, 
Grodzinsky et al., 2000).  
1.3.2.1. Effect of static compression on ECM homeostasis 
Static compression is characterised by fluid loss and compaction of the solid matrix (Kim 
et al., 1994), and its degenerative activity is magnitude-dependent (Sah et al., 1989). 
Water efflux and compressed negatively charged components of the ECM attract in 
positively charged ions (including H+, Na+, K+) causing a reduction in pH (Kim et al., 1994). 
It is thought that these physicochemical changes inhibit proteoglycan synthesis (Sah et 
al., 1989). 
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1.3.2.2. Effect of dynamic compression on ECM homeostasis 
It has been shown that dynamic compression can stimulate matrix synthesis, however, 
different amplitudes, frequency and time of load may have a significant impact on the 
chondrocytes’ response (Sah et al., 1989).  
1.3.2.3. Effect of loading frequency on ECM homeostasis in articular cartilage 
explants 
The frequency of compressive loading indicates how often the tissue is subjected to 
deformation within 1 second. Several studies have investigated how high (0.1-1Hz) and 
low (<0.001Hz) loading frequencies, in which deformation phenomena and fluid flow 
behave differently, affect ECM homeostasis (Sah et al., 1989, Kim et al., 1994). Both 
groups showed that low amplitude strain at the range 0.63 – 10.4% and high frequency 
resulted in proteoglycan synthesis, whereas at low frequency there was either  
a reduction in proteoglycan production or no biosynthetic response (Sah et al., 1989, 
Kim et al., 1994). The explanation of these results may be that fluid flow has a significant 
impact on the chondrocyte’s response due to alterations in the matrix environment i.e. 
pH (Wong et al., 1999). At low frequency, the deformation period is longer than at high 
frequency and there is a consistent fluid flow between cycles, whereas at the minimum 
period of deformation at high frequency there is very little fluid flow (Sah et al., 1989, 
Kim et al., 1994). Wong et al. also showed that compressive load at a rate ≥0.1Hz 
increased protein synthesis, mainly COMP and fibronectin (Wong et al., 1999).  
1.3.2.4. Effect of loading amplitude on ECM homeostasis in articular cartilage 
explants 
One of the key regulators of cartilage biosynthetic activity is the magnitude of load. 
Normal load (0.1 - 5MPa) applied to cartilage explants increased proteoglycan and 
protein synthesis (Arokoski et al., 2000). Patwari et al. showed that injurious cyclic 
compression (≥50% strain, ~23MPa) activated a catabolic response in chondrocytes as 
characterised by up-regulation of MMP-3 and loss of proteoglycans (Patwari et al., 
2003). 
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1.3.2.5. Effect of the duration of loading on ECM homeostasis in articular cartilage 
explants 
The duration of loading, similar to the magnitude and frequency, has an impact on 
chondrocyte biosynthesis (Arokoski et al., 2000). Parkkinen et al. showed that 1.5h of 
load (5MPa, 0.5Hz) induced proteoglycan synthesis (Parkkinen et al., 1993). Király et al. 
demonstrated that 1 - 20h of load (0.5Hz, 4.1MPa) activated a different response in 
chondrocytes and the ECM depending on the duration of applied load. Both a 1 and 20h 
loading period altered the collagen structure with thickening of the superficial zone up 
to 41.4% after 20h (Kiraly et al., 1998). The thickness of the mid zone was increased by 
22% at 1h and 43.4% after 20h of loading, however there was a reduction in thickness 
in the deep zone (Kiraly et al., 1998). Proteoglycan synthesis was increased up to 8.8% 
after 4h of load, whereas 8h of load decreased chondrocyte biosynthetic activity and 
20h totally inhibited proteoglycan synthesis (Kiraly et al., 1998). 
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1.4. Mechano-transduction 
The main function of articular cartilage is to dissipate mechanical loads, therefore to 
maintain ECM homeostasis and cartilage integrity, chondrocytes react to alterations 
within the ECM brought about by mechanical loads (Ramage et al., 2009). The process 
by which cells control their activity and behaviour in response to biomechanical signals 
is referred to as mechano-transduction or mechano-chemical signalling (Figure 1.10). 
 
 
                    
 
Figure 1.10. Diagram of response of articular cartilage to mechanical loading (Adapted 
from Bader et al. 2011). 
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1.4.1. Chondrocyte mechano-sensors/receptors 
The mechano-signalling process is initiated by stimulation of mechano-receptors such 
as ion channels or integrin receptors located on the cell membrane, induced by 
biochemical changes occurring in response to ECM deformation generated by 
mechanical stimuli (Leong et al., 2011, Ramage et al., 2009).  
Primary cilia: Primary cilia, a microtubule-based structure extending from the cell 
surface and protruding into the ECM, is a key mechanical sensor involved in mechano-
chemical signalling in cartilage (Irianto et al., 2014, Salter and Lee, 2010b). The location 
of the chondrocyte primary cilium is ideal to sense mechanical stimuli deformation, as 
the primary cilia is structurally associated with collagen fibrils and can mechanically 
bend  in response to ECM deformity (Wann et al., 2012). Moreover, the primary cilium 
contains several mechano-receptors present at the cell membrane e.g. integrins and ion 
channels allowing them to transduce mechanical signals from the ECM and induce 
biochemical and cellular responses (Salter and Lee, 2010b). It was reported that the 
primary cilia is involved in increased synthesis of proteoglycans through Ca2+ dependent 
signalling pathways mediated by ATP release in 3D chondrocytes/agarose constructs 
subjected to a cyclic compressive load (15% compression, 1Hz, 24h)  (Wann et al., 2012). 
A previous study also reported that mechanical load reversibly affects the length of the 
primary cilium showing decreased length in chondrocytes embedded into 3D agarose 
constructs subjected to a long term compressive load (0-15% compression, 1Hz, 48h); 
whereas shorter periods of the same loading regimes (0.5, 6 and 24h) did not affect the 
length of the primary cilia (McGlashan et al., 2010). 
Ion channels: Mechanical stimulation induces changes in ion flux across the stretch 
activated ion channels (SACs) localised on the plasma membrane which are directly 
activated by mechanical stress causing membrane tension and lipid bilayer distortion 
(Ramage et al., 2009). One of the first signalling responses to mechanical load is 
activation of Ca2+ channels which allow the influx of Ca2+ into the chondrocyte and leads 
to initiation of intracellular Ca2+ dependent signalling pathways (Guilak et al., 1999, 
Wann et al., 2012).  
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Integrins: Another major chondrocyte mechanoreceptor is the α5β1 integrin (Salter et 
al., 1992, Wright et al., 1997). Integrins are a family of heterodimeric transmembrane 
receptors consisting of α and β subunits that determine the ligand specificity of the 
receptor (Ramage et al., 2009). Chondrocytes express several members of the integrin 
family including α1β1, α10β1, αvβ5 in addition to α5β1 (Loeser, 2002).  
The transmembrane location of integrins allows transduction of mechanical signals from 
the ECM converting them into biochemical responses within the cells (Salter and Lee 
2010). While the extracellular domain is exposed to bind ligands such as collagen or 
fibronectin, the intracellular tail interacts with cytoplasmic molecules to transduce the 
external signal into a cellular response (Ramage et al., 2009). Integrins when bound to  
a ligand in the ECM form a focal adhesion complex at the cell surface to transmit the 
mechanical signal intracellularly. Focal adhesion kinase (FAK) is an intracellular tyrosine 
kinase that has been reported to play an important role in integrin-mediated signal 
transduction (Guan, 1997). An inactive FAK molecule binds to a β1 integrin subunit 
resulting in FAK auto-phosphorylation, creating binding sites for the Src family proteins 
which further amplify FAK phosphorylation at specific tyrosine residues to maximise its 
activity (Guan, 1997). The FAK-Src complex activates, via phosphorylation, other signal 
transduction adaptor proteins e.g. paxillin which can modulate the architecture of the 
actin cytoskeleton via a connection with vinculin (Guan, 1997, Ramage et al., 2009) 
binding directly to actin filaments (F-actin) (Golji and Mofrad, 2013).  
1.4.2. Intracellular signalling cascades activated by mechanical forces  
Biomechanical stimulation of the chondrocyte mechano-receptors also induces 
activation of downstream signalling cascades which regulate gene expression and cell 
function (Salter and Lee, 2010b). 
1.4.2.1. Hedgehog (Hh) signalling pathway 
Hh signalling pathway is implicated in chondrogenesis, chondrocyte proliferation and 
differentiation in growth plates during development (Mariani et al., 2014). Recent 
studies reported that the Hedgehog (Hh) signalling pathway is initiated in primary cilia 
(Muhammad et al., 2012). Mammals have three homologues of Hh: Desert (DHh), Indian 
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(IHh), and Sonic (SHh) genes which are necessary to activate this pathway (Pathi et al., 
2001). In the absence of Hh ligands, transmembrane protein Patched 1 (Ptch1) inhibits 
the movement of a signal transducer Smoothened (Smo) to the primary cilium which 
prevents activation of the signalling pathway (Evangelista et al., 2006, Rohatgi et al., 
2007). In the presence of Hh protein which associates with the Ptch1 receptor, the 
inhibitory effect on Smo is relieved, therefore Smo enters the primary cilium where it 
relocalises to the cell membrane and is activated by phosphorylation (Humke et al., 
2010). The Smo protein indirectly activates Gli transcription factors which are 
translocated into the nucleus to induce expression of Hh signalling target genes e.g. 
Ptch1, Gli1 (Humke et al., 2010, Rohatgi et al., 2007). Hh signalling has been reported to 
be abnormally induced in OA cartilage where it promotes cartilage degradation 
triggering expression of catabolic enzymes such as MMP-13 and ADAMTS-5 (Thompson 
et al., 2014); furthermore, inhibition of Hh signalling in OA chondrocytes reduced the 
severity of the disease (Lin et al., 2009). An in vivo study also reported up-regulation of 
Hh signalling and OA biomarkers (MMP-13, ADAMTS-5, collagen type X and Runx2) in 
cartilage of primary cilia knock-out mice (Chang et al., 2012).  Thompson et al. reported 
that 1h of cyclic tensile strain  (CTS; 10%, 0.33Hz) induces the Hh signalling pathway 
concomitant with expression of ADAMTS-5 in healthy bovine adult chondrocytes 
(Thompson et al., 2014); whereas, increasing the amount of strain applied to the cells 
(20%, 0.33Hz) did not activate Hh signalling and ADAMTS-5 suggesting that this pathway 
is mechano-sensitive but the response is dependent on the magnitude of load applied 
(Thompson et al., 2014). 
1.4.2.2. Mitogen activated protein kinases (MAPKs) 
In chondrocytes, the MAPKs play an important role in response to inflammatory 
cytokines (Salter and Lee, 2010b). ERK1/2, p38 and JNK are the central components of 
the MAPK family. The phosphorylation and activation of MAPKs transmit the signal 
down the cascade and activates many downstream genes such as transcription factors, 
cytoskeletal proteins and other protein kinases (Fitzgerald et al., 2008). MAP kinases 
regulate multiple cellular activities, for example: gene expression, mitosis, 
differentiation and cell apoptosis (Salter and Lee, 2010b). Different mechanical stimuli 
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can activate different MAPKs and through this mechanism differential cellular responses 
may occur (Fitzgerald et al., 2008). The activation of extracellular-regulated kinase 
(ERK1/2) can be induced in response to static compression (~50% compression, 2h or 
24h) and dynamic shear stress (3% shear strain at 0.1Hz, 0.5, 2, 6 or 24h) applied to 
cartilage explants (Fitzgerald et al., 2008). This ERK1/2 response to mechanical stimuli 
may have a degradative effect on cartilage homeostasis, as ERK1/2 is believed to be  
a major regulator of pro-inflammatory cytokines IL-1β, IL-6, IL-12, IL-23 and TNF-α 
(Mariani et al., 2014). p38, another component regulating expression of downstream 
genes of the MAPK signalling pathway, has been reported to be activated in articular 
cartilage in response to dynamic compression (0.1MPa, 0.5Hz, 24h), resulting in 
synthesis of nitric oxide (NO) and prostaglandin E2 (PGE2) (Ruiz-de-Luzuriaga et al., 
2003). Both of these molecules play an important role in cartilage integrity as they 
inhibit expression of collagen type II and proteoglycans, and induces chondrocyte 
apoptosis (Amin and Abramson, 1998, Attur et al., 2008). Studies on monolayer 
chondrocyte cultures have shown that the integrin-dependant Jun N-terminal kinase 
(JNK) pathway is involved in up-regulation of proteoglycan synthesis following cyclic 
mechanical stimulation (pressurization) (26.7kPa, 0.33Hz, 30 min, 1, 2 or 3h) (Zhou et 
al., 2007), indicating its role in regulating load-induced cartilage homeostasis. 
Phosphorylation of ERK, JNK and p38 leads to activation of MAPK signalling cascades 
that induce the expression of many transcription factors involved in regulation of many 
genes of catabolic molecules, e.g. AP-1 (c-Fos/c-Jun), RUNX-2, HIF-2α in articular 
cartilage (Mariani et al., 2014).  
1.4.2.3. Nuclear factor kappa B (NF-kappa B) pathway  
The transcription factor NF-ĸB is directly regulated by mechanical stimulation (Agarwal 
et al., 2004, Akanji et al., 2010, Salter and Lee, 2010b) and can up-regulate MMPs, IL-1, 
PGE2 and NO levels (Novack, 2011). The mechanical stimuli appears to affect NF-ĸB 
activity in a magnitude dependent manner in articular cartilage (Salter and Lee, 2010b). 
Physiological biomechanical stimuli (6% elongation, 0.05Hz, 15 – 90 minutes) blocked 
the nuclear translocation of NF-ĸB in monolayer cultures of rabbit articular 
chondrocytes stimulated with IL-1β (Agarwal et al., 2004).  Moreover, in chondrocytes 
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treated simultaneously with load and IL-1β NF-ĸB synthesis was significantly reduced 
when compared to chondrocytes treated with IL-1β only  (Agarwal et al., 2004).  
In contrast, abnormal mechanical load (15% elongation, 0.05Hz, 15 – 90 minutes) 
elevated NF-ĸB synthesis and induced the rapid translocation of NF-κB subunits p65 and 
p50 into the nucleus in a similar manner to IL-1β treatment (Agarwal et al., 2004).  
3D bovine chondrocyte/agarose constructs treated with IL-1β and subjected to 
mechanical compression (15% compression, 1Hz, 60 minutes) demonstrated partial 
translocation of the p65 NF-ĸB subunit when compared to unloaded cells (Akanji et al., 
2010). 
 
1.5. RNA interference (RNAi) 
To date, there are several studies showing that mechanical force has an impact on 
cellular responses through RNA interference expression levels (Qin et al., 2010, Luna et 
al., 2011b, Liu et al., 2014, Dunn et al., 2009, Guan et al., 2011). RNAi, a biological process 
based on sequence specific post-transcriptional gene silencing by single stranded RNA 
(ssRNA) results in messenger RNA (mRNA) degradation or inhibition of mRNA 
translation. The key players in RNA silencing are small RNAs such as: small interfering 
RNA (siRNA), small nucleolar RNA (snoRNA), tRNA–derived RNA fragments/small RNA 
(tRFs/tsRNA), PIWI-interacting RNA (piRNA) and microRNAs (miRs) (Gomes et al., 2013). 
There is also an increasing number of reports describing the vital function of long, non-
coding RNAs (lncRNAs) in many cellular processes. Liu et al. demonstrated that lncRNAs 
differ in expression between healthy and OA cartilage, showing that lncRNAs related to 
cartilage injury promote ECM degradation in OA (Liu et al., 2014). The aim of this study 
is to identify mechano-sensitive miRs in articular cartilage, therefore I will focus on these 
small RNA molecules only from here on in.   
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1.5.1. microRNA 
miRs are very small (20 – 23bp), cytoplasmic RNAs that control post-transcriptional 
regulation of one third of all genes (Miyaki and Asahara 2012). As miRs are involved in 
many fundamental cellular processes, they play extremely important roles in the 
regulation of the proper functioning of organisms. Any dysregulation of miRs may 
contribute to the development of various diseases such as cardiovascular disease, 
cancer, arthritis, etc. The expression pattern of most miRs depends very often on the 
tissue, the developmental stage where they exist and the cellular environment in which 
they are expressed (Miyaki and Asahara, 2012, Dunn et al., 2009). The function of some 
miRs is driven by certain stress factors, for example ageing, inflammation and 
mechanical stress which are also known to contribute to OA development (Miyaki and 
Asahara, 2012).                                 
1.5.1.1. Canonical pathway of miR maturation 
miR is functional only as a mature, single stranded RNA binding to the RNA-induced 
silencing complex (RISC). It is generated as a long pri-miR and then processed by the 
enzymes Drosha and Dicer into the short, single stranded ribonucleotide form.  
The mature miR is then incorporated into the RISC complex and can bind target mRNA 
(Miyaki et al., 2010). The metabolic pathway of miR maturation begins in the nucleus 
and finishes in the cell cytoplasm (Figure 1.11). 
1. miRs are transcribed by RNA polymerase II in the nucleus and the first step of miR 
maturation starts from the moment of transcript inception of the pri-miR.  
2. The next stage also occurs in the cell nucleus and involves removal of approximately 
70 - 90 nucleotides folding into an imperfect stem-loop structure from a long pri-miR 
transcript. The result is a hairpin-like molecule called precursor miR (pre-miR) which has 
two overhanging nucleotides at the 3' end and phosphate residues at the 5'end 
(Cowland et al., 2007, Filipowicz et al., 2005, Mendell, 2005, Pillai, 2005). This process 
involves a microprocessor complex, consisting of the RNase III enzyme Drosha, and the 
double-stranded-RNA-binding protein, Pasha/DGCR8 (Han et al., 2004). 
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3. The next step is the binding of the pre-miR molecule with the karyopherin exportin 5 
(Exp-5) and Ran-GTP complex which is then exported from the nucleus into the 
cytoplasm. Ran (ras-related nuclear protein) is a small GTP binding protein belonging to 
the RAS family that is essential for the translocation of RNA and proteins through the 
nuclear pore complex (Filipowicz et al., 2005, Gregory and Shiekhattar, 2005, Han et al., 
2004, Pillai, 2005). 
4. The cytoplasmic miR biogenesis stage is initiated by Dicer, which has a high affinity 
for double-stranded RNA molecules having two over-hanging nucleotides at the 3 'end. 
5. Dicer, as with Drosha, belongs to the Ribonuclease class III family (RNase III) 
characterised by a 2-nucleotide 3′ overhang in its products; it cuts the double stranded 
RNA at about 22 nucleotides from the binding site. 
6. The product of Dicer is an approximate 22 nucleotide miR-miR* duplex with a shorter 
5' end and about 2 nucleotides longer at the 3' end (Araldi and Schipani, 2010, Dunn et 
al., 2009, Fernandes-Silva et al., 2012, Stefani and Slack, 2008). 
7. It has been reported that only one strand is integrated into the RISC complex and acts 
as a functional miR. RISC is a ribonucleoprotein complex containing members of the 
Argonaute (Ago) family of proteins which have endonuclease activity directed against 
target mRNA strands that are complementary to their bound miR fragment. Ago is also 
responsible for selection of the guide strand (incorporated strand) and destruction of 
the passenger strand (*) of the miR-miR duplex. The RISC complex binds to the miR-miR 
(*) duplex to select the guide strand (Schwarz et al., 2003).  
8. The guide strand is selected by Ago on the basis of the stability of the 5' end.  
The strand characterised by lower thermodynamic energy (has a lower stability base 
pairing of the 2–4 nucleotides at the 5' end, which indicates lower complementarity to 
the 3’UTR end of the second strand) is incorporated into the RISC complex, making the 
miR available to regulate gene expression (Fernandes-Silva et al., 2012, Dunn et al., 
2009, Miyaki et al., 2010, Pillai, 2005). There is an increasing number of studies reporting 
that the passenger strand of several miRs may also be incorporated into the RISC 
complex and play functional roles in post-transcriptional gene regulation (Yang and Lai, 
2011). Step 9 and 10 will be described in more details in Section 1.5.1.3. 
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Figure 1.11. The miR maturation canonical pathway and the working mechanism of 
action. The maturation of a miR is mediated by Drosha and Dicer enzymes. It starts in 
the nucleus of the cell and ends in its cytoplasm, with a mature miR incorporated into 
the RISC and available for post-transcriptional regulation (Fernandes-Silva et al., 2012). 
The activity of a miR depends on matching to its target mRNA. If the complementarity 
of miR and mRNA is perfect, the 3’UTR of the mRNA is cleaved by Ago2 which has a slicer 
activity; if it is not a perfect match, then the translation of mRNA is inhibited (Tong and 
Nemunaitis, 2008).  
Adapted from (http://www.wako-chem.co.jp/english/labchem/article/microRNA.htm). 
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1.5.1.2. Non-canonical pathway of miR biogenesis  
One of the most frequently occurring mechanisms for non-canonical miR biogenesis is  
a splicing-mediated and Drosha independent “mirtron pathway” (Figure 1.12) 
(Berezikov et al., 2007, Ladewig et al., 2012). Introns with hairpin potential are cut out 
from protein coded genes by spliceosomes (Ladewig et al., 2012, Westholm and Lai, 
2011). The initial spliced introns appear in a branched form with the 3’end ligated to the 
5’ end of the intron and can form either conventional mirtrons where both ends of the 
pre-miR is defined by the spliceosome or 5’ and 3’ tailed mirtrons which must be 
processed by nucleases to trim additional nucleotides prior to eventual processing by 
Dicer (Figure 1.12i) (Westholm and Lai, 2011). To form the pre-miR, the “loop form” is 
cleaved by lariat debranching enzyme (Figure 1.12ii) and then the pre-miR hairpin is 
further processed as a pre-miR in a canonical manner (Ladewig et al., 2012, Okamura et 
al., 2007, Westholm and Lai, 2011).  In terms of tailed mirtrons, they require additional 
nucleotide trimming (Figure 1.12iii) prior to binding to Exportin-5. It has been found that 
the 3’ mirtron tail is trimmed by an exosome (RNA 3’->5’ exonucleases complex) 
(Ladewig et al., 2012, Westholm and Lai, 2011). So far, nucleases that remove the 5’ tail 
have not been identified, however it is believed that the major RNA  5’->3’ exonucleases 
(XRN1/2) in eukaryotes do the trimming (Westholm and Lai, 2011).   
Other sources of a Drosha independent pathway of miR biogenesis are tRNA-derived 
RNA such as short tRFs that on the basis of their generation are grouped into: type I 
(Dicer dependent), and type II (Dicer independent) (Raina and Ibba, 2014, Haussecker et 
al., 2010). 3’U tRFs that belong to the Dicer independent group are mainly produced in 
the nucleus by the action of the tRNaseZ during tRNA maturation and exported to the 
cytoplasm (Raina and Ibba, 2014). 5’ tRFs, 3’CCA tRFs belong to the first group and they 
are generated in the cytoplasm from mature tRNA through the Dicer activity that cleaves 
tRNA in the D and T loop producing 5’ tRFs and 3’CCA tRFs respectively (Figure 1.13A) 
(Raina and Ibba, 2014). When immature tRNA leaves the nucleus, RNaseP and tRNaseZ 
localised in the cytoplasm may process pre-tRNA and generate 5’ leader-exon tRFs and 
3’U tRFs. 5’ tRFs, 3’CCA tRFs and 3’U tRFs bind to Ago proteins (preferentially Ago 1, 3 
and 4 over 2) and form a functional RISC complex that can regulate the expression of a 
target mRNA (Kumar et al., 2014).   
45 
 
Another Drosha independent source of pre-miR is the small nucleolar RNA (snoRNA) 
derived pathway (Miyoshi et al., 2010). Some snoRNAs, whose secondary structure is 
characterised by at least two stem-loops linked by a hinge may be a source of miR-like 
molecules (Ender et al., 2008). Only a minor proportion of snoRNAs, involved in 
modifying the function of other noncoding RNAs in the nucleus, are exported to the 
cytoplasm, where Dicer along with other nucleases cleaves it into small RNAs that are 
loaded into the RISC complex (Figure 1.13B), (Brameier et al., 2011, Ender et al., 2008, 
Scott et al., 2009). 
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Figure 1.12. Non-canonical, Drosha independent pathway of mirtron derived miR 
biogenesis. Short introns with hairpin potential are spliced (i) and debranched into  
pre-miR (ii); tailed mirtrons are additionally trimmed (iii). Debranched mirtrons are 
processed further in canonical miR biogenesis. 
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Figure 1.13. Non-canonical, Drosha independent pathway of miR biogenesis via the 
tRNA derived pathway: mature tRNA transported to the cytoplasm can be cleaved by 
Dicer in the T and D loop of tRNA giving the single stranded tRFs that are bound to the 
Ago protein. Dicer independent 3’U tRF formed by RNaseZ activity can also be 
transported to the cytoplasm and act as a miR after binding the Ago protein (A). snoRNA 
derived pathway: some snoRNAs transported to the cytoplasm are cleaved by Dicer 
creating a pre-miR that is incorporated into Ago and acts as a miR (B).   
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1.5.1.3. miR activity and its target sites 
Regulation of gene expression by miRs may occur in two ways, either by mRNA 
destabilisation which is permanent (Figure 1.11:9) or inhibition of translation which has 
been reported to be reversible (Figure 1.11:10). It has been shown that application of 
different stress conditions i.e. amino acid starvation or oxidative stress to human 
hepatoma Huh7 cells led to the release of catalase-1 (CAT-1) from miR-122 inhibition 
(Bhattacharyya et al., 2006). The manner of this control depends on the 
complementarity between the miR and the target mRNA (Marin et al., 2013). The target 
mRNA has at least one region which is totally complementary to the “seed region” of 
the miR, that is responsible for binding to mRNA targets (Mitra and Bandyopadhyay, 
2011), and is located  between the 2nd and 7th nucleotide at the 5’ end of the miR (Saito 
and Sætrom, 2010, Bartel, 2009). These corresponding regions in the mRNA are called 
“seed sites” and according to their sizes and seed region which they are complementary 
to, they are divided into 4 seed matching sites (Mitra and Bandyopadhyay, 2011): 6mer 
that is 6 nucleotides long (starts at the 2nd  miR nucleotide and finishes at the 7th) (Figure 
1.14A), 7merA1 that is 7 nucleotides long (starts at the 1st nucleotide and finishes at the 
7th and has to have adenosine across from the first nucleotide in the miR) (Figure 1.14B), 
7mer-m8 that is also 7 nucleotides long (starts at the 2nd nucleotide and finishes at the 
8th (Figure 1.14C) and 8mer that is 8 nucleotides long (starts at the 1st nucleotide and 
finishes at the 8th) (Figure 1.14D) (Friedman et al., 2009, Bartel, 2009, Mitra and 
Bandyopadhyay, 2011). When the entire miR is completely complementary to the 
mRNA, the mRNA is degraded by the endonuclease Ago2; however, when the miR is not 
perfectly matched to the mRNA, protein production is inhibited by repression of 
translation (Reynard and Loughlin, 2012). Most functional miR target sites are located 
in the 3’UTR of the target mRNA, but some studies have demonstrated that seed sites 
also occur in the coding sequence (CDS) and 5’UTR of the target mRNA (Hausser et al., 
2013, Fang and Rajewsky, 2011, Lee et al., 2009). The 3’ UTR is thought to be more 
accessible for the miR/RISC complex than the other two sites (Fang and Rajewsky, 2011, 
Hausser et al., 2013). 
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Figure 1.14. Types of matching seed sites in mRNA. The seed region located at the 5’UTR 
of the miR has four potential binding sites at the 3’ end of the target gene: 6mer (A), 
7merA1 (B), 7mer-m8 (C) and 8mer (D). Adapted from (Bartel, 2009). 
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1.5.1.4. Nomenclature of miR 
miRBase (www.mirbase.org) is an online database including the nomenclature, 
sequences and predicted targets of mature miRs. bta-mir-146 refers to a bos taurus 
”bta” precursor “mir” 146. The bta-mir-146 has two mature “miR” products:  
bta-miR-146-5p and bta-miR-146-3p, which means that they arise from the 5’ or 3’ 
precursor respectively. Several papers have shown that the passenger strand derived 
from the 3’ precursor (miR*) can be functional, therefore the miR/miR* has been 
changed to -5p/-3p indicating that both forms of miR-146 may control gene expression. 
miRs which are closely related and differ in one or two nucleotides have a lettered suffix 
to their “name”, for example bta-miR-146a-5p, bta-miR-146b-5p meaning that they are 
expressed from bta-mir-146a and bta-mir-146b respectively. Mature miRs which have 
the same sequence and target genes, but have been generated from different genes are 
given additional numerical suffixes e.g. has-miR-1-1 and has-miR-1-2, whose genomic 
loci are on chromosome 20 and 18 respectively (Griffiths-Jones et al., 2006).                                           
1.5.1.5. Importance of miR in articular cartilage  
In 2003 Berstein et al. demonstrated that complete deletion of the enzyme Dicer, 
essential for miR maturation, caused lethal effects on mice embryos indicating a crucial 
role for miRs in embryonic development (Bernstein et al., 2003). However, one of the 
first indications that miRs may be involved in chondrogenesis was shown by Wienholds 
et al. (2005). They demonstrated by in situ hybridization that most of the highly 
conserved vertebrate miRs in zebrafish embryos are expressed in a tissue specific 
manner, and furthermore that miR-140 is expressed only in cartilaginous tissue 
(Wienholds et al., 2005). This expression pattern of miR-140 has been confirmed in 
mouse embryos by Tunddenham et al. who also identified  that miR-140 targets histone 
deacetylase 4 (HDAC4) which inhibits Runx2, a transcription factor that controls 
chondrocyte hypertrophy and osteoblast differentiation (Tuddenham et al., 2006). 
Kobayashi et al. also demonstrated that miRs play a crucial role in chondrocyte 
proliferation and differentiation. Although the Dicer-null mice (Dicer -/-) were viable, 
they showed greatly decreased chondrocyte proliferation and faster hypertrophy 
leading to growth defects and premature death in these mice (Kobayashi et al., 2008). 
51 
 
The importance of miR-140 in skeletal development has been reported by Miyaki et al. 
and Nakamura et al. Independent in vivo studies demonstrated that miR-140 knock-out 
mice exhibited short statures and craniofacial deformities (Miyaki et al., 2010, 
Nakamura et al., 2011). The effect of dwarfism in mice lacking miR-140 expression was 
attributed to premature chondrocyte differentiation and a reduction in proliferating 
chondrocytes which led to shortening of the bones (Miyaki et al., 2010, Nakamura et al., 
2011). It is believed that one of the reasons for reduced chondrocyte proliferation might 
have been increased expression of the aspartyl aminopeptidase enzyme (Dnpep) in  
miR-140 knock-out chondrocytes (Nakamura et al., 2011). Dnpep is a miR-140 target 
which reduces BMP/Smad signalling, however its antagonistic mechanism towards the 
BMP pathway is still unclear (Nakamura et al., 2011). It is known that loss of BMP/Smad 
signalling causes decreased proliferation and increased chondrocyte apoptosis (Retting 
et al., 2009). 
miR-140 is not the only miR involved in cartilage development and more miRs have been 
identified as regulators of chondrocyte differentiation and ECM biosynthesis. Dai et al. 
reported that miR-101 is involved in IL-1β-induced aggrecan and collagen type II 
suppression by targeting the transcription factor Sox9, essential for cartilage formation 
and production of ECM molecules (Dai et al., 2012). Decreased expression of miR-145 
that also controls expression of Sox9, was observed in TGF-β-induced chondrogenic 
differentiation of murine mesenchymal stem cells (Yang et al., 2011). Moreover, 
Martinez-Sanchez et al. reported that over-expression of miR-145 in human 
chondrocytes differentially altered expression of Sox9-inducible downstream genes. 
Decreased levels of collagen type II and aggrecan were observed, in addition to 
reductions in miR-140 and -675 expression, whereas expression of hypertrophic markers 
were elevated e.g. Runx2 and MMP-13, that is regulated by Runx2 (Martinez-Sanchez et 
al., 2012). Similar to miR-140, mechano-sensitive miR-365 also targets HDAC4 and can 
regulate chondrocyte differentiation (Guan et al., 2011). Collagen type II was also 
reported to be negatively regulated by miR29-a/b in murine mesenchymal stem cells 
(Yan et al., 2011) and positively regulated by miR-675 in human articular chondrocytes 
(Dudek et al., 2010). 
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1.5.1.6. miR in OA cartilage 
Due to the important role of the aforementioned miRs in cartilage homeostasis, all of 
them are likely to influence cartilage degradation, however in this subsection I will only 
discuss miRs that have been reported in the literature as being differentially expressed 
in OA cartilage. Iliopoulos et al. found that 16 miRs from 365 tested were differentially 
expressed in human OA cartilage when compared to healthy samples (Iliopoulos et al., 
2008). In turn, Jones et al. identified 17 miRs out of 157 presenting at least a 4-fold 
change in expression level between human OA and healthy cartilage (Jones et al., 2009). 
Based on the direction of significant changes of miR levels altered in OA cartilage 
compared to healthy tissue, miRs were grouped into three classes: up-regulated (Table 
1.2), OA stage-dependent (Table 1.3) and down-regulated (Table 1.4). 
1.5.1.6.1. Up-regulated miRs in OA cartilage 
The analysis of biological function of miR-9 and -98 demonstrated a repressive impact 
of miR-9 on MMP-13 transcription, and also an inhibitory effect of miR-9 and -98 on  
IL-1β-induced tumour necrosis factor alpha (TNFα) synthesis indicating a protective role 
in OA (Jones et al., 2009).  
The examination of miR-21 demonstrated that this miR directly regulates expression of 
growth differentiation factor 5 (GDF-5) in OA cartilage (Zhang et al., 2014b). GDF-5 has 
been shown to be involved in chondrocyte proliferation in later stages of skeletal 
development (Francis-West et al., 1999) suggesting its positive role in cartilage 
regeneration. 
Functional analysis of miR-22 demonstrated elevated expression of IL-1β (a cytokine 
involved in OA pathogenesis) and MMP-13, and decreased expression of aggrecan 
through direct targeting of peroxisome proliferator-activated receptor (PPARA) and 
bone morphogenetic protein 7 (BMP7) (Iliopoulos et al., 2008). 
A recent study showed that the miR-29 family is regulated by several molecules 
important for maintaining cartilage homeostasis including Sox9, TGF-β1 (inhibits miR-29 
expression) and IL-1 (elevates miR-29 expression). miR-29 has also been reported to be 
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up-regulated at the onset of OA (using the DMM model) and in end-stage human OA 
cartilage (Le et al., 2016). A functional analysis of this miR family was assessed by using 
luciferase reporters with specific genes measuring the activity of those involved in 
cartilage degradation: SMAD, NFκB and canonical Wnt signalling pathways induced 
respectively by TGF-β1, IL-1β or Wnt3a. The results indicated involvement of the miR-29 
family in the negative regulation of these pathways, and more specifically the negative 
regulation of ADAMTS-4, MMP3 and Axin2 that are respectively TGF-β1, IL-1 and  
Wnt-inducible genes (Le et al., 2016). Furthermore, the same group reported that the  
miR-29 family directly targets the following Wnt signalling pathway genes: casein kinase 
2 alpha 2 polypeptide (CSNK2A2), Dishevelled 3 (DVL3), Frequently Rearranged In 
Advanced T-Cell Lymphomas 2 (FRAT2), Frizzled family receptor 3 (FZD3) and Frizzled 
family receptor 5 (FZD5) (Le et al., 2016). Functional analysis demonstrated the 
involvement of this miR family in the negative regulation of SMAD, NFκB and canonical 
Wnt signalling pathways indicating critical roles in cartilage homeostasis (Le et al., 2016). 
miR-455-3p has also been reported to be elevated in OA cartilage (Swingler et al., 2012). 
This miR is induced by the growth factor TGFβ and via the direct targeting of Smad2, 
activin receptor 2B (ACVR2A) and chordin-like 1 (CHRDL1) it regulates the 
TGFβ/Smad2/3 dependent signalling pathway (Swingler et al., 2012); this pathway is 
involved in ECM synthesis and degradation therefore its repression is known to lead to 
OA-like changes (van der Kraan et al., 2012).  
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Table 1.2. Up-regulated miRs identified in OA cartilage, along with their putative direct 
and indirect targets. 
 
miR Direct targets 
Indirect 
targets 
References 
miR-9 
Human  
Human:  
MMP-13, TNFα  
 (Jones et al., 2009) 
miR-21 
Human 
Human: 
GDF-5 
 (Zhang et al., 2014b) 
miR-22 
Human 
Human: 
PPARA, BMP7 
Human: IL-1β, 
MMP-13 (p.c.)   
(Iliopoulos et al., 
2008) 
miR-98 
Human 
Human:  
IL-1β (human) 
 (Jones et al., 2009) 
miR-29 
Human, 
mouse 
Human: 
FZD-3/-5, DVL3, FRAT2, 
CSNK2A2 
Human: 
ADAMTS-4, 
MMP-3, Axin2 
(Le et al., 2016) 
miR-455 
Human 
Human, mouse: 
SMAD2, ACVR2A, 
CHRDL1 
 (Swingler et al., 2012) 
 
       Key: p.c. - positive correlation 
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1.5.1.6.2. OA-stage dependent differential expression of miRs 
The level of miR146a is much higher in low-grade OA cartilage and decreases with the 
extent of cartilage degradation, leading to the belief that cartilage degradation might 
progress due to loss of miR-146 (Yamasaki et al., 2009). Therefore, the experiment 
reporting decreased expression of miR-146 in OA human chondrocytes seems to be 
performed on late stage disease tissue, however it was not specified. miR-146 directly 
suppresses the expression of the IL-1-receptor associated kinase 1 (IRAK1) and  
TNF-receptor associated factor 6 (TRAF6), which are induced by inflammatory cytokines 
and are necessary to activate catabolic factors such as MMPs and ADAMTSs (Taganov et 
al., 2006, Li et al., 2011c). Moreover, miR-146a was also reported to stimulate cartilage 
degradation by targeting Smad4, which is an important regulator in the anabolic TGFβ 
pathway, and by indirect up-regulation of vascular endothelial growth factor (VEGF) that 
activates angiogenesis. Up-regulation of miR-146a results in down-regulation of Smad4 
and a higher expression of VEGF (Li et al., 2012, Jin et al., 2014). Interestingly, Li et al. 
reported that miR-146a is an anti-catabolic miR by showing its inhibitory effect on  
MMP-13 and ADAMTS-5, and anabolic effect on aggrecan and collagen type II in human 
chondrocytes treated with IL-1 (Li et al., 2011c).   
The most studied cartilage miR-140 was also reported as involved in cartilage 
pathogenesis, however the data from the literature is conflicting. Decreased levels of 
miR-140 were detected in cartilage collected from OA patients and was found to target 
IGFBP-5 expression, hence influencing cartilage integrity (Tardif et al., 2009). This finding 
was confirmed by Miyaki et al. who showed reduced expression of miR-140 in OA 
chondrocytes compared to healthy control (Miyaki et al., 2010, Miyaki et al., 2009), and 
furthermore, that ADAMTS-5 is a direct target of miR-140 (Miyaki et al., 2010).  
However, Swingler et al. reported an elevation of miR-140 in human OA cartilage 
(Swingler et al., 2012). This group has confirmed HDAC4, a corepressor of Runx-2 and 
Mef-2, as a direct target of miR-140 (Tuddenham et al., 2006). It is thought that the 
contradictory findings regarding the expression of miR-140 in OA may depend on the 
stage of the disease analysed (Le et al., 2013). To date, the regulatory mechanism of 
miR-140 expression in cartilage is still unclear. Nakamura et al. demonstrated that miR-
140 is regulated by SOX9 in zebrafish and mammalian chondrocytes (Nakamura et al., 
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2012). Contradictory information exists in terms of IL-1β influence on miR-140 
expression. Liang et al. demonstrated that miR-140 is up-regulated after treating human 
chondrocytes with 10 ng/ml IL-1β  (Liang et al., 2012), whereas Miyaki et al. showed that 
5 ng/ml of IL-1β supresses miR-140 expression in human chondrocytes (Miyaki et al., 
2009). 
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Table 1.3. OA-stage dependent miR expression, along with their putative direct and 
indirect targets. 
 
miR Direct targets Indirect targets 
        miR-140  
     Human (Miyaki et 
al., 2009, Tardif et al., 
2009) 
  Human (Swingler et 
al., 2012) 
Human: IGFBP-5 (Tardif et al., 
2009) 
Human and mouse: ADAMTS-5 
(Miyaki et al., 2010, Miyaki et 
al., 2009),  
Mouse: HDAC4 (Tuddenham et 
al., 2006)  
 
miR-146a 
 Human (Yamasaki 
et al., 2009) 
 Human (Jones et al., 
2009) 
Human:  ADAMTS-5, MMP-13 
(Li et al., 2011c), IRAK1, TRAF6 
(Li et al., 2011c, Taganov et al., 
2006), TNFα (Jones et al., 2009) 
Human and rat: SMAD4 (Jin et 
al., 2014, Li et al., 2012) 
Human and rat: VEGF 
(p.c) (Jin et al., 2014, Li 
et al., 2012) 
Human: Aggrecan, 
collagen type II (p.c.) 
(Li et al., 2011c) 
 
Key: p.c. - positive correlation 
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1.5.1.6.3. Down-regulated miRs in OA cartilage 
miRs that are decreased in expression in OA cartilage include miR-27a (Tardif et al., 
2009), miR-27b (Akhtar et al., 2010), miR-125b (Matsukawa et al., 2013),   
miR-142-3p (Wang et al., 2016a) and miR-222 (Song et al., 2015). 
miR-27a and miR-27b have been reported to be downregulated in human OA cartilage 
and negatively correlate, either indirectly or directly respectively, with MMP-13 
expression in IL-1-stimulated human OA chondrocytes (Akhtar et al., 2010, Tardif et al., 
2009); in addition, miR-27a has also been demonstrated to act in a secondary manner 
by inhibiting IGFBP-5 (Tardif et al., 2009).  
miR-125b downregulation has also been identified in human OA chondrocytes, where it 
has been shown to repress ADAMTS-4 expression in IL-1β stimulated OA chondrocytes 
by 72% and 62% respectively at the transcriptional and protein levels (Matsukawa et al., 
2013).  
In turn, miR-142-3p found to be reduced in expression in murine OA cartilage, confers 
regulatory effects on cell apoptosis, NFκB and the synthesis of cytokines e.g. IL-1, IL-6 
and TNF-α in response to stimulation with the pro-inflammatory agent 
lipopolysaccharide (LPS) (Wang et al., 2016a). Furthermore, miR-142-3p directly targets 
an inflammatory OA mediator: high mobility group box 1 (HMGB1) (Wang et al., 2016a). 
HMGB1 in synergy with IL-1α, IL-1β and LPS, amplifies the inflammatory response by 
increasing expression of cytokines such as TNFα, IL-6 and IL-8, whereas a HMGB1-IL-1β 
complex enhances MMP-3 production in synovial fibroblasts collected from rheumatoid 
arthritis (RA) and OA patients (Wähämaa et al., 2011). 
Mechanically-regulated miR-222 has also been reported to be down-regulated in OA 
chondrocytes in which it regulates expression of MMP-13 through direct targeting of 
HDAC4 (Song et al., 2015). 
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Table 1.4. Down-regulated miRs identified in OA cartilage, along with their putative 
direct and indirect targets. 
 
miR 
Direct 
targets 
Indirect targets References 
miR-27a 
Human  
 
Human: MMP-13, 
IGFBP-5 (n.c.) 
(Tardif et al., 
2009) 
miR-27b 
Human 
Human: 
MMP-13 
 
(Akhtar et al., 
2010) 
miR-125b 
Human 
Human: 
ADAMTS-4 
 
(Matsukawa et 
al., 2013) 
miR-142-3p 
Mouse 
Mouse: 
HMGB1 
 (Wang et al., 
2016a) 
miR-222 
Human 
Human: 
HDAC4 
     Human:        
MMP-13 (n.c.) 
(Song et al., 
2015) 
 
Key: n.c. - negative correlation 
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1.5.1.7. Mechanically-regulated miRs 
miR expression has become very important in the understanding of biological processes, 
therefore it is not surprising that, to date, many studies have been performed to identify 
mechano-sensitive miRs.  
Experiments performed on endothelial cells (EC) demonstrated that laminar fluid flow 
(12 dyn/cm2, 12h) up-regulates miR-19a which inhibits EC proliferation (Qin et al., 2010). 
In contrast, oscillatory shear stress (±5 dyn/cm2, 1Hz, 24h) increases the level of  
miR-663 expression and at the same time activates the inflammatory response of EC 
which may lead to the development of atherosclerosis (Ni et al., 2011).  
Variations in the levels of miR in response to mechanical load were also documented in 
the trabecular meshwork (TM) of the eye. Cyclic mechanical stress (20% tensile strain, 
1Hz, 3h) up-regulated miR-24 that targets and inhibits the subtilisin-like proprotein 
convertase family furin which activates the latent form of transforming growth factor 
beta 1 (TGF-β1) (Luna et al., 2011b); to date, pathophysiological mechanisms involved 
in changes in TM and dysregulation of normal levels of aqueous outflow in glaucoma are 
not yet understood (Liton et al., 2005). It is presumed that the active form of TGF-β1 can 
significantly change the morphology of the TM such that aqueous humour is less able to 
evacuate from the eye increasing intraocular pressure (Luna et al., 2011a). 
Alterations in miR expression have also been observed in cultured rat cardiac myocytes 
that were subjected to mechanical stretch (20% tensile strain, 1Hz, 4h), with both  
TGF-β1 and miR-208a over-expressed in mechanically stimulated myocytes (Wang et al., 
2013a). miR-208a was also up-regulated after exogenous addition of TGF-β1 (Wang et 
al., 2013a). TGF-β1 plays an important role in hypertrophic remodelling and modulates 
matrix metabolism in the pressure over-loaded heart (Dobaczewski et al., 2011). Wang 
et al. suggest that miR-208a regulation is mediated by TGF-β1 and plays a role in  
stretch–induced cardiac hypertrophy (Wang et al., 2013a).  
Mohamed et al. showed that mechanical stretch (12% tensile strain, 1Hz, 1h) applied to 
a primary cell line of human airway smooth muscle cells (HASMCs) up-regulated miR-16, 
miR-26a and miR-140 and induced airway smooth muscle hypertrophy (Mohamed et al., 
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2010). HASMC hypertrophy plays a role in airway remodelling which is a characteristic 
feature in people with severe asthma (Bentley et al., 2009, Mohamed et al., 2010).  
miR-26a was shown to induce HASMC hypertrophy by direct inhibition of glycogen 
synthase kinase-3β (GSK-3β) that controls cell growth (Haque et al., 2010, Bentley et al., 
2009, Mohamed et al., 2010). 
In vivo studies on tendon fibroblasts demonstrated an elevation of miR-378 and down-
regulation of miR-100 in the Achilles tendons of rats running for 30 minutes at a constant 
speed of 12m/minute with progressively increased treadmill elevation every  
10 minutes: 0°, 5° and 10° (Mendias et al., 2012). The role of these miRs are unknown in 
tendon fibroblasts, but in cervical cell lines the down-regulation of miR-100 is partially 
responsible for increased cell proliferation (Mendias et al., 2012, Li et al., 2011a), 
whereas up-regulation of miR-378 in U87 and MT-1 cell lines also promotes cell 
proliferation, enhances cell survival, tumour growth and angiogenesis (Lee et al., 2007). 
Interestingly, miR-140 which is involved in cartilage development and homeostasis was 
significantly decreased in mechanically stimulated tendons (Mendias et al., 2012). 
1.5.1.8. Mechanically–regulated miRs in chondrocytes 
One of the best known mechano-responsive miRs in chondrocytes is miR-365 that was 
shown to be up-regulated in a 3D model of primary chondrocytes subjected to cyclic 
load with regimes of 5% deformation (1 Hz, 15 min/h for 24 and 48h) (Guan et al., 2011) 
and 10% deformation (1 Hz, 15 min/h for 24h) (Yang et al., 2016a); this was mediated 
via NFκB signalling (Yang et al., 2016a). miR-365 was found to stimulate chondrocyte 
differentiation and catabolic activity via direct targeting of HDAC4 (Guan et al., 2011, 
Yang et al., 2016a); moreover, it has been reported that this miR is IL-1β responsive and 
its increased expression in OA cartilage correlates with decreased HDAC4 (Yang et al., 
2016a). It is well known that HDAC4 regulates chondrocyte hypertrophy and bone 
formation by repressing the expression and activity of the transcription factor Runx2 
which is necessary for pre-terminal chondrocyte differentiation and endochondral 
ossification (Guan et al., 2011). Additionally, a recent study reported the significant 
repression of HDAC4 in cartilage from both primary OA and traumatic OA patients 
associated with elevation of Runx2 and Runx2-regulated molecules e.g. MMP-13 and 
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type X collagen (Cao et al., 2014). Over-expression/inhibition of miR-365 results in  
elevated/reduced expression of Runx2, MMP-13 and type X collagen in primary human 
chondrocytes confirming that miR-365 promotes chondrocyte hypertrophy  (Yang et al., 
2016a).  
Guan et al. showed that miR-146a, which is elevated in the early stages and decreased 
in the late stages of OA, was also up-regulated in a 3D model of primary chicken 
chondrocytes subjected to mechanical load (either 5% or 10% elongation, 1Hz, 15 min/h 
for 24h) (Guan et al., 2014). miR-146a has been reported to be significantly increased in 
human chondrocytes subjected to a static load (10MPa, 60 minutes) (Jin et al., 2014) 
corroborating these findings (Guan et al., 2014).  
miR-221 and miR-222 are also examples of mechanical stress induced miRs that are  
up-regulated with increased weight bearing (Dunn et al., 2009). Their expression level is 
elevated in the weight-bearing anterior medial condyle bovine stifle joint compared with 
the non-weight-bearing posterior medial region (Mendell, 2005, Dunn et al., 2009).  
The precise roles of these miRs are unknown, but on the basis of other studies it is 
thought that miR-221 is involved in the chondrogenic differentiation of mesenchymal 
cells (Kim et al., 2010), whereas miR-222 plays a role in chondrocyte proliferation 
(Goldring and Marcu 2012b). miR-221 has been shown to regulate chondrogenesis by 
inhibition of Mdm2 expression, with down-regulation of Mdm2 preventing Slug protein 
degradation, necessary for inhibition of chondroprogenitor proliferation (Lolli et al., 
2014, Kim et al., 2010). Studies performed on glioma cells demonstrated that miR-222 
regulates the WNT/β-catenin signalling pathway which is also implicated in OA 
pathogenesis (Li et al., 2013, Corr, 2008). miR-222 can regulate the expression of 
β-catenin and other downstream genes of the Wnt/β-catenin pathway by inhibition of 
its direct target DKK2 which is a known Wnt antagonist (Li et al., 2013).  
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1.6. PhD hypothesis 
Recent studies have shown that mechanical load affects the expression of miRs in 
chondrocytes; there is also evidence that the expression of several miRs differ between 
healthy and OA cartilage. Clearly, abnormal mechanical load is a primary risk factor for 
OA and taken together with these recent studies I hypothesise that: 
 Mechano-sensitive miRs in articular cartilage are involved in controlling genes 
that play key roles in cartilage homeostasis and OA development and 
progression. 
1.7. PhD objectives 
1. To establish in vitro regimes representing “physiological” and “non-
physiological” magnitudes of load that induce early transcriptional responses of 
molecules involved in cartilage homeostasis (and has the potential to induce 
biosynthetic/degradative changes at the protein level if applied for suitably 
prolonged periods of time) 
 
2. To establish which miRs, expressed by chondrocytes, are sensitive to mechanical 
force in response to loads characterised in objective 1 
 
 
3. To determine the target genes of mechano-sensitive miRs identified in objective 
2 
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All reagents were obtained from Sigma (Poole, UK) unless otherwise stated. Molecular 
biology analyses were conducted using reagents, plastic ware and filter tips which were 
RNase and DNase free.          
                                           
2.1. Cartilage explants 
2.1.1. Preparation of articular cartilage explants 
Full-depth articular cartilage explants were collected from the metacarpophalangeal 
joints of immature bovine calves (F. Drury and Sons abattoir, Swindon, UK) within 6h of 
slaughter using 5 mm diameter biopsy punches (Selles Medical, Hull, UK). Explants were 
washed four times for 20 minutes each with the first three washes in Hank’s balanced 
salt solution (HBSS) (Invitrogen, Paisley, UK) containing 400U/ml penicillin and 400µg/ml 
streptomycin (Invitrogen, Paisley, UK) and the fourth wash, prior to explant culturing, 
was conducted in HBSS containing 100U/ml penicillin and 100µg/ml streptomycin.  
The culture media used in experiments comprised Dulbecco’s Modified Eagle’s 
Medium–F12 with GlutaMAXTM-I (DMEM/F12 – GlutaMAX™) (Invitrogen, Paisley, UK) 
supplemented with 100U/ml penicillin, 100µg/ml streptomycin, 1x Insulin-Transferrin-
Selenium (ITS) (Invitrogen, Paisley, UK) and 50µg/ml ascorbate-2-phosphate. ITS was 
used to avoid the presence of any growth factors which occur in Foetal Bovine Serum 
(FBS) and to prevent chondrocyte dedifferentiation (Kisiday et al., 2005); addition of 
ascorbate-2-phosphate was used to promote collagen synthesis (Murad et al., 1981). 
The tissue explants were maintained in culture medium in a 5% (v/v) CO2 incubator at 
37°C for three days prior to loading.  
2.1.2. Application of mechanical load to articular cartilage explants 
Cartilage tissue explants were cyclically loaded using the Bose ElectroForce® 3200 rig 
(TA Instruments, Minnesota, USA) (Figure 2.1), controlled through WinTest dynamic 
mechanical analysis (DMA) software (TA Instruments, ElectroForce® Systems Group, 
Minnesota, USA). Explants were placed into a small 70 mm diameter glass Petri dish 
(Fisher Scientific, Loughborough, UK) containing culture media (described in 2.1.1) 
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which was placed on the ElectroForce® 3200 stage. The platen was lowered until it made 
contact with the tissue and the baseline force, prior to loading, was set at 0.1 Newton 
(N) to keep the explant in position. 
 
 
 
Figure 2.1. Schematic diagram of explant loading using the Bose ElectroForce® 3200 rig. 
To establish loading regimes that induce early cartilage ECM responses at the gene level, 
potentially indicative of anabolic (or homeostatic) or catabolic molecule responses, 
three different loading regimes were utilised (2.5MPa, 5MPa or 7MPa). Selection of 
these loading magnitudes was made based on previous studies. In the literature ≤5MPa 
load is generally accepted as physiological load (Fehrenbacher et al., 2003, Grodzinsky 
et al., 2000), while peak loads above 5MPa are considered as degradative (Fehrenbacher 
et al., 2003); unloaded explants were used as controls. Loading was conducted at a set 
frequency of 1Hz which has previously been demonstrated to resemble a fast walking 
speed (Bader et al., 2011). Furthermore, explants were only loaded for 15 minutes to 
enable investigation of early transcriptional changes in the cartilage in response to load 
and then cultured in a CO2 incubator (37°C, 5% (v/v) CO2, 95% humidity).  Explants were 
maintained for 24h post-cessation of load to assess their response to the loading 
regimes and also to investigate appropriate selection of reference genes.        
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2. 2. Primary articular chondrocytes  
2.2.1. Isolation of primary articular chondrocytes 
Slivers of full-depth articular cartilage were removed from bovine metacarpophalangeal 
joints using a sterile scalpel and washed as previously described (Section 2.1.1). Cartilage 
tissue was incubated, with gentle agitation, at 37°C, 5% (v/v) CO2 for 50 minutes in 0.1% 
(w/v) pronase (Roche, West Sussex, UK) dissolved in DMEM/F12 – GlutaMAX™ 
(Invitrogen, Paisley, UK) containing 5% (v/v) foetal calf serum (Invitrogen, Paisley, UK) 
and 100μg/ml penicillin and 100U/ml streptomycin. Pronase was removed and tissue 
subsequently incubated overnight at 37°C, 5% (v/v) CO2 with gentle agitation in 0.04% 
(w/v) collagenase type II isolated from Clostridium histolyticum (Invitrogen, Paisley, UK) 
dissolved in the same media as for pronase. The digestion mixture was filtered through 
a 40μm cell strainer (Fisher Scientific, Loughborough, UK) and the cells pelleted by 
centrifugation at 246g for 5 minutes. The cell pellet was re-suspended in fresh media 
(described in Section 2.1.1) except for exclusion of the antibiotics. A cell count was 
performed using a haemocytometer (Sussex, UK).  
2.2.2. Transfection of primary articular chondrocytes 
Isolated chondrocytes were seeded onto 6-well culture plates (VWR, Lutterworth, UK) 
at a density of 4.4x105/cm2 (4x106 cells/well) in penicillin/streptomycin free 
DMEM/F12–GlutaMAX™ (Invitrogen, Paisley, UK) or plated onto 8-well chamber slides 
(Thermo Fisher Scientific, Hempstead, UK) at a density of 7.14x104/cm2 (5x105 cells/well) 
supplemented with 1x ITS and 50µg/ml ascorbate-2-phosphate. Cells were incubated at 
37°C, 5% (v/v) CO2 for 24h prior to transfection.  
Chondrocytes were transfected with miR oligonucleotides (inhibitors or mimics) using 
DharmaFECT1™ lipid reagent (Dharmacon, UK). To assess transfection levels, Cy3™- anti-
miR™ negative control #1 (Thermo Fisher Scientific, St. Leon-Rot, Germany) was 
transfected into the cells.  mirVana® miR inhibitors (Applied Biosystems, Paisley, UK) or 
miScript miR Mimic (Qiagen, West Sussex, UK) were used to manipulate the level of 
examined miRs, whereas mirVana™ miR Inhibitor Negative Control #1 (Applied 
Biosystems, Paisley, UK) and AllStars negative control siRNA (Qiagen, West Sussex, UK) 
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were used as transfection controls. Mock (DharmaFECT1™ only) and untreated cells 
presented additional controls. Cells were incubated in transfection reagents with 50nM 
final concentration of siRNA at 37°C, 5% (v/v) CO2 for 48h. Transfections were performed 
according to the manufacturer’s protocol and volumes described in this subsection are 
representative of a single well in a 6-well plate. 10μl (20μM stock) siRNA and 8μl 
DharmaFECT1™ were diluted respectively in 90μl and 92μl DMEM/F12–GlutaMAX™ and 
left for 5 minutes at room temperature. They were then combined, mixed and left at 
room temperature for 20 minutes to form the lipid-siRNA complex. The complex was 
subsequently added to 3.8ml penicillin/streptomycin free DMEM/F12–GlutaMAX™ 
supplemented with 1x ITS and 50µg/ml ascorbate-2-phosphate. After removing culture 
media from the plated cells, the total volume (4ml) of transfection mix was transferred 
onto the cells in the well.  
2.2.2.1. Measurement of cell viability/death 
Viability of transfected cells was assessed by a Live/Dead® Assay according to the 
manufacturer’s protocol (Invitrogen, Paisley, UK). The kit contains 2 dyes, green calcein 
AM which is converted into fluorescent calcein by enzymes in live cells, and red ethidium 
homodimer-1 that diffuses into dead cells through their damaged membrane and 
produces a bright red fluorescence in dead cells after binding to nucleic acids. 
Transfected and untreated cells cultured on plastic Nunc Lab-Tek Chamber Slides were 
treated with 0.1µM calcein AM and 0.2µM ethidium homodimer-1 (diluted in culture 
media at 37oC) for 20 minutes in the dark, washed briefly in 37oC 1% PBS (VWR, 
Lutterworth, UK) and imaged with a Zeiss LSM 800 laser confocal microscope using ZEN 
lite software (Carl Zeiss, Cambridge, UK). A 20x objective lens was used to image live 
(green) and dead (red) cells using appropriate filters for FITC and Alexa Fluor® 594 with 
excitation/emission wavelengths of ~490/525nm and ~590/617nm, respectively. Three 
individual regions from each chamber in two repeats were visualised giving in total  
n = 6 images per condition. A count of green and red labelled cells was performed using 
Image J (http://imagej.en.softonic.com) and the percentage of cell viability/death per 
treatment was assessed as a mean from six individual data sets.   
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2.2.2.2. Analysis of transfection efficiency using immunofluorescence microscopy  
The Bx61 upright fluorescence microscope controlled by MicroSuite™ Software 
(Olympus, Essex, UK) was used to assess the siRNA uptake by transfected cells.  
The chamber slides were mounted with VECTASHIELD® containing DAPI (Vector 
Laboratories Ltd, Peterborough, UK) and covered with coverslips. The level of 
transfection was examined using 20x and 40x oil immersion objective lens to image 
chondrocytes with excitation/emission wavelength settings for Alexa Fluor® 594 (red) at 
~590/617nm and DAPI (blue) at ~358/461nm.  
 
2.3. RNA extraction  
2.3.1. RNA extraction from articular cartilage explants for mRNA analysis 
Total RNA was extracted from articular cartilage explants using 500µl Trizol® reagent 
(Invitrogen, Paisley, UK). Snap frozen cartilage tissue was powdered in 250µl Trizol® 
(Invitrogen, Paisley, UK) at 2,000rpm for 90 seconds using liquid nitrogen cooled 
chambers in a Mikro-Dismembrator (Braun Biotech, Melsungen, Germany).  
An additional volume of 250µl Trizol® was added to powdered tissue, pipetted up and 
down several times to ensure complete mixture of the Trizol® with the tissue and 
transferred to 1.5ml RNase free tubes (Alpha Laboratories, Eastleigh, UK). After  
5 minutes incubation at room temperature, 150µl chloroform was added to the Trizol® 
extract to denature proteins and solubilise them in the organic phase. After a further  
10 minutes incubation at room temperature, the samples were subjected to 
centrifugation (12,500g, 15 minutes, 4°C) and the upper aqueous phase containing RNA 
was transferred to a new tube; 300µl of 100% (v/v) ethanol was added and mixed by 
inversion at room temperature. RNA was then purified using Qiagen RNeasy mini kits 
following the manufacturer’s protocols (Qiagen, West Sussex, UK). All centrifugation 
steps were conducted at room temperature. The aqueous phase-ethanol mix was 
applied to the RNeasy spin columns and centrifuged at 15,100g for 15 minutes. The flow-
through was discarded and the columns were washed twice with 300µl RW1 buffer, with 
centrifugation at 12,200g for 45 seconds after each wash. After the second wash, spin 
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columns were washed with 500µl of RPE buffer and centrifuged at 12,200g for  
45 seconds. The flow-through was discarded and the columns were centrifuged at 
21,700g for 2 minutes to eliminate any residual wash buffer. To elute RNA residing in 
the columns, 30µl of water was added to the spin columns placed in new collection 
tubes, and after 1 minute incubation the spin columns were centrifuged at 15,100g for  
45 seconds. RNA was transferred into sterile tubes and submitted for Bioanalyzer 
analysis (Agilent Technologies, Wokingham, UK); remaining RNA was stored at -80°C.    
2.3.2. RNA extraction from articular cartilage explants for miR analysis 
Total RNA was extracted from articular cartilage explants using 500µl Trizol® reagent. 
Snap frozen cartilage tissue was powdered in 250µl Trizol® as previously described 
(Section 2.3.1). An additional 750µl volume of Trizol® was added to the powdered tissue, 
pipetted up and down 30 times to ensure complete mixing of the Trizol® and tissue, and 
transferred to 1.5ml RNase free tubes. After 5 minutes incubation at room temperature, 
200µl chloroform was added to the Trizol®-tissue homogenate and samples were 
vortexed for 15 seconds. Following 10 minutes incubation (5 minutes at room 
temperature and 5 minutes on ice) samples were centrifuged at 13,800g (4°C,  
10 minutes). The aqueous phase was transferred to new RNase free tubes followed by 
precipitation of RNA with 100% (v/v) ethanol (1.25 volumes per aqueous phase volume) 
at room temperature. Total RNA was then purified using a mirVana™ miR Isolation Kit 
(Ambion, Paisley, UK) following the manufacturer’s protocol.  All centrifugation steps 
were carried out at room temperature. The lysate/ethanol mix was transferred to the 
spin column and centrifuged at 10,000g for 15 seconds. The flow-through was removed 
and the spin columns were then washed with 700µl wash solution 1 and then briefly 
centrifuged at 10,000g. The flow-through was again discarded and the spin columns 
were washed twice with 500µl of wash solution 2/3 buffer followed by centrifugation at 
10,000g for 15 seconds after each wash. The supernatant was removed and the spin 
columns were centrifuged at 10,000g for 2 minutes to remove residual ethanol. Finally, 
to elute RNA residing in the columns, 40µl of pre-heated (95°C) elution buffer was added 
to the spin columns placed in new collection tubes; after 1 minute incubation, the spin 
columns were centrifuged at 10,000g for 1 minute. Eluted RNA was applied to the filter 
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cartridge and centrifuged at 46,800g for 1 minute. In a final volume of 40µl, RNA was 
treated with 4µl 10x DNase buffer and 1µl DNase (2U/µl, Ambion, Paisley, UK) for  
30 minutes at 37°C to remove genomic DNA. 4µl of inactivating reagent (Ambion, 
Paisley, UK), was then added to inhibit the DNase activity (2 minutes, room 
temperature). After a brief spin at 14,500g (1.5 minutes, 4°C), RNA was transferred to 
sterile tubes and RNA purity and yield determined using the Bioanalyser (Agilent 
Technologies, Wokingham, UK). RNA was stored at -80°C.  
2.3.3. Total RNA extraction from chondrocytes for both mRNA and miR analysis 
Total RNA was extracted from primary chondrocytes by applying 1ml Trizol® reagent to 
each well containing cells, and contents pipetted up and down several times to increase 
the efficiency of Trizol® activity. The Trizol®- cell homogenate was transferred into 1.5ml 
RNase free tubes and processed as previously described (Sections 2. 3. 1 and 2. 3. 2 for 
mRNA and miR respectively).  
2.3.4. Evaluation of RNA quality and yield - Bioanalyzer analysis 
The Agilent 2100 Bioanalyzer and associated RNA 6000 Nano kit (Agilent Technologies, 
Wokingham, UK) was used to assess the quality and concentration of purified RNA by 
producing an RNA integrity number (RIN); the RIN is a measurement designed to 
establish the integrity of total RNA by determining the ratio of 18S and 28S ribosomal 
subunits. The RIN software algorithm classifies the total RNA based on a numeric system 
from 1 to 10, with 1 being totally degraded and 10 being the most intact (Figure 2.2) 
(Mueller et al., 2004). The analysis of RIN was performed by Central Biotechnology 
Services (School of Medicine, Cardiff University) on 1.5µl of total RNA. 
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Figure 2.2. Sample electrophoretograms illustrating different RNA qualities as described 
by the RNA Integrity Number (RIN). Samples range from intact (RIN 10) to degraded  
(RIN 2) (Mueller et al., 2004). 
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2.4. cDNA synthesis 
2.4.1. Reverse transcription of mRNA template 
First strand complementary deoxyribonucleic acid (cDNA) was generated using 
Superscript™ III reverse transcriptase according to the manufacturer’s protocol 
(Invitrogen, Paisley, UK). 1µl random primers (500µg/ml, Promega, Southampton, UK), 
1µl dNTPs (10mM, Promega, Southampton, UK), 300ng RNA and sterile water were 
added together to give a total volume of 13µl, and incubated at 65°C for 5 minutes. After 
adding 4μl 5×first-strand buffer (250mM Tris-HCl, pH 8.3, 375mM KCl, 15mM MgCl2), 1µl 
dithiothreitol (0.1M DTT) and 1µl Recombinant RNase Inhibitor (40U/µl, Promega, 
Southampton, UK), 1µl Superscript III reverse transcriptase (200U/µl, Invitrogen, Paisley, 
UK) was added and incubated at the following temperatures: 25°C for 5 minutes, 50°C 
for 60 minutes in a Prime Techne thermocycler (Bibby Scientific Limited, Staffordshire, 
UK). The reaction was terminated by heating the samples at 70°C for 15 minutes. 
2.4.2. Reverse transcription of miR template 
cDNA of mature miRs was generated separately from total RNA (purified by mirVana™ 
miR Isolation Kit, Section 2.3.2) using the TaqMan® MicroRNA Reverse Transcription Kit 
(Applied Biosystems, Paisley, UK) and stem-looped RT primers, specific to individual 
miRs, from TaqMan® MicroRNA Assays (Applied Biosystems, Paisley, UK) as indicated 
(Table 2.1). miR was synthesised in a 15µl reaction following the manufacturer’s 
protocol:  1.5µl 10x reverse transcription buffer, 0.15µl dNTPs (100mM), 0.19µl RNase 
inhibitor (20U/µl), 1µl MultiScribe™ Reverse Transcriptase (50U/μl) and 4.16µl sterile 
water were added together to give a total volume of 7µl of Master Mix. Master Mix was 
then added to 5µl RNA (5ng), mixed and centrifuged (16,200g, 5 seconds at room 
temperature). 3µl 5x reverse transcription primers were then added to the Master 
Mix/RNA. Samples were incubated at 16°C for 30 minutes, 42°C for 30 minutes and the 
reaction was terminated by heating the samples at 85°C for 5 minutes. Reactions were 
carried out using a Prime Techne thermocycler (Bibby Scientific Limited, Staffordshire, 
UK). 
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Table 2.1. Stem-looped reverse transcription primer sequences used in the amplification 
of mature miRs using TaqMan® MicroRNA assays. 
 
Assay ID Assay name miRBase ID Mature miR sequence 5’-3’ 
005982_mat bta-miR-21 bta-miR-21-5p UAGCUUAUCAGACUGAUGUUGACU 
002445 hsa-miR-27a* bta-miR-27a-5p AGGGCUUAGCUGCUUGUGAGCA 
001188 mmu-miR-140* bta-miR-140 UACCACAGGGUAGAACCACGGA 
001134 mmu-miR-221 bta-miR-221 AGCUACAUUGUCUGCUGGGUUU 
002276 hsa-miR-222 bta-miR-221 AGCUACAUCUGGCUACUGGGU 
001105 hsa-miR-451 bta-miR-451 AAACCGUUACCAUUACUGAGUUU 
002339 hsa-miR-483-3p bta-miR-483 UCACUCCUCUCCUCCCGUCUU 
002376 hsa-miR-543 bta-miR-543 AAACAUUCGCGGUGCACUUCUU 
 
 
2.5. Quantitative Polymerase Chain Reaction (qPCR) 
mRNA quantification of genes of interest in experimental samples were measured by 
qPCR with either Brilliant III Ultra-Fast SYBR® Green QPCR Master Mix (Agilent 
Genomics, Berkshire, UK) or TaqMan® Fast Advanced Master Mix (Applied Biosystems, 
Paisley, UK). 
2.5.1. Primers 
Bovine-specific primer sequences (Tables 2.2 - 2.3) were either adapted from the 
literature or designed using Primer-Blast software with the following criteria: [i] to span 
exon-exon boundaries and [ii] to generate an amplicon within the range of 70-250bp. 
Designed primers were checked through the NCBI BLAST database to eliminate the 
possibility of binding to unintended targets. Primers (Eurofins Genomics, Ebersberg, 
Germany) were optimised by polymerase chain reaction (PCR). Primer efficiencies were 
examined by generating standard curves of individual genes, created from a series of 
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five 10-fold dilutions of pooled cDNA from untreated (controls) and treated 
(loaded/transfected) samples. Efficiencies in the range of 95-110% indicated that the 
examined genes were appropriate for cross-comparing with other genes of interest. 
 
Table 2.2. Quantitative PCR primer sequences for reference genes, annealing 
temperature (AT°) and product size. 
 
Primers Sequences 5’-3’ 
Annealing 
temperature 
(AT°) 
Amplicon length 
(bp) 
SDHA-F 
SDHA-R 
GATGTGGGATCTAGGAAAAGGCCTG 
ACATGGCTGCCAGCCCTACAGA 
60 104 
YWHAZ-F 
YWHAZ-R 
CTGAGGTTGCAGCTGGTGATGACA 
AGCAGGCTTTCTCAGGGGAGTTCA 
60 180 
PPIA-F 
PPIA-R 
GGTGGTGACTTCACACGCCATAATG 
CTTGCCATCCAACCACTCAGTCTTG 
60 186 
RPL4-F 
RPL4-R 
TTTGAAACTTGCTCCTGGTGGTCAC 
TCGGAGTGCTCTTTGGATTTCTGG 
60 199 
HPRT-F 
HPRT-R 
TAATTATGGACAGGACCGAACGGCT 
TTGATGTAATCCAACAGGTCGGCA 
60 127 
GAPDH-F 
GAPDH-R 
TTGTCTCCTGCGACTTCAACAGCG 
CACCACCCTGTTGCTGTAGCCAAAT 
60 133 
β-actin-F 
β- actin-R 
CATCGCGGACAGGATGCAGAAA 
CCTGCTTGCTGATCCACATCTGCT 
60 157 
18S-F 
18S-R 
GCAATTATTCCCCATGAAACG 
GGCCTCACTAAACCATCCAA 
60 123 
 
Primer sequences for 18S were taken from (Frye et al., 2005), whereas the other primer 
sequences were obtained from (Anstaett et al., 2010). 
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Table 2.3. Quantitative PCR primer sequences for target genes of interest, annealing 
temperature (AT°) and product size. 
Primers Sequences 5’-3’ 
Annealing 
temperature 
(AT°) 
Amplicon 
length (bp) 
References 
MMP1-F 
MMP1-R 
CAAATGCTGGAGGTATGATGA 
AATTCCGGGAAAGTCTTCTG 
60 82 
(Shieh and 
Athanasiou, 
2007) 
MMP3-F 
MMP3-R 
TGGAGATGCTCACTTTGATGATG 
GAGACCCGTACAGGAACTGAATG 
60 221 
(Li et al., 
2011b) 
MMP7-F 
MMP7-R 
GGAGCGAAGCAATCCCACTGACG 
GGGTCCCCATGAGCTCTTCTTGC 
60 91  
MMP9-F 
MMP9-R 
TAGCACGCACGACATCTTTC 
GAAGGTCACGTAGCCCACAT 
60 121 (Blain et al., 
2010) 
MMP-13-F 
MMP-13-R 
CCCTTGATGCCATAACCAGT 
GCCCAAAATTTTCTGCCTCT 
60 201 (Blain et al., 
2010) 
ADAMTS4-F 
ADAMTS4-R 
CTCCATGACAACTCGAAGCA 
CTAGGAGACAGTGCCCGAAG 
60 169 (Blain et al., 
2010) 
ADAMTS5-F 
ADAMTS5-R 
CTCCCATGACGATTCCAAGT 
TACCGTGACCATCATCCAGA 
60 155 (Blain et al., 
2010) 
Collagen2-F    
Collagen2-R 
AACGGTGGCTTCCACTTC 
GCAGGAAGGTCATCT GGA 
60 69 
(Darling and 
Athanasiou, 
2005) 
Aggrecan-F 
Aggrecan-R 
GCTACCCTGACCCTTCATC 
AAGCTTTCTGGGATGTCCAC 
60 76 
(Darling and 
Athanasiou, 
2005) 
TIMP-1-F 
TIMP-1-R 
CTGCGGATACTTCCACAGGT 
ATGGATGAGCAGGGAAACAC 
60 75 (Li et al., 
2011b) 
TIMP-2-F 
TIMP-2-R 
ATAGTGATCAGGGCCAAAGCAGTC 
TGTCCCAGGGCACGATGAAGTC 
60 277 (Milner et al., 
2006) 
TIMP-3-F 
TIMP-3-R 
GACATCGTGATCCGAGCCAA 
TGGGGCATCTTGGTGAATCC 60 119 
(Al-Sabah, 
2014, PhD 
thesis, Cardiff 
University) 
HDAC4-F 
HDAC4-R 
AACAAGGAGAAGGGCAAAGAG 
CGTCCTTCCCGTACCAGTAGC 
60 150  
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Runx2-F 
Runx2-R 
CATGGTGGAGATCATCGCTG 
CGCCATGACAGTAACCACAG 
60 172  
SPRY4-F 
SPRY4-R 
           GATAGCGGCGTCCGATCC   
AGGCTTCTAGGGGCCTTTGAG 
60 94  
Wnt3A-F 
Wnt3A-R 
GGGGCTGGCAGAGTGTCCCT 
GGCGCAGAGGATGGGCTGTG 
60 72  
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2.5.2. SYBR® Green qPCR 
SYBR® Green qPCR requires a fluorescent dye which specifically binds to  
double-stranded DNA in the PCR reaction. SYBR® Green I binding to the newly 
synthesised double-stranded DNA generates a fluorescent signal that is proportional to 
the amount of amplified DNA. The point at which the fluorescence signal is significantly 
higher than the background is referred to as the threshold cycle (Ct). The Ct value for 
individual amplification is the number of cycles at which the amplification plot crosses 
the baseline set (threshold) (Figure 2.3A). The Ct values were used to establish the 
relative quantification for all genes analysed. As SYBR® green I binds all double stranded 
DNA, the dissociation curve was performed at the end of the qPCR to confirm that only 
the product of interest was amplified as indicated by a single fluorescent peak on the 
melting curve (Figure 2.3B). To work out relative changes in target gene expression the 
2-ΔΔCT method (Livak and Schmittgen, 2001) was used; relative quantification is presented 
as fold change in a gene of interest in experimental samples in comparison to 
unloaded/negative control samples. The fold change was normalised to the geometric 
mean of two reference genes in combination that were identified as being unaffected 
by the experimental conditions under investigation. qPCR reactions were performed 
with the Mx3000P®QPCR System and MxPro QPCR software (Stratagene, Cambridge, 
UK) using Brilliant III Ultra-Fast SYBR® Green QPCR Master Mix (Agilent Technologies, 
Wokingham, UK) on RNase/DNase-free 96 well plates (Agilent Technologies, 
Wokingham, UK). cDNA was amplified in a total reaction volume of 20μl (Table 2.4).  
The plate contents were collected by centrifugation for 1 minute and amplification 
performed using the conditions shown in Table 2.5. An annealing step was carried out 
at 60°C unless indicated otherwise (Table 2.2 and Table 2.3). 
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Figure 2.3. Representative amplification plot and melting curve for TIMP-3 SYBR® Green 
qPCR. Amplification plot showing cycle numbers at which fluorescent signal from the 
gene of interest was significantly elevated against the background and crossed the 
threshold (Ct values) (A). Melting curve generated from amplicons subjected to 
dissociation analysis showing a single peak indicative that only a single product was 
amplified in the qPCR reaction (B). The orange line shows no amplification and 
represents a no template control. 
 
A. 
B. 
80 
Table 2.4. Components for a single SYBR® Green qPCR reaction. 
 
Component Volume 
                     2x SYBR® Green QPCR Master Mix buffer 10μl 
primers (forward and reverse) 
(10µM stock) 
0.4μl 
cDNA / water (non-template control) 1μl 
water 8.6µl 
Total 20µl 
  
 
 
Table 2.5. SYBR® Green qPCR cycling conditions to amplify genes of interest. 
 
Cycle step Temperature (°C) Time Cycles 
Initial Denaturation 95 3 minutes  1 
Denaturation 95 15 seconds 
40 
Annealing/Extension 60 20 seconds  
Dissociation 
95 
60 
95 
 1 minutes 
30 seconds 
30 seconds 
1 
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2.5.3. Probes 
Quantification of expression levels of target genes of interest were measured using 
bovine-specific TaqMan® probes (Applied Biosystems, Paisley, UK) as described (Table 
2.1 and Table 2.6). 
 
Table 2.6. TaqMan® Gene expression assays used in the quantification of genes of 
interest. 
Gene Assay ID Assay name 
Amplicon 
length 
CPEB3 Bt02655331_m1 
CPEB3 TaqMan® Gene 
Expression 
71 
LIFR Bt02626849_m1 
LIFR TaqMan® Gene 
Expression 
121 
 
 
2.5.4. TaqMan®PCR 
TaqMan® qPCR relies upon the use of fluorescently labelled oligonucleotides 
complementary to the region of target gene which produces a fluorescent signal upon 
amplification of cDNA. Each TaqMan® MGB (minor groove binder) probe contains:  
(i) reporter fluorescent dye (FAM™ dye) at the 5′ end (ii) a non-fluorescent quencher 
(NFQ) attached to the 3’ end to block the activity of fluorescent dye and (iii) a minor 
groove binder (MGB) at the 3´ end that allows an extremely stable duplex to form with 
single stranded target DNA. The probe is designed to bind the gene of interest and 
resides between the forward and reverse primers. During strand elongation, the DNA 
polymerase cleaves the hybridized target gene probe, separating the fluorescent 
reporter from the quencher, hence promoting a fluorescent signal. Despite differences 
in the chemistry between SYBR® Green and TaqMan® qPCR, the concept and principles 
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of the data analysis are identical. Quantification of the relative expression levels of 
target genes amplified using probe qPCR was performed as described for SYBR® Green 
(Section 2.5.2).  
TaqMan® qPCR was conducted using the same system, software and 96-well plates as 
for SYBR® Green qPCR (Section 2.5.2); however, TaqMan® Fast Advanced Master Mix 
(AmpliTaq® Fast DNA Polymerase, Uracil-N glycosylase (UNG), dNTPs with dUTP, ROX™ 
dye (passive reference), optimised buffer components; Applied Biosystems, Paisley, UK) 
were utilised instead. Following the manufacturer’s protocol, miR expression was 
analysed in a reaction of 10μl (Table 2.7), whilst mRNA expression of target genes was 
assessed in a 20μl reaction (Table 2.8), with qPCR performed under specific cycling 
conditions (Table 2.9).  
 
Table 2.7. Components for a single TaqMan® miR qPCR reaction. 
 
Component Volume 
TaqMan® Fast Advanced Master Mix (2x) 5μl 
TaqMan® Gene Expression Assay (20x) 0.5μl 
reverse transcribed miR/water 1μl 
water 3.5μl 
Total       10μl 
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Table 2.8. Components for a single TaqMan® gene expression qPCR reaction. 
 
Component Volume 
TaqMan® Fast Advanced Master Mix (2x) 10μl 
TaqMan® Gene Expression Assay (20x) 1μl 
cDNA/water 2μl 
water 7μl 
Total       20μl 
 
 
Table 2.9. TaqMan qPCR cycling conditions to amplify miRs or genes of interest. 
 
Cycle step Temperature (°C) Time Cycles 
UNG incubation 
(to avoid DNA contamination)  
50 2 minutes 1 
Polymerase activation 95 20 seconds 1 
Denaturation 95 3 seconds 
40 
Annealing/Extension 60 30 seconds 
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2.6. Selection of suitable reference genes for quantitative PCR  
To optimise the most appropriate reference genes for the experimental system in use 
i.e. mechanical load, transfection with miR inhibitor or mimic, a panel of reference genes 
was analysed: SDHA, YWHAZ, PPIA, RPL4, HPRT, GAPDH, β-actin, (Anstaett et al., 2010) 
and 18S (Frye et al., 2005) (Table 2.10). Selection of the most stable combination of 
reference genes for normalisation of experimental samples was performed using 
RefFinder software (http://fulxie.0fees.us/). RefFinder integrates the most popular 
softwares designed for assessment of reference gene stability on the basis of gene Ct 
values: geNorm (Vandesompele et al., 2002), BestKeeper (Pfaffl et al., 2004), 
Normfinder (Andersen et al., 2004) and the comparative delta-Ct method (Silver et al., 
2006). Each of these computational programmes contains individual algorithms to 
evaluate the most appropriate reference gene. Based on the data from each individual 
software, RefFinder assigns a value to each tested gene and then calculates the 
geometric mean of their values to rank the genes according to their stability (from most 
to least stable). 
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Table 2.10. Function of tested reference genes. 
Gene Function 
    
Reference 
β-actin 
(β-actin) 
Cytoskeletal structural molecule 
(Gunning et 
al., 2015) 
GAPDH 
(glyceraldehyde-3-phosphate 
dehydrogenase) 
An enzyme involved in glycolysis and 
gluconeogenesis 
(Glare et al., 
2002) 
HPRT1 
(hypoxanthine 
phosphoribosyltransferase 1) 
An enzyme involved in biosynthesis of purine 
nucleotides via the salvage pathway (from 
intermediates of degraded RNA and DNA) 
(Torres and 
Puig, 2007) 
PPIA 
(peptidylprolyl isomerase A 
(cyclophilin A)) 
A molecule with isomerase activity which assists 
in protein folding 
(Thali et al., 
1994) 
RPL4 
(ribosomal protein L4) 
It is a component of large ribosomal subunit 
involved in forming the protein exit tunnel  
(O'Connor 
et al., 2004) 
SDHA 
(Succinate Dehydrogenase 
Complex Flavoprotein 
Subunit A) 
A flavoprotein-containing subunit of SDH 
complex which is bound to the inner membrane 
of the mitochondria and participates in 
oxidative phosphorylation.  
(Lee et al., 
2016) 
YWHAZ 
(Tyrosine 3-
Monooxygenase/Tryptophan 
5-Monooxygenase Activation 
Protein Zeta) 
Molecule belonging to 14-3-3 protein family 
which modulate signal transduction by binding 
phospho-serine containing proteins and is 
therefore implicated in a wide array of cellular 
activities such as cell signalling, division, 
apoptosis and cytoskeletal organization.  
(Kuboki et 
al., 2012, 
Mackintosh, 
2004, Yang 
et al., 
2016b) 
18S 
(18S ribosomal RNA) 
Ribosome subunit 
(Doudna 
and Rath, 
2002) 
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2. 7. Global gene analysis using Affymetrix mRNA arrays 
Analysis of the entire bovine genome was performed using the Bovine GeneChip® Gene 
1.0 ST array containing 26,773 genes to identify mechanically-regulated transcripts. 
Explants were subjected to either a 2.5MPa or 7MPa load (1Hz, 15 min) or left unloaded, 
and RNA processed 4h or 24h post-cessation of load; arrays were conducted on two 
independent sets of samples (n = 6, N = 2) (Central Biotechnology Services, School of 
Medicine, Cardiff University). RNA quality was assessed using the Bioanalyzer (Section 
2.3.4) with all selected samples containing a RNA integrity number (RIN) of >8.  RNA 
(100ng) was biotinylated using Genechip® WT Plus Reagent kit and subsequently 
hybridized to the Genechip® Bovine 1.0 ST arrays.  Genechip® poly A RNA control kit was 
used to ensure equivalent preparation and labelling efficiencies.  Hybridized RNA was 
detected using the Genechip® Hybridization, wash and stain kit.  Arrays were washed 
and stained in conjunction with Genechip® Fluidics station 450, and arrays scanned using 
the GeneChip® Scanner 3000 7G. 
2.7.1. Bioinformatic analysis of Affymetrix mRNA arrays 
The mRNA arrays were analysed by Dr Timothy Stone (Central Biotechnology Services 
Bioinformatician, Cardiff, UK) in the R Statistical programming environment using the 
“oligo” (Carvalho and Irizarry, 2010) and “limma” (Ritchie et al., 2015) packages that are 
available on Bioconductor (https://www.bioconductor.org/). The arrays were 
normalised via RMA normalisation (Irizarry et al., 2003). The quality of the arrays was 
assessed via principal component analysis to determine if there were any sample arrays 
that contained significant global outliers in terms of gene expression. Statistical testing 
for differential expression was  performed by testing P-values using Benjamini-Hochberg 
(Benjamini and Hochberg, 1995) and adjusted p-values at a threshold of 5% were used 
to determine statistical significance.  
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2.8. Next Generation Sequencing of miRs 
Identification of mechanically-regulated miRs in articular cartilage was performed using 
Next Generation Sequencing (NGS). Explants were subjected to either a 2.5MPa or 7MPa 
load (1Hz, 15 minutes) or left unloaded, and RNA processed 2, 6 or 24h post-cessation 
of load. 
2.8.1. Preparation of pooled samples 
RNA samples (n = 6) from each loading regime and duration post-load (Figure 2.4A) were 
pooled respectively to create representative samples containing >3.5µg of RNA per 
sample (Figure 2.4B). For every combination of load and period post-load,  
3 independent repeat experiments were performed providing 3 independent samples 
of pooled RNA per regime (Figure 2.4C). 
     
Figure 2.4. Schematic diagram of pooled experimental RNA to create representative 
samples. 6 independent samples from each period post load (A) were pooled to provide 
a single sample (B). Each experiment was performed 3 times which resulted in  
3 representative independent repeats (C) of each combination of loading regime and 
period post-cessation of load. Key:  MPa - megapascal, Hz - hertz, PL - post-load,  
h - hours.               
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2.8.2. miR library preparation  
The purity and yield of total RNA was assessed using the Bioanalyzer (Section 2.3.4), and 
RNA integrity number (RIN) of all RNA samples was ≥8. Library preparation for all 
samples was conducted on 6μl of total RNA containing 450ng of RNA. The library 
preparation workflow consisted of the following 9 steps: 1. Ligation of 3’ adaptor,  
2. Primer hybridisation, 3. Ligation of 5’ adaptor, 4. Reverse transcription, 5. PCR, 6. 
Electrophoresis and recovery of library band, 7. Elution of library from gel, 8. Next 
Generation Sequencing, and 9. Data analysis (Figure 2.5). To prepare miR libraries, 
NEBNext® Small RNA Library Prep Set for Illumina® (Multiplex Compatible: BioLabs, 
Hitchin, UK) components were used. 
 
 
 
Figure 2.5. Schematic diagram of miR Illumina Next Generation Sequencing workflow. 
Adapted from (Borodina et al., 2011). 
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2.8.2.1. Amplification of miR libraries 
Amplification of miR libraries was performed according to the manufacturer’s protocol 
(BioLabs, Hitchin, UK). The 3’ adaptor ligation was conducted in a 20μl total volume.  
1μl 3’ SR Adaptor for Illumina was added to 450ng RNA and incubated in a thermal cycler 
at 70°C for 2 minutes. 10μl 3’ Ligation Reaction Buffer (2x) and 3μl 3’ Ligation Enzyme 
Mix were added to the tubes on ice and incubated at 25°C for 1h. To prevent formation 
of 3’ Adaptor - 5’ Adaptor, the primer hybridisation step was performed to transform 
the single stranded DNA adaptor into double-stranded DNA molecules. This step was 
conducted by adding 1μl SR RT primer for Illumina and 4.5μl water. Samples were 
heated at 75°C for 5 minutes and then transferred to 37°C for 15 minutes, followed by 
15 minutes at 25°C. 5’ SR Adaptor was ligated by mixing 1μl 5’ SR Adaptor for Illumina 
(denatured at 70°C for 2minutes), 1μl 5’ Ligation Reaction Buffer (10x) and 5’ Ligation 
Enzyme Mix, and heating at 25°C for 1h. Reverse transcription of miRs was then 
performed by adding 8μl First Strand Synthesis Reaction Buffer (5x), 1μl Murine RNase 
Inhibitor and 1μl ProtoScript II Reverse Transcriptase (200,000U/ml) to 30μl of adaptor 
ligated RNA and incubation at 50°C for 1h. PCR amplification was conducted 
immediately after cDNA synthesis. 50μl LongAmp® Taq 2x Master Mix, 2.5μl SR Primers 
for Illumina, 2.5μl bar coded primers (10µM) and 5μl water were mixed with 40μl 
reverse transcription reaction. PCR reaction was performed using the MJ Research  
PTC-200 thermal cycler (Hertfordshire, UK) under the following conditions (Table 2.11). 
Table 2.11. PCR cycling conditions utilised to amplify miR libraries. 
Cycle Step          Temperature (°C)                    Time     Cycles 
Initial denaturation                      94              30 seconds         1 
Denaturation                      94              15 seconds 
       15 Annealing                      62              30 seconds 
Extension                     70              15 seconds 
Final Extension                     70                5 minutes        1 
Hold                      4           ∞  
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2.8.2.2. Purification of cDNA 
To remove primers, nucleotides, polymerases and salts from the PCR product, 100μl PCR 
amplified cDNA was purified using a QIAquick PCR Purification Kit (Qiagen, West Sussex, 
UK) following the manufacturer’s protocol. All centrifugation steps were carried out at 
18,000g at room temperature. PB Buffer was added to the PCR sample in a ratio of 1:5 
and then transferred to QIAquick spin columns placed in collection tubes, followed by 
centrifugation for 60 seconds. The flow-through was discarded and the columns washed 
with 750μl PE Buffer and centrifuged twice for 2 minutes with removal of flow-through 
in between; the second spin was conducted with lids of the spin columns opened. 
QIAquick columns were transferred to clean 1.5ml tubes and 30μl Buffer EB (10mM  
Tris-HCl, pH 8.5) was added. The QIAquick columns were incubated at room 
temperature for 1 minute before being centrifuged for 1 minute to elute the DNA. 
2.8.2.3. Confirmation and size selection of amplified miRs 
To select miR libraries, purified cDNA samples were run on 8% polyacrylamide gels 
(Table 2.12).  
 
Table 2.12. Reagents used in the preparation of an 8% polyacrylamide gel. 
Reagents 8% polyacrylamide gel  
40% 19:1 bis/acrylamide 3 ml 
5x TBE buffer 1.5 ml 
10% (w/v) ammonium persulphate (APS)  300 µl 
Tetramethylethylenediamine (TEMED) 15 µl 
dH2O  10.185ml 
Total 15 ml 
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Samples were mixed with 1µl 6x Bromophenol Blue Dye (BioLabs, Hitchin, UK) and 
loaded into the wells of the gel (one sample per gel) next to 5μl diluted (1:2) DNA ladder 
(final concentration 125ng; BioLabs, Hitchin, UK). Electrophoresis using 0.5x TBE as 
running buffer was carried out at 120V until the dye was at the bottom of the gel. The 
gel was stained in 5ml 0.5% TBE with 5µl SYBR® Gold Nucleic Acid Gel Stain (10,000x) 
(Invitrogen, Paisley, UK) for 5 minutes. The SYBR® gold stained libraries were then 
visualised using an UV transiluminator (Figure 2.6A) and bands in the appropriate region 
of the gel were excised using a sterile scalpel blade (Figure 2.6B). miR libraries were 
located at the level of ~140bp. 
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2.8.2.4. Elution and purification of miRs from 8% polyacrylamide gel 
Gel bands were transferred into microtube gel breaker tubes (made by puncturing the 
bottom of a sterile, nuclease-free, 1.5ml microcentrifuge tube 5 times with a 21‐gauge 
needle); the punctured tubes were located in 2ml collection tubes and centrifuged at 
13,000g for 5 minutes at room temperature. 250µl of 1x DNA Gel Elution Buffer (NEB 
Next® Small RNA Library Prep Set for Illumina® (Multiplex Compatible) kit) was added to 
the collection tubes containing the excised gel and the tubes were shaken at room 
temperature for 4h. The eluates with the remaining gels were then transferred to the 
top of the Corning Costar® Spin-X® Columns (0.45µm); to remove the gel debris, the 
columns were centrifuged at 13,000g for 5 minutes until all the eluate moved to the 
bottom of the collecting tube. 
2.8.2.9. Purification and concentration of miR libraries 
2μl of glycogen (GlycoBlue™; Invitrogen, Paisley, UK), 40μl of 3M sodium acetate  
(pH 5.2) and 975μl of pre‐chilled (‐25°C) 100% (v/v) ethanol were added to the eluted 
miRs, and briefly vortexed and centrifuged prior to incubation at -80°C for 30 minutes 
to precipitate the miRs. The samples were then centrifuged at 13,000g for 30 minutes 
at 4°C and the resulting DNA pellet was washed with 80% (v/v) ethanol. After further 
centrifugation (14,500g, 30 minutes, 4°C) the supernatant was removed and the pellet 
left to air dry. The pellet containing the miR library was treated with 12µl TE buffer to 
resuspend the cDNA. miR libraries (a library from a single sample contains an individual 
barcode for later identification) was measured and then the libraries were pooled and 
sent for NGS to The Genome Analysis Centre™ (Norwich, UK) to be sequenced on a 
HiSeq™ Sequencing System. 
2.8.3. Bioinformatic analysis of miR Next Generation Sequencing 
The data obtained from the miR deep sequencing was analysed by bioinformatician  
Mr. Andrew Skelton (Newcastle University Medical School). Initially, raw FASTQ files 
were run through FastQC to assess the quality of the data, and confirm the presence of 
a known 3’ adapter, as the 5’ adapters had already been removed (Andrews, 2010). 
Cutadapt was used to trim the FASTQ files (Martin, 2011), and discard any reads less 
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than 17 bases in length. Trimmed FASTQ files were aligned against known bos taurus 
miR sequences from miRBase. Quantification was determined by counting aligned reads 
against a reference, using a combination of RSamTools (Morgan, 2011) and ShortRead 
(Morgan et al., 2009) bioconductor packages. Differential expression was assessed using 
DESeq2 (Love et al., 2014). Global experimental variance was analysed using principal 
component analysis to assess for outlier samples. Statistical significance from 
differential expression tests was determined by retaining miRs that had an adjusted  
p value < 0.05 (Benjamini and Hochberg, 1995).  
2.9. Next Generation Sequencing of chondrocytes transfected with miR inhibitors 
Next Generation Sequencing (NGS) was performed on primary chondrocytes transfected 
with specific miR inhibitors to identify putative target mRNAs; cells were transfected 
with miR-21-5p, miR-221 or miR-222 inhibitors, a non-targeting control or untransfected 
cells for 48 h prior to analysis. 
2.9.1. Preparation of pooled samples  
RNA samples (n = 3) from each condition (Figure 2.7A) were pooled respectively to 
create representative samples containing >2µg of RNA per sample (Figure 2.7B). 
Transfection was conducted on 3 independent repeat experiments for miR-21-5p,  
miR-221 and miR-222 inhibitor and untransfected cells (n = 3, N = 3), but mirVana™ miR 
Inhibitor Negative Control #1 (Applied Biosystems, Paisley, UK) was included in 2 repeats 
only (n = 3, N = 2) (Figure 2.7C). 
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Figure 2.7.  Schematic diagram of pooled experimental RNA to create representative 
samples for Illumina® TruSeq® sequencing. 3 independent samples from each treatment 
(A) were pooled into one (B). Each experiment was performed on 3 independent cell 
preparations for miR-21-5p, miR-221 and miR-222 inhibitor and untransfected cells  
(n = 3, N = 3), however for the non-targeting miR inhibitor (MirVana™ miR Inhibitor 
Negative Control #1) this was performed on 2 independent cell preparations only (n = 3, 
N = 2) (C). 
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2.9.2. mRNA library preparation  
The purity and yield of total RNA was assessed using the Bioanalyzer (Section 2.3.4) and 
Qubit® 3.0 fluorometer using Qubit® RNA BR Assay Kit (Invitrogen, Paisley, UK). RNA 
integrity number (RIN) of all RNA samples was ≥9. The library preparation was conducted 
according to the Illumina® TruSeq® Stranded mRNA Sample Preparation LS protocol 
(Illumina, Cambridge, UK) (Figure 2.8). 
 
           
Figure 2.8. Schematic diagram of the Illumina Next Generation Sequencing workflow. 
Adapted from (Borodina et al., 2011). 
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2.9.2.1. Sample preparation, purification and fragmentation of mRNA 
This step aims to purify the poly(A) containing mRNA using poly-T oligo attached 
magnetic beads. This process contains two rounds of purification. RNA is chemically 
fragmented and prepared for cDNA synthesis in the final elution (Figure 2.9).   
Library preparation for all samples was conducted on 50μl of total RNA containing 1µg 
of RNA. Isolation of poly(A) mRNAs was performed by adding 50µl of RNA Purification 
Beads (RPB) (Illumina, Cambridge, UK) to the RNA. Samples were incubated at 65°C for 
5 minutes to denature the RNA and subsequently incubated at room temperature for  
5 minutes to facilitate binding of the poly(A) mRNA to the beads. To separate the poly(A) 
mRNA bound to the beads from the remaining solution, the samples were placed on  
a magnetic stand at room temperature for 5 minutes followed by discarding the 
supernatant without disturbing the beads. To remove unbound RNA, the beads were 
washed by gently pipetting up and down with 200µl of Bead Washing Buffer (BWB). 
After 5 minutes incubation on a magnetic stand at room temperature, the supernatant 
containing most of the ribosomal and non-messenger RNA was removed from each 
sample. To elute the mRNA from the beads, 50µl of Elution Buffer (ELB) was added 
gently to the beads and then incubated at 80°C for 2 minutes. This step released both 
the mRNA and the rRNA that had bound non-specifically to the beads, therefore  
a second round of purification was performed. To rebind mRNA to the beads and 
decrease the amount of non-specific rRNA binding, 50µl of Bead Binding Buffer was 
added to each sample; samples were pipetted up and down and incubated at room 
temperature for 5 minutes, followed by 5 minutes on the magnetic stand. Next, all of 
the supernatant was removed and the beads were washed by adding BWB and pipetting 
up and down. After 5 minutes incubation on the magnetic stand at room temperature, 
the supernatant containing contaminants that did not rebind to the beads was 
discarded. Samples were removed from the magnetic stand and 19.5µl of Fragment, 
Prime, Finish Mix was added to each sample; this reagent contains random hexamers 
for reverse transcription priming and acts as a reaction buffer for the 1st strand cDNA 
synthesis. Samples were incubated at 94°C for 8 minutes to elute, fragment and prime 
the RNA.  
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Figure 2.9. Schematic diagram of sample preparation, purification and fragmentation of 
mRNA for Next Generation Sequencing (TruSeq Stranded mRNA Sample Preparation 
Guide); Key: RPB - RNA Purification beads, BWB - Bead Washing Buffer, ELB - Elution 
Buffer and BBB - Bead Binding Buffer, FPF - Fragment, Prime, Finish mix. Adapted from 
TruSeq Stranded mRNA Sample Preparation Guide. 
2.9.2.2. First strand cDNA synthesis 
Cleaved RNA fragments were reverse transcribed into first strand cDNA using Super 
Script II reverse transcriptase (200U/µl, Invitrogen, Paisley, UK). To avoid  
DNA-dependent synthesis, Actinomycin D which inhibits DNA transcription and does not 
affect RNA-dependant synthesis was added to the First Strand Synthesis Act D mix (FSA). 
After the elute, fragment and prime step (step 13, Figure 2.9, Section 2.9.2.1), samples 
were placed onto the magnetic stand at room temperature for 5 minutes; 17µl  
of supernatant from each tube was transferred into the new tube whilst on the magnetic 
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stand. Following this, 8µl of the FSA and Super Script II mix, in a ratio of 9:1 was added 
to each sample and mixed gently. The samples were placed in a thermal cycler and 
heated at 25°C for 10 minutes, 42°C for 15 minutes, followed by 15 minutes at 70°C. 
In the next three steps in-line DNA controls such as: End Repair Control, A-Tailing Control 
and Ligation Control were used to assess the enzymatic efficiency of the following 
reagents: Second Strand Marking Master Mix, A-Tailing Mix and Ligation Mix, 
respectively. Each in-line control contains a fragment of dsDNA and was designed to 
determine whether the enzymes present in the aforementioned mixes were active.   
The results of the activity of examined enzymes is estimated based on the presence of 
sequences of the specific DNA controls in the final sequencing data; if the sequence of 
in-line DNA control is present, it indicates that the enzyme worked perfectly, however if 
the sequence of in-line control is absent, it suggests that the step failed. 
2.9.2.3. Second strand cDNA synthesis  
The purpose of this reaction is to remove the RNA template and replace it with the 
second cDNA strand. Second strand cDNA was synthesised by using Second Strand 
Master Mix (SMM) containing polymerase I, RNase H and a nucleotide mixture in which 
dTTP is replaced by dUTP. The incorporation of dUTP into the second strand inhibits its 
amplification as polymerase, used in this reaction, is not able to incorporate beyond this 
nucleotide. 5µl of End Repair Control (diluted in Resuspension Buffer at a ratio of 1:50) 
was added to each sample, followed by the addition of 20µl of Second Strand Marking 
Master Mix. The mix was pipetted up and down and then placed into the thermal cycler, 
and incubated at 16°C for 1h. 90µl of AMPure XP beads (BioLabs, Hitchin, UK) was added 
to each sample by pipetting up and down for 5 minutes at room temperature. After 15 
minutes incubation at room temperature, the sample was transferred onto the 
magnetic stand for 5 minutes at room temperature, and then 135µl of supernatant was 
discarded without disturbing the beads. The beads were washed twice with 200µl of 
80% (v/v) ethanol, with complete removal of the supernatant at each step. The second 
supernatant was removed and the beads left to air dry for 15 minutes. 17.5µl of 
Resuspension Buffer was added to each sample, pipetted up and down, incubated for 2 
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minutes and left for 5 minutes on the magnetic stand at room temperature. 15µl 
supernatant containing ds cDNA was transferred to new 0.2ml PCR tubes.  
2.9.2.4. Adenylation of 3’ends 
To avoid ligation of two blunt fragments of ds cDNA during the adaptor binding reaction, 
a single ’A’ nucleotide was added to the 3’ ends of the DNA. This strategy provided the 
correct ligation between the adenylated 3’ends of the ds cDNA and increased the 
efficiency of the reaction as the adapters are ‘T’ tailed. 2.5µl of A-Tailing Control (diluted 
in Resuspension Buffer in a ratio of 1:100) was added to each sample followed by 12.5µl 
A-Tailing Mix. After pipetting up and down, the samples were incubated for 30 minutes 
at 37°C followed by 5 minutes at 70°C and a hold at 4°C.  
2.9.2.5. Ligation of adapters 
NGS permits the sequencing of multiple libraries on a single lane, however this is reliant 
on the pooling of libraries. Thus, the purpose of this step was to barcode the DNA 
libraries with their individual indexed adapters that would allow libraries to be 
distinguished during bioinformatics analysis. Ligation of barcoded adapters was 
conducted immediately after adenylation of the 3’ends.    
2.5µl of Ligation Control (diluted in Resuspension Buffer in a ratio of 1:100) was added 
to each sample followed by 2.5µl Ligation Mix. After adding 2.5µl of RNA Adapter Index 
to each library the samples were incubated at 30°C for 10 minutes. To inactivate the 
ligation, 5µl of Stop Ligation Buffer (STL) was added to each tube and pipetted up and 
down to mix. Based on the AMPure XP Beads capability to bind amplicons greater than 
100bp, 42µl of AMPure XP Beads were added to each sample and pipetted gently up and 
down to select the libraries and remove all unbound adapters and adapter dimers. After 
15 minutes incubation at room temperature, the samples were transferred onto the 
magnetic stand for 5 minutes and then 79.5µl supernatant was removed. With the 
samples left on the magnetic stand, the beads were washed twice with 200µl of 80% 
(v/v) ethanol, with complete removal of the supernatant at each step.  
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The second supernatant was removed and the beads left to air dry for 15 minutes. 17.5µl 
of Resuspension Buffer was added to each sample, pipetted up and down, incubated for 
2 minutes and subsequently incubated for 5 minutes on the magnetic stand at room 
temperature. 50µl supernatant containing the libraries was transferred to new 0.2ml 
PCR tubes and the entire cleaning process was repeated one more time. The second  
ds cDNA clean-up was performed using 50µl of AMPure XP Beads, followed by removal 
of 95µl of supernatant. After the second wash with 80% (v/v) ethanol and corresponding  
air-dry, 22.5µl of Resuspension Buffer was added to each library and pipetted up and 
down until the beads were fully resuspended. After 2 minutes incubation at room 
temperature, the samples were placed on the magnetic stand and when the liquid was 
clear 20µl of supernatant containing the cDNA was transferred into new 0.2ml PCR 
tubes.  
2.9.2.6. DNA fragment enrichment 
The purpose of this library amplification step was to (i) amplify first strand cDNA only,  
(ii) enrich properly ligated DNA fragments (with adapters on both ends), (iii) increase the 
amount of libraries for NGS and library quantification, and (iv) add a sequence of 
nucleotides (primers) to the template strands that allows them to hybridize with 
oligonucleotides attached to the surface of the flow cell.   
5µl of PCR Primer Cocktail (PPC) and 25µl of PCR Master Mix (PMM) was added to each 
sample. Amplification was conducted under the following conditions (Table 2.13).  
To purify the PCR product, 50µl of AMPure XP Beads was pipetted gently with each PCR 
amplified library, incubated for 15 minutes at room temperature and separated from 
the supernatant on the magnetic stand. 95µl of supernatant was removed and the beads 
were washed twice with 200µl of 80% (v/v) ethanol as previously described (Section 
2.9.2.5). Air-dried beads were pipetted with 32.5µl of Resuspension Buffer and 
incubated for 2 minutes at room temperature. The samples were placed on the 
magnetic stands and 30µl of supernatant containing amplified libraries was transferred 
to new PCR tubes. 
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Table 2.13. PCR cycling conditions to amplify the libraries for Next Generation 
Sequencing.   
 
Cycle Step          Temperature (°C)                    Time     Cycles 
Initial denaturation                      98              30 seconds         1 
Denaturation                      98              10 seconds 
       15 Annealing                      60              30 seconds 
Extension                     72              30 seconds 
Final Extension                     72                5 minutes        1 
Hold                      4           ∞  
 
2.9.2.7. Library validation and normalisation  
Accurate quantitation of DNA libraries is a key step in achieving reliable and good quality 
results from NGS as it informs on (i) ensuring the correct balance between all libraries 
pooled/loaded on the flow cell sample and (ii) amplifying the correct amount of clusters, 
as both over-clustering and under-clustering reduces the yield of data (Bronner et al., 
2014). 
2.9.2.8. Quality control 
Library sizes were determined using the 2200 TapeStation (Agilent Technology 
Wokingham, UK) following the manufacturer’s protocol. Firstly, Load D1000ScreenTape 
and loading tips were placed into the 2200 TapeStation. 3µl of D1000 Sample Buffer was 
mixed with 1µl of each library and 1µl of D1000 Ladder. Samples were vortexed using 
an IKA vortex and adaptor at 2000rpm for 1 minute, and samples collected using a short 
centrifugation step. Samples were loaded into the 2200 TapeStation and read using the 
Agilent 2200 TapeStation software. 
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2.9.2.9. Quantity control 
Libraries were quantified twice using: (i) a Qubit 3.0 fluorometer and Qubit® dsDNA BR 
Assay Kit (Invitrogen, Paisley, UK) to assess library concentration, and (ii) qPCR according 
to the KAPA Library Quantification Kits® platforms (Kapa Biosystems, London, UK) after 
assessing the quality of prepared libraries to check whether the library dilutions made 
on the basis of Qubit 3.0 results were comparable. 
2.9.2.10. Normalisation and pooling of libraries   
Based on the Qubit 3.0 results, all cDNA libraries were diluted in 10 mM Tris-HCl, pH 8.0 
(25°C) + 0.05% Tween® 20 to normalise them to a final cDNA concentration of 4nM. To 
confirm that the performed dilution provided around 4nM DNA in all libraries, absolute 
qPCR was performed. Reactions were conducted using the same system, software and 
96-well plates as described previously (Section 2.5.2), but with KAPA Library 
Quantification Kits® (2x KAPA SYBR® FAST qPCR Master Mix, 10x Primer Premix, 50x ROX 
Low).  As the library amount must be in the range of the six standard concentrations 
provided in the kit (20 - 0.0002pM), the 4nM libraries were used to make 1:10,000 
dilutions. During the qPCR process, the cDNA was amplified in a 10.2µl reaction 
containing 6µl 2x KAPA SYBR® FAST qPCR Master Mix with 10x Primer Premix, 0.2µl 50x 
ROX Low and 4μl of either libraries or standards or water (non-template control - NTCs). 
The plate was centrifuged for 1 minute to collect the contents and remove air bubbles. 
Standards, library dilutions and NTCs were assayed in triplicate, and amplification 
performed under the cycling conditions described (Table 2.14). Upon confirmation of 
similar library concentrations (~4nM), 5µl of each library (n = 14) was pooled in a new 
0.2ml PCR tubes.  
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Table 2.14. Absolute qPCR cycling conditions to normalise the final concentration of 
prepared libraries. 
 
Cycle step Temperature (°C) Time Cycles 
Initial Denaturation 95 5 minutes  1 
Denaturation 95 30 seconds 
35 
Annealing/Extension 60 45 seconds  
Dissociation 
95 
60 
95 
 1 minutes 
30 seconds 
30 seconds 
1 
 
 
2.9.2.11. Denaturation and dilution of libraries 
To allow efficient hybridisation of cDNA strands to primers attached to the surface of 
the flow cell, the pooled libraries were denatured. 5µl 0.2M sodium hydroxide was 
added to 5µl of 4nM pooled libraries, mixed, centrifuged at 280g for 1 minute and then 
incubated for 5 minutes at room temperature to denature the libraries into single 
strands. To entirely neutralise sodium hydroxide after the incubation period, 5µl of 
200mM Tris-HCl (pH7) was added to the sample, mixed and centrifuged at 280g for  
1 minute. As the recommended loading library concentration is 1.8pM, the denatured 
libraries were firstly diluted to 20pM by adding 985µl pre-chilled hybridisation buffer 
(HT1). Next, 1.3ml of a 1.8pM library was prepared by mixing 117µl of a 20pM denatured 
library solution with 1,183µl pre-chilled HT1.  
The low-concentration spike-in (1%) of Illumina PhiX Control was used to provide  
a sequencing control. 10nM PhiX stock was diluted with 15µl resuspension buffer (RSB) 
to give the PhiX Control at 4nM. The control was denatured and diluted as described for 
the libraries. Next, 1.2µl (denatured and diluted) PhiX Control (20pM) was combined 
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with 1299µl of the (denatured and diluted) libraries (1.8pM) followed by loading onto 
the NextSeq®500/550 High Output Flow Cell Cartridge v2 and sequenced in 
NextSeq™500. 
2.9.3. Bioinformatic analysis of mRNA Next Generation Sequencing  
The dataset of RNA-Seq was analysed by bioinformatician Dr Daniel Pass (School of 
Biosciences, Cardiff University, Cardiff, UK). The reads were de-multiplexed and aligned 
to a reference bovine genome (UMD3.1) using TopHat, a splice junction aware 
mapper (Kim et al., 2013). HTSeq-count was utilised to quantify mapped reads to gene 
models (Anders et al., 2014) and EdgeR was used to statistically interrogate the data 
(Robinson et al., 2010). Identification of possible sample outliers in global gene 
expression patterns across samples was performed using principal component analysis. 
Statistical testing for differential expression was performed on count normalised 
reads using a Fischer’s exact test. Benjamini-Hochberg corrected p-values at a threshold 
of p<0.05 were used to imply statistical significance (Benjamini and Hochberg, 1995). 
 
2.10. RT2 Profiler PCR array system 
RT2 Profiler PCR array (Qiagen, West Sussex, UK) is a customised bovine specific PCR 
array developed by Dr A. Al-Sabah. The 96-well qPCR plate array includes 84 WNT 
related genes and 12 wells containing a combination of (i) reference genes, (ii) positive 
controls and (iii) reverse transcription controls. The arrays were utilised to identify direct 
targets of down-regulated miRs in primary chondrocytes transfected with specific miR 
inhibitors; cells were transfected with miR-21-5p, miR-221 or miR-222 inhibitors,  
a non-targeting control or untransfected cells for 48h prior to analysis. 
2.10.1. cDNA synthesis 
cDNA was synthesised using a RT2 First Strand Kit (Qiagen, West Sussex, UK) as it 
contains additional RNA samples that are used as a reverse transcription positive control 
for the array. Total, non-DNase treated RNA extracted from primary chondrocytes 
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(Section 2.3.3) was pooled to generate a representative sample for: untreated, 
transfected with mirVana™ miR Inhibitor Negative Control #1 or transfected with 
mirVana™ miR-21-5p, miR-221 or miR-222 inhibitors. 200ng of RNA from each sample 
(n = 3) was taken to create a pooled sample for each condition. The reverse transcription 
was conducted according to the manufacturer’s protocol (Qiagen, West Sussex, UK). 
First 2µl of genomic DNA elimination buffer (GE buffer) was added to 500ng of pooled 
RNA and RNase-free water was added to make a 10µl total volume.  The reaction was 
incubated in the Prime Techne Thermocycler for 5 minutes at 42°C followed by 1 minute 
on ice. The reverse transcription mix containing 4μl of 5× BC3 buffer, 1μl of Control P2 
buffer, 2μl RE3 Reverse Transcriptase Mix and 3μl of RNase-free water was added to 
each sample, pipetted up and down and then incubated at 42°C for 15 minutes.  
The reaction was terminated by heating the samples at 95°C for 5 minutes followed by 
addition of 91μl of RNase-free water. 
2.10.2. WNT RT2 Profiler PCR Array 
A bovine-specific WNT RT2 Profiler PCR Array was used for evaluation of the expression 
of Wnt related genes (see Appendix 1-3 for gene list). The qPCR mix of 1350μl 2× RT2 
SYBR® Green Mastermix (Qiagen, West Sussex, UK), 102μl of cDNA and 1248μl RNase-
free water was prepared and mixed in a loading reservoir. 25μl qPCR mix was transferred 
into each well of the WNT RT2 Profiler PCR Array. SYBR® Green qPCR was conducted 
using a LightCycler® 96 System with LightCycler® 96 SW 1.1 software (Roche, West 
Sussex, UK). The amplification reaction was performed under the following conditions: 
1 cycle of 10 minutes at 95°C , 40 cycles of 15 seconds at 95°C and 1 minute at 60°C.  
Analysis of the expression levels of target genes was performed using the RT² Profiler 
PCR Array Data Analysis software (Qiagen, West Sussex, UK) which normalised the Wnt 
related genes to three automatically chosen reference genes identified by the software.  
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2.11. Statistical analysis 
qPCR data are presented as mean ± SD after normalisation to identified reference genes 
for explants (SDHA and YWHAZ) or for cells (HPRT and YWHAZ) and further normalised 
to the untreated controls. Data were analysed using the Anderson-Darling test to 
confirm the normality of the data and differences in variances tested using the Bartlett’s 
test  (Minitab 16; http://onthehub.com/). Data that was not normal or equal was subject 
to log or rank transformation (Minitab 16). One or two way analysis of variance (ANOVA) 
(Minitab 16), as indicated in the text, was performed to determine the significance of 
mechanical load, manipulation of miR expression levels or mechanical load and time 
post-load on gene expression, respectively. Results were considered statistically 
significant at p<0.05. Data which was ± two standard deviations from the mean were 
considered outliers and removed from the data set. 
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              Chapter 3  
Characterisation of physiological and 
non-physiological magnitudes of loading 
regimes  
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3.1. Background  
Normal load, also termed “physiological” promotes a fine balance in the expression of 
cartilage molecules helping to maintain cartilage function and integrity. When cartilage 
is subjected to abnormal, also called “non-physiological” or “injurious” load, the stability 
of the ECM is disrupted and catabolic processes predominate in the tissue which can 
promote cartilage degeneration (Grodzinsky et al., 2000, Lee et al., 2005a). It has been 
well-established that biomechanical factors play a crucial role in the healthy 
development and homeostasis of articular cartilage (Lee et al. 2005). Articular cartilage 
is subjected to a wide range of mechanical stimuli which depending on the type, 
magnitude, frequency and duration of the applied load may stimulate a degenerative or 
biosynthetic response in chondrocytes (Grodzinsky et al., 2000, Hodge et al., 1986).  
To date, several in vitro studies have explored the influence of load on cartilage, but 
these focused on the effect of long term mechanical load (from hours (h) to days) 
(Fitzgerald et al., 2008, Kiraly et al., 1998, Kurz et al., 2001, Palmoski and Brandt, 1984). 
Fitzgerald et al. demonstrated that transcription of ECM proteins such as aggrecan and 
type II collagen was increased up to 30-100% by long term (24h) dynamic compression  
(3-5%, 0.1Hz) (Fitzgerald et al., 2008). In contrast, Kurz et al. showed that compressive 
injurious load (12-23MPa, [~50% compression], 0.1Hz) applied for 12h resulted in 
significant decreases in total protein synthesis (Kurz et al., 2001).  
These and other studies demonstrate the influence of mechanical stimulation on 
articular cartilage, and show how important it is for maintaining ECM homeostasis. 
Furthermore, it demonstrates how different factors e.g. amplitude, duration and 
frequency of applied load influence the tissues’ biological response.  
The aim of the work described in this experimental chapter was to identify loading 
regimes that initiate the early signalling events that induce responses suggesting 
physiological and non-physiological magnitudes of load. To date, there is no published 
data investigating short durations of dynamic compressive load on articular cartilage 
and its influence on early responses in chondrocytes; therefore, it was necessary to 
optimise short-term loading regimes that induce early transcriptional effects in 
chondrocytes. For the purpose of optimising the loading regimes, expression of 
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mechano-responsive genes which are responsible for maintaining ECM homeostasis 
were studied. The studied genes belong to the following groups: ECM structural 
molecules (aggrecan, collagen type II), MMPs (MMP-1, -3, -9, -13), ADAMTSs  
(ADAMTS-4, -5) and TIMPs (TIMP-1, -2, -3). 
Quantitative PCR (qPCR) is a sensitive method to assess transcriptional changes in 
experimental samples, therefore the selection of stable internal reference genes used 
for normalisation is crucial. Unfortunately, it is a common issue that reference genes, 
also referred to as housekeeping genes (HKGs), are chosen mainly on the basis of data 
from earlier publications. However, it must be taken into consideration that the stability 
of the HKGs expression obtained and presented in previous studies which were 
performed under certain experimental parameters is relevant only to that study (Kozera 
and Rapacz, 2013).  
Most published studies analysing mechano-responsive genes in chondrocytes have used 
18S ribosomal RNA, ACTB (β-actin) or glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) as reference genes without consideration of their sensitivity to mechanical 
stress. Surprisingly, a study conducted by Lee et al. analysing the stability of 18S rRNA, 
β-actin, β-glucuronidase, β-2 microglobulin and GAPDH in articular chondrocytes 
subjected to mechano-stimulation clearly showed that these genes (excluding 18S) are 
mechano-sensitive (Lee et al., 2005b), therefore should not be utilised as reference 
genes in qPCR in mechanobiology experiments.  
Knowledge and methodologies have developed hugely over the years giving us for 
example softwares such as BestKeeper (Pfaffl et al., 2004), geNorm (Vandesompele et 
al., 2002) and NormFinder (Andersen et al., 2004) that determine the most stable 
gene(s) relative to experimental conditions. To use suitable reference genes in this 
study, it was necessary to identify genes in which the mRNA level remained unaffected 
by mechanical load. 
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Summary of the aims of this experimental chapter: 
 To identify reference genes with the most stable expression in both loaded 
and unloaded cartilage explants 
 To identify physiological and non-physiological loading regimes that induce 
early transcriptional events in chondrocytes 
 To identify more globally genes that are sensitive to load  
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3.2. Results  
3.2.1. Analysis of RNA quality 
Confirmation that total RNA extracted from the experimental samples (loaded and 
unloaded) was of good quality and sufficient yield for downstream analysis was 
performed using the Agilent 2100 bioanalyzer. A Ribosomal Integrity Number (RIN) is 
obtained for each sample (0 degraded – 10 excellent) and as can be observed, all 
samples had RIN scores of >8 (Figure 3.1A). Ribosomal peak plots and gel electrophoresis 
of the RNA samples also indicated the presence of 18S and 28S rRNA with no sign of 
degradation (Figure 3.1B,C).  
Total RNA from these loaded and unloaded explants was used to investigate the most 
appropriate reference genes for mRNA analysis to characterise the loading regimes; 
unloaded explants were used as a control.  
3.2.2. Investigation of appropriate reference genes for assessing cartilage 
chondrocyte mechano-responsiveness 
One of the criteria of the MIQE guidelines (Minimum Information for Publication 
of Quantitative Real-Time PCR Experiments) that eliminates the usage of unstable 
reference genes for mRNA normalisation affecting the fold change of target genes giving 
false results is to use not less than three experimentally validated reference genes for 
each tissue/cell type or experimental condition, unless there are special circumstances 
(Bustin et al., 2009, Bustin et al., 2010). To identify the most stable reference genes 
expressed in articular cartilage subjected to different compressive loading regimes 
(2.5MPa, 5MPa and 7MPa, 1Hz, 15 minutes), eight bovine reference genes from 
previous study were selected for validation (Anstaett et al., 2010). Stability of reference 
genes was assessed using commonly used computational programmes: Bestkeeper 
(Pfaffl et al., 2004), geNorm (Vandesompele et al., 2002), NormFinder (Andersen et al., 
2004) and the comparative ΔCt method (Silver et al., 2006), and the data integrated using 
RefFinder software (http://www.leonxie.com/referencegene.php). Each individual 
programme uses its own algorithm to compare and rank reference genes in terms of 
their stability.  
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The comparative ∆Ct method compares Ct values of a single putative reference gene 
across experimental samples and determines the standard deviation of all samples and 
then compares this value with other potential reference genes. The lower the standard 
deviation the more stable the gene expression is across the experimental parameters 
e.g. compressive load. Large variation was presented by GAPDH and HPRT questioning 
the suitability of these as reference genes, whereas SDHA, PPIA, RPL4, β-actin, 18S and 
YWHAZ were consistent in unloaded tissue and those subjected to load (Figure 3.2A). 
BestKeeper assesses the stability of putative reference genes in two ways. Firstly, the 
standard deviation of the geometric mean of the Ct values for an individual gene is 
calculated to exclude unstable genes from the panel of potential internal controls 
(SD>1.5). Secondly, a pairwise comparison of individual genes is performed to the 
BestKeeper index, which is a geometric mean of all putative reference genes to assess 
whether there is a correlation (Pearson correlation) of a single gene to the index.  
The stronger the correlation between the pair of genes the more likely it is that they are 
not responsive to the studied experimental conditions (Pfaffl et al., 2004). BestKeeper, 
similar to the comparative ∆Ct method indicated HPRT and GAPDH as the least stable 
putative internal controls. The remainder of the tested genes were similarly stable, 
however the best stability was presented by SDHA and 18S (Figure 3.2B).  
geNorm determines reference gene stability (M) which is an average pairwise variation 
between a single putative reference gene and the other remaining group of reference 
genes included in the same study. The geNorm cut off value is M=1.5 suggesting that 
genes with M>1.5 should not be used as internal control genes (Vandesompele et al., 
2002). SDHA and YWHAZ were considered as the most stable genes from the panel of 
tested genes while GAPDH and HPRT were selected as the worst option for 
normalisation of gene expression to these reference genes (Figure 3.2C). 
NormFinder software is unique as it takes into consideration experimental parameters. 
It determines stability of control genes based on the variation in their expression within 
one specific group of samples and across differently stressed experimental groups 
(Andersen et al., 2004). GAPDH and HPRT presented the lowest stability, whereas RPL4, 
SDHA and PPIA were noticeably the most stable (Figure 3.2D).  
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Based on the rankings obtained from each of the aforementioned softwares, RefFinder 
assigns an appropriate value to each gene and calculates their geometric mean to 
provide the final ranking of putative internal reference genes (from most to least stable)  
(Liang et al., 2014). RefFinder analysis showed SDHA as the most stable whereas RPL4 
and YWHAZ were equally next in line of stable gene expression. In comparison, GAPDH 
and HPRT turned out to be the least stable reference genes amongst the eight tested 
(Figure 3.3).  
The MIQE guidelines allows the use of less than three reference genes if there is  
a reasonable explanation, therefore SDHA and YWHAZ have been selected as 
appropriate internal controls excluding RPL4 as it showed the same stability as YWHAZ. 
After selecting the best combination of internal reference genes, standard curves for 
these genes were generated using 10-fold dilutions of pooled cDNA from loaded and 
unloaded samples to determine PCR efficiency. Representative standard curves of SDHA 
and YWHAZ indicated efficiencies of 104% and 101.3% respectively which are within the 
acceptable range of 95-115% (Figure 3.4). On the basis of these results, SDHA and 
YWHAZ were used as reference genes for the study due to their suitability for 
normalisation of gene expression in both loaded and unloaded articular cartilage using 
the parameters tested.  
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Figure 3.3. Reference gene stability output using RefFinder software. RefFinder software 
using data output from the comparative ∆Ct method, BestKeeper, NormFinder and 
geNorm ranked the commonly used reference genes (18S, βactin, GAPDH, HPRT, PPIA, 
RPL4, SDHA, YWHAZ) from most to least stable. RefFinder software analysis indicated 
that SDHA is the most stable housekeeping gene in experimental cartilage explants 
(unloaded, 2.5MPa and 7MPa). 
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Figure 3.4. qPCR standard curves of SDHA (A) and YWHAZ (B) conducted on pooled 
cDNAs from samples subjected to 2.5MPa and 7MPa loading regimes (1Hz, 15 minutes) 
and unloaded explants. Data represents 3 independent experiments (n = 18 
explants/experiment). qPCR efficiencies of the selected reference genes were verified 
to be within the acceptable range of 95-115%.  
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3.2.3. Optimisation of loading regimes 
To establish loading magnitudes which either activated mainly an anabolic/turnover 
response or induced mainly expression of catabolic molecules, a preliminary study was 
conducted using three different loading regimes: 2.5MPa, 5MPa and 7MPa each at 1Hz 
for 15 minutes and mRNA levels assessed 24h post-load. These loads and frequency 
parameters were chosen on the basis of publications in which loading magnitudes 
between 0.1 - 5MPa were considered as normal and above 5MPa as abnormal (Arokoski 
et al., 2000, Hodge et al., 1986), and the frequency 1Hz which is considered as the 
frequency of fast walking (Bader et al., 2011).  
3.2.4. Characterisation of physiological and non-physiological loading regimes on 
the basis of ECM mRNA expression levels. 
Explants subjected to the various loading regimes of 2.5MPa, 5MPa or 7MPa 
demonstrated differing transcriptional profiles representing catabolic and anabolic 
molecule responses. Expression of genes in explants subjected to a 7MPa load could not 
be compared directly to the transcriptional level of these genes in samples treated with 
lower loading regimes, as the loading was performed on different days which relied on 
the use of different unloaded controls. 
 ECM genes: Neither aggrecan nor collagen type II mRNA levels were significantly 
altered by any of the loading regimes tested (Figure 3.5A-D). 
 
 MMP genes:  Neither 2.5MPa nor 7MPa loading regimes changed the expression 
of MMP1 (Figure 3.6A,C), but surprisingly a 5MPa load induced a significant 
increase in MMP1 mRNA levels (6.4-fold: p=0.001; Figure 3.6A). MMP-3 was 
significantly up-regulated in explants subjected to 5MPa (2.5-fold: p=0.01;  
Figure 3.6C) and 7MPa (6.8-fold: p<0.001; Figure 3.6D) load, whereas no 
statistically significant response was observed in explants subjected to a 2.5MPa 
load (Figure 3.6C). Significant up-regulation of MMP-3 transcripts was also 
observed between the 2.5MPa and 5MPa loaded explants (4.4-fold: p<0.001; 
Figure 3.6C) with a noticeable trend of increasing expression with increasing load 
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(Figure 3.6C,D). In contrast, MMP-9 and MMP-13 mRNA levels were significantly 
down-regulated at 2.5MPa (6.25-fold: p=0.001; Figure 3.6E and 5.5-fold: 
p<0.001; Figure 3.6G, respectively) and 5MPa (6.9-fold: p<0.001; Figure 3.6E and 
5.5-fold: p<0.001; Figure 3.6G, respectively). However, decreases observed at 
7MPa were not statistically significant (Figure 3.6F,H). 
 
 ADAMTS genes: Mechano-regulation of ADAMTS-4 mRNA levels was observed 
with significant increases in all explants correlating with increasing application of 
load i.e. 2.5MPa (2.2-fold: p=0.002; Figure 3.7A), 5MPa (5.1-fold: p<0.001;  
Figure 3.7A) and 7MPa (6-fold: p<0.001; Figure 3.7B). A load-dependent increase 
in ADAMTS-4 levels between 2.5MPa and 5MPa (2.4-fold: p=0.002; Figure 3.7A) 
was also observed. Interestingly, ADAMTS-5 transcription was significantly 
increased only by the 7MPa load (5.5-fold: p<0.001; Figure 3.7D). 
 
  TIMP genes: Both TIMP-1 and TIMP-3 transcription were significantly elevated 
in all explants subjected to 2.5MPa, 5MPa and 7MPa (Figure 3.8A,B,E,F). TIMP-1 
mRNA was up-regulated in explants subjected to 2.5MPa (1.6-fold: p=0.008; 
Figure 3.8A), 5MPa (2.6-fold: p<0.001; Figure 3.8A) and 7MPa (3.6-fold: p<0.001; 
Figure 3.8B). A significant increase was also observed between the 2.5MPa and 
5MPa (1.6-fold, p=0.006; Figure 3.8A). In terms of TIMP-3, each loading regime 
activated TIMP-3 transcription in a magnitude-dependent manner: 2.5MPa  
(1.8-fold: p=0.016; Figure 3.8E), 5MPa (6-fold: p<0.001; Figure 3.8E) and 7MPa 
(10.2-fold: p<0.001; Figure 3.8F) load. In contrast to TIMP-1 and -3, transcript 
levels of TIMP-2 were significantly decreased in response to all applied loading 
regimes. The level of TIMP-2 reduction was similar in all loaded explants: 2.5MPa 
(2.04-fold: p<0.001; Figure 3.8C), 5MPa (2.36-fold: p<0.001; Figure 3.8C) and 
7MPa (2.27-fold: p<0.001; Figure 3.8D). 
Based on these preliminary findings, a load of 2.5MPa (1Hz, 15 minutes) to represent a 
physiological magnitude and 7MPa (1Hz, 15 minutes) to represent a non-physiological 
magnitude were selected.    
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Figure 3.5.  mRNA quantification of Aggrecan (A,B) and Collagen type II (C,D) in cartilage 
explants subjected to varying loading regimes (1Hz, 15 minutes); unloaded explants 
served as controls. Gene expression was analysed in the cartilage explants 24h post-load 
using qPCR with Sybr™ green technology and mRNA levels normalised to the geometric 
mean of reference genes (SDHA, YWHAZ) and relative to the unloaded control. Data are 
presented as mean ± SD (n = 6) and is representative of three independent experiments. 
Two graphs of the same gene e.g. A and B show data of independently performed 
loading experiments for 2.5MPa, 5MPa and for 7MPa; the presence of statistically 
significant differences between the controls for 2.5MPa, 5MPa and controls for 7MPa 
does not allow cross-comparison of data from all loading regimes. Statistical analysis 
was performed using a 1-way ANOVA with Tukey’s post-hoc test. Key: control - 
unloaded, 2.5MPa, 5MPa, 7MPa (loaded).   
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Figure 3.6. mRNA quantification of MMP-1 (A,B), MMP-3 (C,D), MMP-9 (E,F) and  
MMP-13 (G,H) in cartilage explants subjected to varying loading regimes (1Hz, 15 
minutes); unloaded explants served as controls. Gene expression was analysed in the 
cartilage explants 24h post-load using qPCR with Sybr™ green technology and mRNA 
levels normalised to the geometric mean of reference genes (SDHA, YWHAZ) and 
relative to the unloaded control. Data are presented as mean ± SD (n = 6) and is 
representative of three independent experiments. Two graphs of the same gene e.g.  
A and B show data of independently performed loading experiments for 2.5MPa, 5MPa 
and for 7MPa; presence of significant differences between the controls for 2.5MPa, 
5MPa and controls for 7MPa does not allow cross-comparison of data from all loading 
regimes. Statistical analysis was performed using a 1-way ANOVA with Tukey’s post-hoc 
test. Key: control-unloaded, 2.5MPa, 5MPa, 7MPa (loaded) [* p<0.05, ** p<0.01,  
*** p<0.001].
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Figure 3.7. mRNA quantification of ADMTS-4 (A,B) and ADAMTS-5 (C,D) in cartilage 
explants subjected to varying loading regimes (1Hz, 15 minutes); unloaded explants 
served as controls. Gene expression was analysed in the cartilage explants 24h post-load 
using qPCR with Sybr™ green technology and mRNA levels normalised to the geometric 
mean of reference genes (SDHA, YWHAZ) and relative to the unloaded control. Data are 
presented as mean ± SD (n = 6) and is representative of three independent experiments.  
Two graphs of the same gene e.g. A and B show data of independently performed 
loading experiments for 2.5MPa, 5MPa and for 7MPa; presence of significant differences 
between the controls for 2.5MPa, 5MPa and controls for 7MPa does not allow cross-
comparison of data from all loading regimes. Statistical analysis was performed using a 
1-way ANOVA with Tukey’s post-hoc test. Key: control - unloaded, 2.5MPa, 5MPa, 7MPa 
(loaded) [** p<0.01, *** p<0.001].
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Figure 3.8. mRNA quantification of TIMP-1 (A,B), TIMP-2 (C,D) and TIMP-3 (E,F)  
in cartilage explants subjected to varying loading regimes (1Hz, 15 minutes); unloaded 
explants served as controls. Gene expression was analysed in the cartilage explants  
24h post-load using qPCR with Sybr™ green technology and mRNA levels normalised to 
the geometric mean of reference genes (SDHA, YWHAZ) and relative to the unloaded 
control. Data are presented as mean ± SD (n = 6) and is representative of three 
independent experiments. Two graphs of the same gene e.g. A and B show data of 
independently performed loading experiments for 2.5MPa, 5MPa and for 7MPa; 
presence of significant differences between the controls for 2.5MPa, 5MPa and controls 
for 7MPa does not allow cross-comparison of data from all loading regimes. Statistical 
analysis was performed using a 1-way ANOVA with Tukey’s post hoc test. Key: control  
- unloaded, 2.5MPa, 5MPa, 7MPa (loaded) [* p<0.05, ** p<0.01, *** p<0.001].   
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3.2.5. Global overview of differentially expressed genes in explants subjected to loads 
of 2.5MPa and 7MPa and analysed 4h and 24h post-load 
Physiological (2.5MPa) and non-physiological (7MPa) loading magnitudes, based on the 
differential expression of selected anabolic and catabolic molecules in explants 
subjected to mechanical load (section 3.2.4) were established on explants processed at 
24h post-load cessation. Having established these two specific loading regimes, the next 
step was to analyse global changes in gene expression in unloaded tissue versus cartilage 
subjected to loads of 2.5MPa or 7MPa (1Hz, 15 minute); explants were then either 
processed at 4h (material generated by Dr A. Al-Sabah) or 24h post-cessation of load 
using GeneChip® Bovine 1.0 ST arrays.  
The 4h post-load presented 778 differentially expressed genes in explants loaded with 
2.5MPa in which 47.18% were down-regulated and 52.83% were up-regulated, whereas 
a 7MPa load induced the down-regulation of 57.74% and elevated 45.26% out of 2,848 
significantly altered genes (Table 3.1A,B). The comparison between loads showed 76 
differentially altered molecules (2.63% down-regulated and 97.37% up-regulated) 
(Table 3.1C). A 24h post-cessation analysis of relative gene expression in explants 
subjected to 2.5MPa and 7MPa loading regimes compared to unloaded tissue presented 
respectively 91 (39.36% decreased and 60.64% elevated) and 1,995 (40.09% reduced 
and 53.91% elevated) mechanically-regulated molecules (Table 3.2A,B). In turn, only 8 
genes were differentially expressed when comparing the 7MPa and 2.5MPa loads 
showing evenly 50% of down- and up-regulated genes (Table 3.2C).  
Among the mechano-sensitive genes expressed after 4h in explants subjected to 2.5MPa 
and 7MPa loads, there were some genes that showed differential transcription also at 
24h post-load in tissue subjected to the same loading regimes. To these genes belong 
for example up-regulated components of the transcription factor AP-1, such as: FOS Like 
Antigen 1(FOSL-1) (4h: 2.5MPa (6.94-fold: FDR=0.001), 7MPa (16.50-fold: FDR>0.001), 
24h: 2.5MPa (3.13-fold: FDR=0.045), 7MPa 8.92-fold: FDR>0.001) and JunB  
Proto-Oncogene (JUNB) (4h: 2.5MPa (4.11-fold: FDR>0.001), 7MPa (5.81-fold: 
FDR>0.001), 24h: 2.5MPa (2.15-fold: FDR=0.012), 7MPa (2.61-fold: FDR>0.001)). FBJ 
Murine Osteosarcoma Viral Oncogene Homolog (FOS) also presented elevated 
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expression in both time points (4h: 2.5MPa (4.03-fold: FDR>0.001), 7MPa (8.25-fold: 
FDR>0.001), 24h: 7MPa (1.96-fold: FDR=0.005)), however 2.5MPa at 24h post-load did 
not show an alteration in FOS transcription. Similar to FOS, transcription of the cartilage 
catabolic molecule ADAMTS-1, which degrades cartilage proteoglycans (Kuno et al., 
2000), was also up-regulated at both time points (4h: 2.5MPa (7.72-fold: FDR>0.001), 
7MPa (22.13-fold: FDR>0.001), 24h: 7MPa (2.81-fold: FDR=0.011)); however, 2.5MPa at 
24h did not indicate transcriptional changes.  
There were also a number of genes that demonstrated altered mRNA level at 4h post-
load but did not show statistically significant changes by 24h. To these genes belong for 
example another elevated AP-1 component, such as: BJ Murine Osteosarcoma Viral 
Oncogene Homolog B (FOSB) (2.5MPa (8.88-fold: FDR>0.001), 7MPa (40.31-fold: 
FDR>0.001)) (Table 3.1A,B). 
A number of genes showed altered expression at 24h only and additionally some of 
them represented a load-dependent nature, as they were altered at the high load 
(7MPa) only. To these genes belong for example decreased pro-collagenase, such as 
ADAM Metallopeptidase With Thrombospondin Type 1 Motif 2 (ADAMTS-2) (7MPa: 
1.75-fold: FDR=0.047) involved in cartilage remodelling by biosynthetic processing of 
fibrillar procollagens (Alper et al., 2015). 
A 2.5MPa (1Hz, 15 minutes) loading regime analysed 4h post-load demonstrated that 
the most elevated gene was Inhibin Beta A (INHBA) (13.97-fold: FDR>0.001) which is 
known to be up-regulated in OA cartilage (Bateman et al., 2013, Snelling et al., 2014). 
The most reduced transcription under this condition was Enoyl-CoA, hydratase/3-
hydroxyacyl CoA dehydrogenase (EHHADH) (3.8-fold: FDR>0.001) which is part of the 
classical peroxisomal fatty acid β-oxidation pathway and was also observed to be  
down-regulated in skeletal muscle in response to mechanical overload (Chaillou et al., 
2013) (Table 3.1A). 
In explants subjected to a 7MPa (1Hz, 15 minutes) load and processed at 4h post-load, 
the 50 most differentially expressed genes showed only increased levels of mRNA  
(Table 3.1B). The strongest response (40.31-fold: FDR>0.001) was observed for the 
mechano-sensitive transcription factor FBJ osteosarcoma oncogene B (FosB).  
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Comparison of expression of mechano-regulated genes between low (2.5MPa) and high 
(7MPa) loading regimes demonstrated a dose dependency of load on the tissue’s 
transcriptional response. The most induced transcription was in the expression of FosB 
(4.54-fold: FDR=0.002) in cartilage stimulated with a 7MPa load compared to 2.5MPa 
load. The most decreased gene in 7MPa loaded explants compared to 2.5MPa load was 
miR-2366 (2.42-fold: FDR=0.046) whose biological role is still unknown (Table 3.1C). 
The top 50 significant mechanically-regulated molecules at 24h post-cessation of each 
load are listed (Table 3.2). Laminin subunit gamma-2 (LAMC2) reported to be mechano-
sensitive (Wehland et al., 2015) showed the highest elevation in a load-dependent 
manner: 2.5MPa (7.07-fold: FDR=0.032) and 7MPa (19.27-fold: FDR=0.001). Although, 
very little is known about microseminoprotein (MSMP/PSMP) which is the most reduced 
(4.17-fold: FDR=0.033) in response to a physiological (2.5MPa) loading magnitude, it is 
believed to be involved in Akt phosphorylation and caspase activation in PC3 cells 
(prostate cancer cell line) (Pidgeon et al., 2002). Chordin-like BMP inhibitor 
(CHRDL2/CHL2), which is mainly expressed in chondrocytes of developing cartilage 
(Nakayama et al., 2004) was significantly reduced (11.49-fold: FDR>0.001) in explants 
subjected to non-physiological (7MPa) magnitude.  
Interestingly, the most differentially regulated genes in the 7MPa loaded explants when 
compared to 2.5MPa load did not overlap with these identified from comparing the 
respective loaded explants to unloaded tissue. So far, nothing has been published in 
terms of the role of G-Protein Coupled Receptor, Family C, Group 5, Member A (GPRC5A) 
in cartilage, which was the most increased gene in explants subjected to 7MPa load in 
comparison 2.5MPa load (3.40-fold: FDR=0.039). The gene with the most decreased 
expression (2.51-fold: FDR=0.039) in explants subjected to non-physiological compared 
to physiological magnitude of load was ras-like and estrogen-regulated growth inhibitor 
(RERG) involved in inhibition of breast cancer cell proliferation (Finlin et al., 2001).  
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Table 3.1. Top 50 genes from microarray analysis with highest relative expression in 
response to physiological (2.5MPa) and non-physiological (7MPa) magnitudes of load at 
4h post-load. Relative gene expression in explants subjected to 2.5MPa (A) or 7MPa (B) 
when unloaded explants were used as a control, and 7MPa compared with 2.5MPa load 
(C).  
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Table 3.2. Top 50 genes from microarray analysis with highest relative expression in 
response to physiological (2.5MPa) and non-physiological (7MPa) magnitudes of load at 
24h post-load. Relative gene expression in explants subjected to 2.5MPa (A) or 7MPa 
(B) when unloaded explants were used as a control, and 7MPa compared with 2.5MPa 
load (C). 
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3.2.5. Classification of differentially expressed genes in explants subjected to 2.5MPa 
and 7MPa loading regimes into protein classes 
To create a better understanding of the identified global mRNA changes in cartilage 
explants subjected to physiological and non-physiological loading magnitudes processed 
either at 4 or 24h post-load, differentially expressed genes were organised into protein 
classes using the PANTHER classification system (http://www.pantherdb.org/).  
Functional classification of those genes which were significantly differentially expressed 
was performed according to the protein class to which the genes belong. The analysis 
indicates several protein classes which include the differentially expressed genes 
regulated by mechanical stimuli. The 3 biggest groups of protein class from each 
treatment were analysed in more detail.   
Figure 3.9 illustrates the output of PANTHER analysis of differentially expressed genes 
in response to (i) 2.5MPa and (ii) 7MPa load relative to the unloaded control, and (iii) 
7MPa load compared to the physiological (2.5MPa) magnitude of load in explants 
processed 4h post-load. Each segment represents the proportional distribution of the 
genes classified according to the different protein sub-classes, with the 3 or 4 most 
abundant groups discussed in more detail.   
4h post-load: 778 genes responded significantly to a 2.5MPa load relative to the 
unloaded explants (Figure 3.9i). The 3 biggest protein classes in response to  
a physiological magnitude (2.5MPa) were nucleic acid binding molecules (13.7%; C), 
transcription factors (11.2%; D) and enzyme modulators (8.5%; A). In comparison,  
a 7MPa load induced the differential expression of 2,848 genes relative to unloaded 
explants (Figure 3.9ii). The 3 most abundant protein classes were: nucleic acid binding 
molecules (12.5%; C), transcription factors (7.9%; D) and transferases (7.7%; E).  
The expression of only 76 genes were significantly altered between the 7MPa and 
2.5MPa loading regimes (Figure 3.9iii), and of these the most abundant protein classes 
represented included equal distribution in: nucleic acid binding molecules (C) and 
transcription factors (D) (9.2%), followed equally by: kinases (B) and transferases (E) 
(6.6%).  
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2.5MPa (1Hz, 15 minutes) load: A 2.5MPa loading regime induced 778 genes, in which 
107 were classified as nucleic acid binding molecules, however PANTHER software was 
only able to ascribe protein subclasses to 76 of these. Among these 76 genes, an almost 
even distribution was demonstrated by DNA binding proteins (39.5%) and RNA binding 
proteins (40.8%), whereas helicases and nucleases constituted respectively 11.8% and 
7.9% of all nucleic acid binding proteins (Figure 3.10A).  
The transcription factor chart was represented by 5 protein subclasses, with only 45 
molecules out of the 87 classified. The greatest proportion (33.3%) was represented by 
zinc finger transcription factors and the smaller group (24.4%) was made up of 
transcription cofactors. The helix-turn-helix transcription factors constituted 15.6% of 
overall distribution, whereas even dispersal was represented by nuclear hormone 
transcription factors and basic helix-loop-helix transcription factors (13.3%; Figure 
3.10B).  
The results for the enzyme modulator protein class demonstrates 5 subgroups in which 
61 out of the 66 genes were assigned.  A significant majority were categorised as  
G-protein modulators (44.3%), and the next most abundant subgroups were: kinase 
modulators (21.3%), protease inhibitors (14.8%) and G-proteins (13.1%), whereas the 
smallest group was represented by phosphatase modulators (6.6%; Figure 3.10C). 
7MPa (1Hz, 15minutes) load: Amongst the 2,848 genes with altered mRNA expression 
in response to a 7MPa load, 357 genes were classified as nucleic acid binding. 
Unfortunately, 72 out of the 357 genes were not annotated for PANTHER detection, but 
the other 285 molecules came from RNA binding proteins, DNA binding proteins, 
nucleases and helicases with a respective distribution of 51.2%, 31.2%, 9.8% and 7.7% 
(Figure 3.11A).  
The second greatest group of regulated proteins was transcription factors which 
contained 220 molecules which fitted into this protein subclass. Most (45.6%) of the 
proteins were classified as zinc-finger transcription factors, the smaller group (25.2%) 
was transcription cofactors. The helix-turn-helix transcription factors (12.2%), nuclear 
hormones (8.2%) and basic helix-loop-helix transcription factors (6.1%) were 3 medium 
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size clusters, the smallest proportion was represented by basic leucine zipper 
transcription factors (2%) and HMG box transcription factors (0.7%) (Figure 3.11B).  
The third group comprised 220 genes belonging to the transferases protein class and all 
of these molecules fitted to the available protein subclasses. The biggest group 
comprised kinase molecules (44.5%), followed by glycosyltransferases (17.3%), 
acetyltransferases (12.7%), acyltransferases (10%), methyl- and nucleotidyltransferases 
were induced equally (5.9%), and the smallest group was represented by transaminases 
(2.7%) and phosphorylases (0.9%; Figure 3.11C). 
7MPa vs 2.5MPa (1Hz, 15minutes) load: This load comparison presented 76 differentially 
expressed genes, in which the most abundant groups were: nucleic acid binding proteins 
and transcription factors consisting of 7 genes each, however only 1 gene out of 7 from 
each protein group was recognised and classified as RNA binding protein for nucleic acid 
binding proteins and basic helix-loop-helix transcription factors for transcription factor 
group (Figure 3.12A-B). All 3 protein kinases involved in the next most abundant kinase 
group (8.9%; Figure 3.12C) were also classified as transferases, the group which in this 
experiment was created based on 5 molecules and also constituted 6.6% of overall gene 
distribution (Figure 3.12D). 
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Figure 3.9. Classification, according to protein classes provided by PANTHER annotation, 
of differentially expressed genes at 4h post-load in articular cartilage subjected to 
2.5MPa or 7MPa load (1Hz, 15 minutes). The pie chart represents the protein classes to 
which the differentially expressed genes were classified in response to 2.5MPa (i)  
or 7MPa (ii) load in comparison to unloaded explants. The chart also represents the 
protein classes attributed to genes significantly altered between the two loading 
regimes (iii).   
 136 
 
 
 
Figure 3.10. Pie charts demonstrating the characterisation of the differentially 
expressed genes according to protein class in response to a 2.5MPa load analysed 4h 
post-load. Unloaded explants were used as a control. Microarray data was classified 
using the PANTHER classification system, and the 3 most abundant groups are depicted.  
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Figure 3.11. Pie charts demonstrating the characterisation of the differentially 
expressed genes according to protein class in response to a 7MPa load analysed 4h  
post-load. Unloaded explants were used as a control. Microarray data was classified 
using the PANTHER classification system, and the 3 most abundant groups are depicted. 
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Figure 3.12. Pie charts demonstrating the characterisation of the differentially 
expressed genes according to protein class in response to a 7MPa load analysed 4h  
post-load. Explants subjected to 2.5MPa load were used as a control. Microarray data 
was classified using the PANTHER classification system, and the 4 most abundant groups 
are depicted. 
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Figure 3.13 illustrates the output of PANTHER analysis of differentially expressed genes 
in response to (i) 2.5MPa and (ii) 7MPa load relative to the unloaded control, and (iii) 
7MPa load compared to the physiological (2.5MPa) load in explants processed 24h post-
load. Each segment represents the proportional distribution of the genes classified 
according to the different protein sub-classes, with the 3 or 4 most abundant groups 
discussed in more detail.   
24h post-load: By the later time point of 24h post-cessation of load, noticeably fewer 
genes were differentially expressed in response to the applied mechanical loads except 
for the 7MPa load (Figure 3.13).  
2.5MPa (1Hz, 15 minutes) load: The 2.5MPa load (Figure 3.13i) induced significant 
alterations in the transcription of 91 genes in which 12.1% belonged to the signalling 
molecules (D). The next most abundant protein classes regulated by this loading regime 
were: hydrolases (9.9%; B), nucleic acid binding proteins (C) and transferases (E) 
contained evenly 8.8% of the 91 genes studied.  
8 signalling molecules out of 11 were represented by cytokines (50%), membrane-bound 
signalling molecules (25%) and growth factors (25%) (Figure 3.14A). 
The next greatest group of protein was hydrolases that contain 9 molecules, but only 7 
of them fit the protein subclass. Most (42.8%) of the proteins were classified as 
proteases, the other subgroups were represented equally (14.3%) by deaminases, 
lipases, phosphatases and phosphodiesterases (Figure 3.14B).  
Nucleic acid binding protein class was based on 6 genes out of 8 classified to this group. 
More than half (66.7%) of the explored genes were RNA binding proteins. The next 
subgroups represented evenly by 16.5% of molecules was DNA binding proteins and 
nucleases (Figure 3.14C).  
The last group was transferase molecules in which 8 genes were involved, but cluster 
sizes of kinases (42.9%), glycosyltransferases (28.6%) and evenly abundant (14.3%) 
acetyltransferases and transaminases were created based on 7 genes (Figure 3.14D).  
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7MPa (1Hz, 15minutes) load: The largest protein class, accounting for 12% of the 1,995 
genes differentially expressed in response to the 7MPa load (Figure 3.13ii) was 
represented by nucleic acid binding proteins. A significant majority of analysed 
molecules were categorised as RNA binding proteins (52.5%) and DNA binding proteins 
(40.1%), whereas the rest were represented by nucleases (6.8%) and helicases (0.6%) 
(Figure 3.15A). 
In the group of hydrolases 157 genes were involved (7.9%), but only 110 were available 
using PANTHER software for classification. Among these 110 genes, more than half were 
classified as either phosphatases (31.8%) or proteases (30.9%). The next group that 
covered 12.7% was lipases. The smallest fraction of molecules accounted for esterases 
(8.2%), phosphodiesterases (6.4%), deaminases (3.6%) and glycosidases (2.7%), 
deacetylases (2.2%), phyrophosphatases and galactosidases (1.5%; Figure 3.15B).  
The third most abundant protein class, created from genes significantly modulated in 
response to 7MPa load was enzyme modulators (7.5%). The distribution in this group 
was based on 127 genes despite the fact that 150 genes were originally classified to this 
group of receptors. Of these 127 molecules, almost half of the proteins were 
represented by G-protein modulators (48%). The next most abundant subgroups were: 
G-proteins (18.1%), protease inhibitors (16.5%), and kinase modulators (14.2%), 
whereas the smallest group was represented by phosphatase modulators (3.1%; Figure 
3.15C). 
7MPa vs 2.5MPa (1Hz, 15minutes) load: Interestingly, the comparison between 7MPa 
and 2.5MPa load (Figure 3.10iii) showed changes in the expression of 8 genes, however, 
the distribution of differentially expressed genes in this comparison was based on 6 
molecules only. Although each gene represented a different protein class, the protein 
classes reflected in this data set included: calcium binding proteins, enzyme modulators, 
receptors, signalling molecules, transfer/carrier proteins and transferases which had 
also been evidenced when comparing transcriptional differences between the loaded 
and unloaded explants.   
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Figure 3.13. Classification, according to protein classes provided by PANTHER 
annotation, of differentially expressed genes at 24h post-load in articular cartilage 
subjected to 2.5MPa or 7MPa load (1Hz, 15 minutes). The pie chart represents the 
protein classes to which the differentially expressed genes were classified in response 
to 2.5 MPa (i) or 7MPa (ii) load in comparison to unloaded explants. The chart also 
represents the protein classes attributed to genes significantly altered between the two 
loading regimes (iii).  
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Figure 3.14. Pie charts demonstrating the characterisation of the differentially 
expressed genes according to protein class in response to a 2.5MPa load analysed 24h 
post-load. Unloaded explants were used as a control. Microarray data was classified 
using the PANTHER classification system, and the 4 most abundant groups are depicted. 
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Figure 3.15. Pie charts demonstrating the characterisation of the differentially 
expressed genes according to protein class in response to a 7MPa load analysed 24h 
post-load. Unloaded explants were used as a control. Microarray data was classified 
using the PANTHER classification system, and the 3 most abundant groups are depicted. 
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3. 3. Discussion 
Articular cartilage consists mainly of hyaluronan/proteoglycan and collagen type II 
networks which confers the tissue with viscoelastic properties, facilitating the 
dissipation of load that is placed on joints during movement and provides a frictionless 
surface for joint motion. Turnover of the cartilage matrix is maintained by an equilibrium 
of catabolic and anabolic processes; however, once the catabolic molecules i.e. MMPs, 
ADAMTSs are active over a prolonged period, the balance is shifted resulting in cartilage 
damage and ultimately tissue degradation. 
One of the factors that maintains cartilage in a healthy and homeostatic condition is 
physiological levels of mechanical load. It is essential because it regulates chondrocyte 
activities to balance the expression of molecules that are needed for cartilage turnover.  
It has been shown that non-physiological load: either insufficient load (e.g. 
immobilisation or purely static load) or overload (e.g. sudden (traumatic) or prolonged 
(obesity)) leads to an imbalance in ECM turnover resulting in cartilage degeneration 
(Griffin and Guilak, 2005).  
It is well known that many factors affect the response of chondrocytes to mechanical 
force (Bader et al., 2011, Lee and Bader, 1997), therefore the purpose of this 
experimental chapter was:  
 To identify low and high magnitudes of load that induce early transcriptional 
variations in anabolic/catabolic molecules in response to a short-term loading 
episode 
 To identify more globally genes that are sensitive to load  
 To identify more globally genes that are sensitive to load  
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3.3.1. Identification and validation of appropriate reference genes that are 
unaffected by mechanical load   
Quantitative PCR (qPCR) is one of the most commonly used techniques in scientific 
studies due to its sensitivity in detection, and over the last decade the usage of this 
method to quantify mRNA levels increased from 8% to 88%  (Bustin, 2000, Kozera and 
Rapacz, 2013, Thellin et al., 2009). qPCR may be a reliable method to assess the level of 
gene expression, but only if it is correctly optimised for the designed experiment (Thellin 
et al., 2009). One of the critical factors that is key to perform is a consistent analysis of 
reliable reference genes (Kozera and Rapacz, 2013). To select the most appropriate 
internal gene(s) for data normalisation, recommendations have been proposed by the 
MIQE guidelines concerning selection of reference gene(s): (i) experimental validation 
of reference gene stability and (ii) usage of at least three reference genes if there is no 
reason for using fewer (Bustin et al., 2009, Bustin et al., 2010). Reference genes are used 
to assess variations in studied gene expression levels induced by experimental 
parameters (McCulloch et al., 2012).  In order to act as a reference gene, expression 
levels should be unaffected by the treatment regime being applied e.g. mechanical load 
(McCulloch et al., 2012). Using and normalising data to inappropriate reference genes 
can bear false positive or negative results, because an applied stimulus can affect the 
expression of not only the genes of interest but also the reference genes themselves 
(Dheda et al., 2004, Kozera and Rapacz, 2013). Historically, many scientific groups 
showing the effect of mechanical load on cartilage have normalised their data to 
common reference genes such as 18S, GAPDH and β-actin. These genes were normally 
chosen based on the literature, not by experimental optimisation of the most stable 
reference gene (McCulloch et al., 2012). Knowing how important the selection of 
endogenous reference genes is to obtain reliable qPCR results, it is surprising that only 
one group, prior to our study (Al-Sabah et al., 2016) tried to optimise the most suitable 
internal reference controls for chondrocytes subjected to mechanical stimulation.  
Lee et al. reported that 18S was the most appropriate from 5 tested putative reference 
genes (18S, GAPDH, β-actin, β-glucuronidase, and β-2 microglobulin) for articular 
chondrocytes and intervertebral discs subjected to mechanical load (Lee et al., 2005b).  
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As the selection of reference genes for a new experimental design needs to be 
confirmed experimentally (Bustin et al., 2010), I have taken a panel of reference genes 
(Anstaett et al., 2010) to assess their stability under the parameters I have used in the 
experimental setup. To identify the most stable reference genes, three independent 
experimental repeats of cartilage either subjected to different loading regimes or left 
unloaded were examined. qPCR data from each reference gene were analysed using 
RefFinder software (http://fulxie.0fees.us/) that combines 4 different algorithms: 
BestKeeper (Pfaffl et al., 2004), geNorm (Vandesompele et al., 2002), NormFinder 
(Andersen et al., 2004) and comparative ∆Ct (Silver et al., 2006), to select the most stable 
reference genes on the basis of Ct values. The MIQE guidelines suggests use of at least 
three reference genes unless there is a reason to select less (Bustin et al., 2010). Several 
reports indicate the importance of selecting at least 2 reference genes for normalisation 
(Kozera and Rapacz, 2013, Nicot et al., 2005, Thellin et al., 2009, Vandesompele et al., 
2002), because the use of only one internal reference gene can lead to relatively large 
errors and false results (Vandesompele et al., 2002). RefFinder analysis indicated that 
SDHA, YWHAZ and RPL4 were the most stable reference genes under the experimental 
conditions tested; because YWHAZ and RPL4 had similar levels of stability, YWHAZ was 
selected as the second reference gene for data normalisation. Therefore, all of the 
remaining data in this chapter were normalised to the geometric mean of the two most 
appropriate internal reference genes: SDHA and YWHAZ. GAPDH which is commonly 
used as an internal reference gene (Glare et al., 2002), and also previously utilised in 
cartilage mechanobiology studies, was classified as one of the least stable from the 8 
tested and, therefore an inappropriate reference gene for data normalisation in loaded 
cartilage. This result is not surprising as GAPDH is an enzyme involved in glycolysis, 
providing the main source of energy production in chondrocytes. The unstable nature 
of GAPDH was also confirmed in other studies performed on canine (Maccoux et al., 
2007) and human osteoarthritic articular cartilage (Pombo-Suarez et al., 2008), and in 
the differentiation of ATDC5 chondroprogenitor cells (Zhai et al., 2013). In contrast to 
most studies performed on chondrocytes, Silver et al. presented GAPDH as the most 
appropriate internal control for data normalisation in human reticulocytes (Silver et al., 
2006).  β-actin and 18S appear to have very similar levels of stability in my experimental 
design and both of them are relatively stable even though the actin cytoskeleton has 
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been shown to be reorganised in response to load (Blain, 2009, Knight et al., 2006). 
However, β-actin and 18S were classified as inappropriate internal controls for 
experiments with the ATDC5 cell line, with HPRT and PPIA recommended as the most 
suitable (Zhai et al., 2013), which contrasts to my observations in cartilage tissue under 
load. As can be seen, one endogenous reference gene can behave differently in different 
tissues and even in the same tissue when exposed to different stimuli, therefore it is 
absolutely essential to validate at least 2 potential reference genes for each 
experimental condition.    
 
3.3.2. Characterisation of physiological and non-physiological magnitudes of load 
that induce transcriptional differences in chondrocyte response  
In most previously published studies, cartilage was subjected to load for different 
periods of time ranging from hours (h) (Kiraly et al., 1998, Parkkinen et al., 1993) to days 
(Lee and Bader, 1997, Mauck et al., 2000) or even weeks (Otterness et al., 1998, Pap et 
al., 1998). The purpose of this current study was to establish loading regimes to 
determine the earliest changes at the gene level induced by load. 
To establish the required regimes, cartilage explants were loaded under three different 
magnitudes: 2.5MPa, 5MPa or 7MPa (1Hz, 15 minutes) and mRNA levels of markers of 
cartilage homeostasis measured 24h post-load. The aforementioned loading regimes 
were selected for testing based on previous studies (unpublished) and the literature 
where load ≤5MPa was declared as physiological, whereas ≥5MPa was reported as non-
physiological/injurious (Arokoski et al., 2000, Hodge et al., 1986). To determine the 
magnitude of load that induces changes in cartilage homeostasis during normal 
movement, a frequency of 1Hz was applied as it is equivalent to fast walking (Bader et 
al., 2011). Application of load for 15 minutes appeared to be sufficient to observe 
changes at the mRNA level up to 24h post-cessation of load. To assess whether the 
applied load triggered changes at the transcriptional level and if so whether genes of 
molecules involved in anabolic or catabolic events were preferentially regulated, a panel 
of genes were selected that were either representative of anabolic (aggrecan, collagen 
type II, TIMP-1, TIMP-2 and TIMP-3) or catabolic (MMP-1, -3, -9, -13, ADAMTS-4, -5) 
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markers of cartilage metabolism; these genes were selected on the basis that they have 
previously been demonstrated to be influenced by mechanical load in articular cartilage 
(Blain et al., 2001, Blain, 2007, Kiraly et al., 1998, Kurz et al., 2001). 
Analysis of mRNA levels in cartilage subjected to the different loading regimes 
demonstrated that aggrecan and collagen type II transcription were unaffected, when 
compared to the unloaded explants. Interestingly, several previous studies have shown 
the mechano-responsive character of these anabolic molecules (Grodzinsky et al., 2000, 
Kurz et al., 2001, Thomas et al., 2011), therefore  it is likely that the period of loading 
was not long enough to induce transcriptional changes in these particular genes, 
corroborating a study that demonstrated that changes in aggrecan and collagen type II 
gene expression were dependent on the duration of load (Smith et al., 2000).   
Increased MMP transcription can indicate an imbalance of ECM homeostasis, therefore 
to investigate whether any of the loading regimes initiate a catabolic molecules 
response, expression of specific MMPs that are known to be significantly altered under 
conditions of abnormal load were measured by qPCR. Neither 2.5MPa or 7MPa load 
affected the mRNA level of the collagenase MMP-1 which indicates that even if a non-
physiological magnitude is applied to cartilage, but for too short a period of time, the 
tissue does not respond to it in agreement with Monfort et al. who showed that healthy 
cartilage subjected to normal load does not change MMP-1 expression (Monfort et al., 
2006). However, surprisingly the 5MPa load significantly increased MMP-1 transcription 
suggesting its mechano-sensitive nature as previously reported (Fitzgerald et al., 2004, 
Leong et al., 2011). However, this data is contradictory as it is not clear why the highest 
load (7MPa) did not induce MMP-1 transcription similar to the 5MPa load.  
MMP-3, which is able to activate itself and other MMPs - for example pro-collagenases 
(pro-MMP- 1, -13) and pro-gelatinases (pro-MMP-9, -2) (Johnson et al., 2011, Monfort 
et al., 2006, Ramos-DeSimone et al., 1999), moreover it has a capability to degrade 
collagen type II, IV, and IX, proteoglycans, laminin and fibronectin (Ye et al., 1996); was 
found to be up-regulated in explants subjected to either a 5MPa or 7MPa load.  The 
mechano-sensitive nature of MMP-3 has been reported in previous studies (Blain, 2007, 
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Leigh et al., 2008, Monfort et al., 2006, Patwari et al., 2003) and qPCR confirmed this 
finding.  
In my study, according to qPCR results MMP-9 and MMP-13 were significantly decreased 
in explants subjected to either a 2.5MPa or 5MPa load, whereas transcript levels were 
unaffected by a 7MPa load. These results, using the optimised loading regimes, 
corroborate the mechano-sensitive nature of MMP-9 and MMP-13 in cartilage explants. 
However, in contrast it has previously been shown that injurious static load (~20MPa 
applied for only 1 second) elevated MMP-9 expression (Lee et al., 2005c). Furthermore, 
when comparing the activity of MMP-13 in: (i) OA mouse knee subjected to moderate 
load versus an unloaded OA knee, (ii) non-OA loaded mouse knee to unloaded, MMP-
13 expression was observed to decrease in response to physiological load  (Hamamura 
et al., 2013).  Decreased MMP-13 expression, as detected in my study, was also observed 
when physiological levels of tensile strain (3%, 0.25Hz) were applied for 4-24h to 
chondrocytes  (Madhavan et al., 2006).  
Proteoglycans are one of the first ECM molecules to undergo degradation in the process 
of cartilage degeneration, therefore measuring transcript levels of the catabolic 
enzymes that are the most effective aggrecanases may help to specify the early effects 
that applied load has on cartilage chondrocytes. ADAMTS-4 and ADAMTS-5 are reported 
as highly involved in aggrecan degeneration, although the contribution of these 
molecules to cartilage pathology remains unclear and appears to be species-dependant. 
Experiments conducted on ADAMTS-4 or -5 knock-out mice demonstrated that 
ADAMTS-5 is the major aggrecanase involved in mouse cartilage degeneration, as only 
ADAMTS-5 knock-out mice were protected from early aggrecan loss in an OA model 
induced by joint destabilisation (Glasson et al., 2004, Glasson et al., 2005, Stanton et al., 
2005). In contrast to murine OA cartilage, ADAMTS-4 is suggested to be more important 
in human cartilage degradation as it is elevated in OA tissue (Malfait et al., 2002, Naito 
et al., 2007). Song at al. also showed higher expression of ADAMTS-4 compared to 
ADAMTS-5 in OA articular cartilage, however both enzymes were elevated in human OA 
cartilage (Song et al., 2007). Elevated expression of ADAMTS-4 and-5 in response to 
mechanical load corroborated data from a previous study which identified ADAMTS-4 
as 2-fold elevated and ADAMTS-5 as the second most increased (40-fold) gene in bovine 
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cartilage subjected to injurious static load (~20MPa/1sec) (Lee et al., 2005c). Increased 
levels of ADAMTS-4 mRNA were observed under all of the loading regimes tested by 
qPCR suggesting that ADAMTS-4 is induced to regulate load-induced ECM turnover, 
whereas ADAMTS-5 responsiveness to only a non-physiological magnitude (7MPa) 
suggests that this ADAMTS is less committed to cartilage homeostasis than to cartilage 
degeneration.  
In this study, the load-dependant nature of TIMP-1, TIMP-2 and TIMP-3 was also 
demonstrated. TIMP-1 and TIMP-3 expression was subtly up-regulated in response to 
the lowest load, and there was a greater increase in transcript levels in response to the 
5MPa and 7MPa loads. This may mean that these TIMPs, as protease inhibitors, are 
synthesised to balance the production of catabolic molecules to maintain cartilage 
homeostasis, as all TIMPs are known to control the expression of many MMPs (Murphy, 
2011); additionally, TIMP-3 is crucial in inhibiting ADAMTS-4 and ADAMTS-5 activities 
(Sahebjam et al., 2007). Surprisingly, TIMP-2 did not follow the trend of elevation in 
response to mechanical load.  qPCR presented almost the same level of down-regulation 
in all tested loading regimes indicating that TIMP-2 in my experimental design was  
load-, but not magnitude-dependent.  
The aim of the work described above was to optimise two individual loading regimes 
that induced different biochemical responses in cartilage chondrocytes. None of the 
loads tested altered the gene expression of selected anabolic molecules, however all of 
the assessed loading regimes differentially affected the gene expression of some 
catabolic molecules. Based on the transcriptional changes observed at the mRNA level  
I chose two loading regimes for further studies: (i) 2.5MPa load (1 Hz, 15 minutes) that 
induced a homeostatic response of chondrocytes to a normal (physiological) magnitude 
of load, and (ii) 7MPa load (1 Hz, 15 minutes) that led to elevated gene expression levels 
of some catabolic molecules. This loading magnitude dependent effect suggested that 
the 7MPa load can be considered as a potentially, high enough magnitude to induce a 
degradative response if it was applied for a prolonged period of time.  
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3.3.3. Global overview of genes that are sensitive to compressive mechanical load 
Although loading regimes that will be used for the subsequent identification of 
mechano-sensitive miRs were established, a comparison of transcriptional changes in 
explants processed either at 4h or 24h post-cessation of load was performed to identify 
global changes in mechano-sensitive genes and assess whether these effects were 
transitory or sustained.  Changes in gene transcript levels in explants subjected to 
2.5MPa or 7MPa (1Hz, 15 minutes) load and processed either at 4 or 24h after load were 
assessed using GeneChip® Bovine 1.0 ST arrays (all experimental work for explants 
processed at 4h post-load was conducted by Dr Aisha Al-Sabah).  
The 24h post-load array results confirmed: (i) unchanged levels of aggrecan and collagen 
type II as shown in qPCR data, (ii) elevated level of MMP3, ADAMTS-4, TIMP-1/-3,  
(iii) decreased expression of TIMP-2 in response to 7MPa load. The microarray data 
showed also that the expression of a greater number of genes were significantly altered 
in cartilage 4h post-cessation of load compared to 24h suggesting that many genes 
present transitory transcriptional alterations in response to mechanical stimuli.  
Transcription factor, FOS-like antigen (FOSL-1/Fra-1) has been noted in this study as one 
of the most load-dependent genes, showing increased expression with elevated 
magnitude of load at both tested time points. FOSL-1 dimerizes with proteins from the 
JUN family, JUNB which was also shown to be a load-dependent molecule, and JUND 
proteins forming the transcription factor AP-1 (Ijiri et al., 2008). This plays an important 
role in cartilage homeostasis as it was reported that activation of AP-1 reduces the 
expression of Sox-9, a major transcription factor controlling collagen type II expression 
(Hwang et al., 2005). Moreover, it has been also reported that 30 minutes of cyclic 
compression (1KPa, 1Hz) applied on chondrocytes increased AP-1 binding to MMP-3 
and-13 resulting in their higher expression (Bader et al., 2011). As the role of FOSL-1 and 
JUNB in the regulation of cartilage homeostasis is clear, it is not surprising that both 
FOSL-1 (Thorfve et al., 2012) and JUNB (Rhee et al., 2016) are up-regulated in OA 
cartilage. My results additionally confirmed the mechano-sensitive nature of FOSL-1 in 
cartilage consistent with the findings in engineered cardiac tissue subjected to 48h of 
cyclic mechanical stretch (5% elongation, 0.5Hz) (Ye et al., 2013). FOSL-1 and JUNB were 
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also up-regulated at 4h post-load in rat bone following in vivo cyclic loading (13N, 2Hz, 
3 minutes) (Mantila Roosa et al., 2011). As AP-1 is a series of dimeric complexes 
composed from the JUN and FOS family (Shaulian and Karin, 2002), and known to be 
early response transcription factors to mechanical stimuli, it is not surprising that 
previous studies demonstrated and also confirmed the mechano-sensitive nature of 
other molecules from the FOS family presented in this chapter (Haasper et al., 2008, 
Inoue et al., 2004, Thomas et al., 2011). Interestingly, a significant up-regulation of FOSB 
was observed only at 4h post-load, however FOS was found to be up-regulated at 24h 
in response to the 7MPa load only. These data suggest a load and time-dependent 
nature of FOSB and FOS transcription. The mechano-responsiveness of FOS has 
previously been reported with up-regulation at 4h post-load in chondrocytes subjected 
to 30 minutes of tensile strain (7.5%, 1Hz) (Thomas et al., 2011). In turn, Inoue et al. 
reported the mechano-inductive nature of FOSB in mice, showing increased FOSB 
expression in mouse hind limb bone after only 30 minutes (the highest expression by 
2h) of re-loading in rotating cage after 4h tail-suspension (Inoue et al., 2004). Moreover, 
the mechano-sensitivity of FOSB was also demonstrated in vitro by its increased 
expression in response to fluid shear stress (100-120rpm, 30 minutes) in mouse 
osteoblasts (Inoue et al., 2004) and to 3 repeats per day of 2h cyclic stretching (2% or 
8% elongation, 1 Hz) within 3 days in human bone marrow stromal cells (hBMSCs) 
(Haasper et al., 2008). All of these studies corroborate data demonstrating the 
mechano-responsive nature of the components of the AP-1 transcription factor.  
The mechano-responsive nature of ADAMTS-1 demonstrated by Roosa et al. in in vivo 
loaded rat forelimb was also confirmed in this study (Mantila Roosa et al., 2011).  
This group reported that ADAMTS-1, which is a known catabolic molecule in articular 
cartilage as it cleaves cartilage proteoglycans (Kuno et al., 2000), is an early response 
gene (4h post-load) to cyclic mechanical loading (13N, 2Hz, 3 minutes); these results are 
also transient as the changes are not noticeable at later time points (Mantila Roosa et 
al., 2011). This study corroborates the mechano-sensitivity of ADAMTS-1 which was 
highly expressed at 4h post-load in explants subjected to both loading regimes, and the 
level of its expression decreased at the later time point showing 10-fold lower 
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expression at 24h post-load in response to 7MPa than at the 4h time point, with no 
change in response to a 2.5MPa load.  
Another load- and time-dependent gene identified in this study is Inhibin Beta A 
(INHBA/ActivinA) which is an activator of anabolic SMAD2/3 pathway, and due to its 
anti-catabolic function it supresses aggrecan degradation in cartilage (Alexander et al., 
2007). INHBA plays an  important role in cartilage turnover and is up-regulated in OA 
cartilage which suggests its effort to reactivate a leading role for SMAD2/3 above 
SMAD1/5/8 which becomes dominant in OA (Snelling et al., 2014). The only previous 
study showing sensitivity of INHBA to mechanical load was in human periodontal 
ligament cells subjected to cyclic deformation (12%, 6 seconds elongation every 90 
seconds, 12h or 24h) (Pinkerton et al., 2008). This finding supports data showing that 
dynamic mechanical compression of healthy articular cartilage is a stimulator of  
TGF-β/Smad2/3 signalling pathway (Madej et al., 2014) which is cartilage protective as 
it stimulates aggrecan and collagen type II synthesis (Swingler et al., 2012). 
Interestingly, so far there is no publication about the mechano-sensitive nature of 
Laminin Subunit Gamma 2 (LAMC2) which according to microarray results performed on 
articular cartilage subjected to 2.5MPa and 7MPa (1Hz, 15 minutes) load and processed 
at 4 or 24h post-load is highly load-dependent. The closest data that confirms the 
influence of load on LAMC2 expression reported the increased expression of LAMC2 in 
human chondrocytes cultured in hypergravity (1.8g) conditions for 2h in comparison to 
normal gravity (1g) conditions (Wehland et al., 2015). Although studies on the tissues 
suggest that LAMC2 may play an important role in cartilage homeostasis, there are no 
publications on the role of LAMC2 in cartilage OA development. Garg et al. showed that 
LAMC2 binds to epidermal growth factor receptor (EGFR) and modulates its activity in 
anaplastic thyroid carcinoma (ATC); inhibition of LAMC2 partially blocks EGFR activation 
and its signalling pathway (Garg et al., 2014). This fact suggests that reduced expression 
of LAMC2 may also silence EGFR in articular cartilage and affect cartilage homeostasis, 
as it has been reported that DMM mice with reduced EGFR activity demonstrate 
enhanced cartilage degradation with higher expression of ADAMTS-5 and MMP-13 
(Zhang et al., 2014a).  
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Although, there are no publications concerning the influence of Enoyl-CoA, Hydratase/3-
Hydroxyacyl CoA Dehydrogenase (EHHADH) on cartilage homeostasis, it is known that 
enoyl-CoA hydratases are involved in fatty acid metabolism that provides energy for 
different cellular processes (Nelson, 2005), therefore it may play a crucial role in tissue 
homeostasis. This study corroborated the mechano-sensitive nature of EHHADH,  
as Chaillou et al. previously reported decreased expression of this gene in overload-
induced hypertrophic skeletal muscles of the dorsal aspect of the lower hind limb 
(Chaillou et al., 2013).  
Interestingly, this study is the first to demonstrate the mechano-sensitive nature of  
a number of other genes. Load- and time dependent ADAMTS-2 gene expression 
according to the microarray data has not yet been reported as mechano-responsive in 
the literature. This gene was down-regulated in response to 7MPa load at 24h only and 
was reported to be increased in OA cartilage (Kevorkian et al., 2004). ADAMTS-2 is a 
procollagen proteinase which processes the procollagens of fibrillar collagens to create 
collagen molecules used for generating fibrils (Alper et al., 2015, Kevorkian et al., 2004). 
The up-regulation of ADAMTS-2 in OA chondrocytes may be explained by increased 
production of collagen in OA chondrocytes likely to compensate for collagen type II loss 
(Kevorkian et al., 2004), whereas down-regulation in response to 7MPa indicates that a 
7MPa (1Hz, 15 minutes) load is not sufficient to induce osteoarthritic damage and also 
it suggests that the 7MPa load inhibits pro-collagen processing in  loaded cartilage. 
The most increased gene in 7MPa loaded explants when compared to 2.5MPa loaded 
tissue was G Protein-Coupled Receptor Class C Group 5 Member A (GPRC5A) also known 
as retinoic acid induced gene 1 (RAIG1) or retinoic acid induced three (RAI3). It was first 
found by Cheng et al. in 1998 in a human oral squamous carcinoma cell line as retinoic 
acid-inducible G protein binding receptor (Cheng and Lotan, 1998) and is known as an 
orphan receptor because its ligand remains unidentified (Acquafreda et al., 2009). 
Additionally, to date there are no papers indicating a role of GPRC5A in cartilage 
homeostasis, but Harada et al. showed GPRC5A as a putative binding partner of Frizzled 
proteins what suggests a possible role in activation of canonical and non-canonical Wnt 
signalling pathway (Acquafreda et al., 2009, Harada et al., 2007). 
 155 
 
Ras-like and (o)Estrogen-Regulated Growth inhibitor (RERG) was the most decreased 
gene in explants subjected to a non-physiological load in comparison to a physiological 
loading magnitude. RERG is a highly oestrogen responsive gene and its expression is 
correlated with oestrogen receptor (ER) levels as it contains 2 ER binding sites in the 
promoter region (Key et al., 2006); furthermore,  elevated and decreased mRNA levels 
were observed in a breast cancer cell line (MCF-7) treated with β‐oestradiol or ER 
antagonist tamoxifen, respectively (Finlin et al., 2001). Therefore, the reduced 
expression of RERG can be explained by the fact that the expression level of ERα (ESR1) 
was also reduced in explants subjected to a 7MPa load with respect to 2.5MPa load, 
however this mRNA alteration was not statistically significant (1.37-fold: FDR=0.39) 
(data not shown). In cartilage, the same as in bone, ERα and ERβ are expressed and in 
the literature there is increasing evidence that ERα, which mediates most of the 
oestrogen function in bone such as synthesis of bone matrix proteins, osteoblast 
proliferation and promotion of osteoclast death, is activated in response to physiological 
mechanical load indicating that mechanical stimuli play an important role in bone 
homeostasis and density (Lee and Lanyon, 2004, Windahl et al., 2013). ERβ role in bone 
is still under investigation, however a recent study reported its antagonistic role towards 
ERα (Khalid and Krum, 2016). Although, there is no publication suggesting the mechano-
responsive nature of ER in chondrocytes, the microarray data in the current study 
indicated mechanically-regulated expression of ERα. However, the transcriptional level 
of this gene was significantly decreased (1.28-fold: FDR=0.004) in explants subjected to 
a 7MPa load and processed at 24h post-load when compared to unloaded tissue (data 
available electronically). Explants subjected to either 2.5MPa or 7MPa loads and 
processed at 4h post-load or 2.5MPa load at 24h post-load did not show statistically 
significant changes in any of these genes which suggests that differential expression of 
ERα and RERG in cartilage is load- and period post-cessation of load dependent. Due to 
the increased activation of ERα in response to physiological mechanical stimuli in bone, 
the down-regulated mRNA expression in explants subjected to 7MPa (1Hz, 15 minutes) 
load suggests that this loading regime is too high to induce synthesis of ERα. 
Prostate associated microseminoprotein (MSMP/ PC3-secreted microprotein), which 
was the most decreased gene observed in explants subjected to a 2.5MPa loading 
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regime processed at 24h post-load, has not previously been demonstrated to be 
mechano-responsive nor play an influence on cartilage homeostasis. However, it is 
believed to be involved in Akt phosphorylation and caspase activation in PC3 (prostate 
cancer cell line) suggesting an involvement in apoptosis (Pidgeon et al., 2002). Hence, 
the observation of decreased MSMP transcription over the 24h period suggests the load 
does not induce apoptosis reflecting my findings from live/dead explant staining (data 
not shown). 
Another gene that was regulated in a load- and time-dependent manner in this study 
was chordin-like BMP inhibitor (CHL2/ CHRDL2). A greater down-regulation was 
observed in response to a 7MPa load in comparison to unloaded tissue than in response 
to a 2.5MPa load, 24h after loading, whereas the mRNA level of CHL2 at 4h post-load 
remained unchanged. Bone morphogenetic proteins (BMPs) were originally identified 
as factors promoting endochondral bone formation, however most recent studies have 
revealed that this protein family includes different molecules, inducing the growth 
factors (GDF) subfamily and collectively they are important in many organogenesis 
processes (Hogan, 1996, Nakayama et al., 2004, Tsumaki et al., 2002). Although the 
entire mechanism of influence of the BMP family on cartilage formation and 
development is still unclear, it is known that BMP-2, -4, -6 and -7, and GDF-5 are involved 
in cartilage development (Tsumaki et al., 2002). The activity of these BMP proteins is 
controlled by their receptors and inhibitors, and one of these inhibitors is CHL2 
(Nakayama et al., 2004). CHL2 was identified as a negative regulator of cartilage 
formation from mesenchymal stem cells by reducing cartilage matrix accumulation and 
was identified only in the superficial layer of mouse embryo developing joint cartilage 
with very weak expression in adult mouse cartilage (Nakayama et al., 2004). Therefore, 
the down-regulation of CHL2 with high non-physiological load would potentially 
promote a cartilage repair mechanism in response to the potentially damaging load. 
Microarray analysis of mechanically-regulated genes in explants subjected to 2.5MPa 
and 7MPa (1Hz, 15 minutes) load and processed at 4h or 24h post-load, showed also the 
mechano-responsiveness of several miRs including miR-221 and -222 that have already 
been shown as mechano-sensitive in weight bearing locations of bovine cartilage in stifle 
joints (Dunn et al., 2009). 
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3.3.4. Protein classes of differentially expressed genes in response to 2.5MPa and 
7MPa loading regimes at 4h and 24h after loading 
To create a more organised picture of the identified global mRNA changes in cartilage 
explants subjected to physiological and non-physiological magnitudes of load and 
processed either at 4 or 24h post-load, the significantly altered genes were organised 
into protein classes using the online available PANTHER classification system 
(http://www.pantherdb.org/).  
The grouped gene data performed using PANTHER showed that the greatest number of 
genes differentially expressed in explants processed at 4h post-load belong to nucleic 
acid binding proteins and transcription factors as these protein classes represent the top 
two most abundant of all the groups in explants subjected to both loading regimes. 
Explants processed at 24h post-load did not present such a similarity between loading 
regimes, but this might reflect the diversity of the more long-term transcriptional 
response to load. The most abundant protein subclasses in 24h post-load explants 
stimulated with a physiological (2.5MPa) magnitude were signalling molecules and 
hydrolases, whereas a non-physiological (7MPa) magnitude mostly induced the 
expression of molecules belonging to nucleic acid binding proteins and hydrolases.  
The panel of all protein groups that were differentially expressed in response to 2.5MPa 
and 7MPa loads was similar in each condition suggesting that these protein groups are 
the most sensitive classes of molecules in response to mechanical stimuli in articular 
cartilage. The trend of greater transcriptional changes in explants subjected to 7MPa 
load than 2.5MPa suggests that these loading regimes may turn into degradative and 
biosynthetic/turnover load, respectively, if applied for long enough periods of time. For 
many of the mechano-responsive genes, their regulation is more pronounced at 4h 
compared to 24h post-load. The greater fold-changes observed at 4h relative to 24h 
suggest transitory mechanically-responsive effects on many genes e.g. FOSL-1 (4h post-
load: 2.5MPa (6.94-fold), 7MPa (16.51-fold), 24h post-load: 2.5MPa (3.13-fold), 7MPa 
(8.92-fold); this is also supported by the fact that a greater number of genes show 
altered mRNA expression at 4h post-load as opposed to 24h post-cessation. It is yet to 
be determined whether or when the expression of this cohort of mechanically regulated 
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genes return to basal expression. Although the differentially regulated protein classes 
identified in response to a 7MPa load were comparable at both time points, subtle 
differences were observed in the protein classes identified at 4h and 24h post-cessation 
of the 2.5MPa load. This may be attributed to the transitory changes in expression levels 
of the mechanically-regulated genes identified at 24h following a 2.5MPa load.  
The difference in the top 3 most abundant protein classes in explants subjected to 
2.5MPa load and processed at 4h versus 24h post-cessation may be attributed to  
(i) a less pronounced transcriptional response i.e. fold-change in expression, in cartilage 
subjected to a 2.5MPa load compared to a 7MPa load and (ii) the transitory  
mechano-regulation of many of these genes in explants subjected to 2.5MPa and 
processed 24h post-load. If my hypothesis is right, it would indicate that many of the 
genes belonging to nucleic acid binding proteins and transcription factors present 
transitory differential expression, whereas the changes in transferases are more 
sustained.   
 
To summarise this subsection: these results demonstrate that the transcriptional 
response and associated protein classification is both load and time-dependant and this 
suggests that the timeframe to observe early transcriptional effects may be very 
different depending on the gene under investigation (Garg et al., 2014).  
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3.3.5. Summary: 
 SDHA and YWHAZ are the most stable and appropriate reference genes, in 
cartilage explants subjected to different magnitudes of load, for data 
normalisation and reliable qPCR results. 
 Transcriptional validation of mechano-responsive genes encoding anabolic and 
catabolic molecules has shown that: (i) 2.5MPa and 5MPa (1Hz, 15 minutes) 
loads triggered a response characteristic of homeostasis, whereas the (ii) 7MPa 
(1Hz, 15 minutes) loading regime induced predominantly catabolic genes, 
known to be highly expressed in OA cartilage, therefore it can be considered as 
potentially mechanically compromised. 2.5MPa and 7MPa (1Hz, 15 minutes) 
loading regimes were selected as representative of physiological and non-
physiological magnitudes of load.    
 Mechanical stimulation affects predominantly the transcriptional level of many 
nucleic acid binding and signalling molecules 
 Time points post-cessation of load affect the transcriptional level of the studied 
genes. Differential expression of some genes was obvious only at 4 or 24h post-
load, whereas other significantly altered molecules are differentially expressed 
at both time points however their levels of expression differ.  
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     Identification of mechanically-regulated  
                                       miRs 
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4.1. Background 
Mechanical force induces the expression of some genes that activate important 
pathways in articular cartilage to either maintain tissue homeostasis or promote  
a catabolic response, as previously explained in Chapter 3.  
miRs are produced by all types of cells and control the expression of one third of all 
human genes (Lewis et al., 2005). Their sequences are highly conserved indicating the 
significance of their function; they are involved in the regulation of many biological 
processes such as apoptosis, proliferation, differentiation, development, cell cycle, cell 
metabolism and homeostasis (Miyaki et al., 2010). There is increasing evidence that 
alterations in miR levels are very often associated with changes in matrix molecule 
expression and may cause the development of many diseases (Soifer et al., 2007, 
Ardekani and Naeini, 2010). OA is one such disease that is characterised by altered miR 
expression levels when compared to healthy tissue (Araldi and Schipani, 2010, Goldring 
and Marcu, 2012, Pauley and Cha, 2011, Swingler et al., 2012). 
It is well known that one of the main risk factors for OA development is abnormal 
mechanical load, but it is unknown whether non-physiological loading can influence 
ECM metabolism via miR activation.   
Before I started my PhD study, only a few studies had reported the mechano-responsive 
nature of miRs in different cell types: airway smooth muscle cells (Mohamed et al., 
2010), endothelial cells (Qin et al., 2010, Ni et al., 2011), trabecular meshwork cells (Luna 
et al., 2011b) and tendon fibroblasts (Mendias et al., 2012). To date, not many studies 
have been published on the mechano-sensitive character of miRs in articular cartilage 
or chondrocytes, and how their regulation may affect expression levels of downstream 
target genes. Guan et al. demonstrated that expression of miR-365  
is significantly elevated in chicken and mouse primary chondrocytes subjected to  
a 24h mechanical stimulation (5% elongation, 1Hz, 15min/h) (Guan et al., 2011); 
furthermore, miR-365 was found to regulate chondrocyte differentiation via targeting 
of the central regulator of chondrocyte hypertrophy: histone deacetylase 4 (HDAC4) 
(Guan et al., 2011). Jin et al. identified miR-146a, a miR known to be differentially 
expressed in OA pathogenesis (Yamasaki et al., 2009), as being significantly increased, 
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in human chondrocytes subjected to a static 10MPa load (60 minutes), showing its 
influence on chondrocyte apoptosis by targeting SMAD4 (Jin et al., 2014). Dunn et al. 
demonstrated that expression of miR-221 and miR-222 were differentially up-regulated 
between anterior weight-bearing and posterior non-weight-bearing of medial femoral 
condyles of stifle joint providing further examples of cartilage mechano-responsive miRs 
(Dunn et al., 2009). 
Based on these findings and the fact that mechanical load can promote either ECM 
homeostasis or degradation in cartilage, I hypothesised that chondrocytes differentially 
express many more miRs in response to load than have been discovered so far and that 
these specific mechano-responsive miRs induce homeostatic or catabolic effects in 
cartilage matrix composition, and hence affect functional integrity of the tissue.  
To further investigate the mechano-responsive nature of miRs in chondrocytes 
subjected to mechanical load, Next Generation Sequencing (NGS) analysis was 
performed on miR libraries prepared from loaded and unloaded cartilage explants.  
As miRs are up-stream of their target genes, two different regimes (based on previous 
optimisation in Chapter 3) and three different time points post-cessation of load were 
examined to identify early events in the mechano-regulation of cartilage miRs. 
 
Summary of the aims of this experimental chapter: 
 To identify and validate “early response" mechanically-regulated miRs in 
articular cartilage 
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4.2. Results 
4.2.1. Differential expression of miR-140, -221 and -222 at 24h post-load (7MPa only) 
Prior to the submission of miR libraries for NGS analysis, the expression levels of  
miR-140, -221 and -222 were assessed by TaqMan qPCR on explants subjected to load 
(2.5MPa, 7MPa or unloaded) and analysed 2h and 24h post-load (Figure 4.1).  
No changes were observed at the early (2h) time point for any of the miRs screened 
(Figure 4.1A,C,E), whereas significant changes in expression were present at 24h  
post-load. Although miR-140 levels appeared to be decreased in response to both 
loading regimes (Figure 4.1B), this was only statistically significant in explants subjected 
to a 7MPa load (1.38-fold: p=0.043). Furthermore, miR-221 expression was significantly 
up-regulated (2.99-fold: p=0.029) in explants subjected to a 7MPa load compared to 
unloaded tissue (Figure 4.1D). A noticeable, but not statistically significant up-regulation 
of miR-221 was also observed between explants subjected to 7MPa and 2.5MPa loads 
(2.77-fold: p=0.07). A statistically significant up-regulation of miR-222 was observed in 
response to a 7MPa load when compared to unloaded explants (2.65-fold: p=0.001, 
Figure 4.1F). A comparison of miR-222 levels in explants subjected to 7MPa and 2.5MPa 
demonstrated a significantly greater expression of this miR with increasing load  
(2.36-fold: p=0.024). Clearly, the selected miRs are responsive to increasing mechanical 
loads in articular cartilage.  
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Figure 4.1. Relative expression levels of miR-140 (A,B), miR-221 (C,D) and miR-222 (E,F) 
in cartilage explants subjected to 2.5MPa or 7MPa load (1 Hz, 15 minutes) and analysed 
2h (A,C,E) or 24h (B,D,F) post-load respectively; unloaded explants served as controls. 
Analysis of pooled samples (N = 3) that were either unloaded (n = 6) or were subjected 
to 2.5MPa (n = 6) or 7MPa (n = 6) load was conducted using qPCR with TaqMan™ Fast 
Advance technology; miR levels were normalised to the reference genes (SDHA, YWHAZ) 
and further normalised to the unloaded control tissue. Data are presented as mean ±SD 
(N = 3 pooled samples from independent experiments). Statistical analysis was 
performed using a 1-way ANOVA with Tukey’s post hoc test. Key: Control - unloaded, 
2.5MPa, 7MPa (loaded) [* p<0.05, ** p≤0.01, *** p≤0.001].  
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4.2.2. Identification of mechano-regulated miRs and time post-load required for 
differential expression of mechano-sensitive miRs  
Assessment of global changes in the expression of miRs in loaded and unloaded cartilage 
explants were performed using Next Generation Sequencing. Application of either  
a 2.5MPa or 7MPa load (1Hz, 15 minutes) and analysis conducted 2, 6 or 24h post-
cessation of load elicited differing early transcriptional changes in many miRs when 
compared to the unloaded control cartilage.   
NGS was performed in The Genome Analysis Centre™ (Norwich, UK) and the data was 
analysed by Andrew Skelton (Institute of Cellular Medicine, Newcastle University) using 
(i) a combination of RSamTools (Morgan, 2011) and ShortRead (Morgan et al., 2009) 
bioconductor packages to count aligned reads against a reference, and (ii) a DESeq2 
algorithm to compare the expression of known miRs to identify mechano-responsive 
miRs. To detect differentially expressed miRs, it was necessary to know the raw number 
of reads of miRs in the representative samples for each parameter to calculate the 
average (base mean) from N = 3 individual repeats. Identification of mechano-sensitive 
miRs and the most appropriate time to observe such changes in miRs expression was 
assessed on the base mean from each loading regime and each time point post-
cessation of load.  
 
 
 
 
 
 
 
 
 
 166 
 
4.2.2.1. Most abundant miRs in articular cartilage subjected to load 
The figures below illustrate the top 50 most abundantly expressed miRs in unloaded and 
loaded (2.5MPa and 7MPa) cartilage explants at 2h (Fig. 4.2A), 6h (Fig. 4.2B) and 24h 
(Fig. 4.2C) post-load.  Several of the most abundant miRs detected are known to play 
very important roles in cartilage homeostasis, and their expression levels are reported 
to differ in OA tissue. To this group of miRs we can include for example:  miR-27a (Akhtar 
et al., 2010), miR-27b (Yu et al., 2011), miR-125b (Matsukawa et al., 2013), miR-140 
(Araldi and Schipani, 2010, Swingler et al., 2012), miR-148a (Vonk et al., 2014) and  
miR-455-3p (Swingler et al., 2012). The most abundantly expressed miRs under each 
loading regime and at all three time points were miR-140 and miR-148a. 
Based on the number of reads of miR sequences in each sample, the mean of the reads 
was calculated as an average of 3 independent experiments. To assess for potential 
changes in the expression levels of the miRs, the counts were compared between 
unloaded and loaded or between different loading regimes at the three different time 
points post-cessation of load. miR transcripts that were identified as being significantly 
altered at 2, 6 or 24h post-load are presented (Table 4.1) along with their base mean 
numbers (Figure 4.5). 
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Figure 4.2. Top 50 most abundantly expressed miRs in articular cartilage at 2h post-load. 
Analysis of pooled samples that were either unloaded (n = 6) or were subjected to 
2.5MPa (n = 6) or 7MPa (n = 6) load (1Hz, 15 minutes) was conducted by Next Generation 
Sequencing across all samples (N = 3).  
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Figure 4.3. Top 50 most abundantly expressed miRs in articular cartilage at 6h post-load. 
Analysis of pooled samples that were either unloaded (n = 6) or were subjected to 
2.5MPa (n = 6) or 7MPa (n = 6) load (1Hz, 15 minutes) was conducted by Next Generation 
Sequencing across all samples (N = 3).  
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Figure 4.4. Top 50 most abundantly expressed miRs in articular cartilage at 24h  
post-load. Analysis of pooled samples that were either unloaded (n = 6) or were 
subjected to 2.5MPa (n = 6) or 7MPa (n = 6) load (1Hz, 15 minutes) was conducted by 
Next Generation Sequencing across all samples (N = 3).  
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Table 4.1. Mechanically regulated miRs identified in explants subjected to compressive 
load (2.5MPa or 7MPa, 1Hz, 15 minutes) compared to unloaded explants, and processed 
2, 6 or 24h post-load (FDR ≤ 0.05). 
 
2h post-load 6h post-load 24h post-load 
bta-miR-23a bta-miR-222 bta-miR-7 
bta-miR-23b-3p bta-miR-677 bta-miR-20a 
bta-miR-27a-5p bta-miR-486 bta-miR-21-5p 
bta-miR-98 bta-miR-1249 bta-miR-27a-5p 
bta-miR-148b bta-miR-2889 bta-miR-100 
bta-miR-1260b  bta-miR-155 
bta-miR-2478  bta-miR-221 
bta-miR-2898  bta-miR-222 
  bta-miR-425-5p 
  bta-miR-431 
  bta-miR-451 
  bta-miR-483 
  bta-miR-495 
  bta-miR-543 
  bta-miR-760-3p 
  bta-miR-2318 
  bta-miR-2344 
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Figure 4.5. The base mean counts of all differentially expressed miRs when comparing 
expression levels between 7MPa and 2.5MPa vs unloaded or 7MPa vs 2.5MPa load. The 
mean base counts from three independent experiments for unloaded and loaded 
explants is presented according to: unloaded (A,D,G), 2.5MPa load (B,E,H) and 7MPa 
load (C,F,I) at 2h (1), 6h (2) and 24h (3) post-load. 
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2h post-load: Expression levels of miR-27a-5p (4.42-fold: FDR<0.001) and miR-2898 
(1.73-fold: FDR=0.008) were significantly increased and decreased respectively in 
explants subjected to a 2.5MPa load in comparison to unloaded tissue (Figure 4.6A).  
A 7MPa load significantly elevated expression levels of miR-23a (1.46-fold: FDR=0.034), 
miR-23b-3p (1.54-fold: FDR=0.004), miR-27a-5p (7.09-fold: FDR<0.001), miR-98  
(1.70-fold: FDR=0.001) and miR-148b (1.64-fold: FDR=0.039, Figure 4.6B); in contrast, 
identified miRs that were significantly down-regulated in response to a 7MPa load 
included miR-1260b (1.55-fold: FDR=0.025), miR-2478 (1.77-fold: FDR=0.001) and  
miR-2898 (2.45-fold: FDR<0.001, Figure 4.6B). However, there were no significant 
changes in miR levels when comparing the data obtained from the 2.5MPa versus 7MPa 
loads. 
6h post-load: Very few changes in miR expression were observed after 6h post-cessation 
of load, however a 2.5MPa load decreased miR-486 expression (1.92-fold: FDR=0.002) 
in cartilage explants when compared to unloaded tissue (Figure 4.7A). In contrast,  
a 7MPa load elevated the levels of miR-222 (1.57-fold: FDR=0.008) and miR-667  
(2.15-fold: FDR<0.001, Figure 4.7B). When comparing the two loading regimes directly, 
a 7MPa load induced higher expression of miR-667 (1.93-fold: FDR=0.001) and miR-2889 
(2.39-fold: FDR<0.001), whilst reducing miR-1249 levels (1.78-fold: FDR=0.013) 
compared to the lower load of 2.5MPa (Figure 4.7C). 
24h post-load: Analysis of miR expression 24h post-cessation of load indicated that only 
miR-222 was differentially increased (1.81-fold: FDR=0.003) in response to a 2.5MPa 
load when compared to unloaded explants (Figure 4.8A). In response to the 7MPa 
regime, many more miRNAs were mechanically regulated including elevation of: miR-7 
(1.70-fold: FDR=0.017), miR-21-5p (2.27-fold: FDR<0.001), miR-27a-5p (3.02-fold: 
FDR<0.001), miR-100 (1.43-fold: FDR=0.048), miR-155 (1.47-fold: FDR=0.042), miR-221 
(3.39-fold: FDR<0.001), miR-222 (7.41-fold: FDR<0.001), miR-431 (1.82-fold: 
FDR=0.030), miR-495 (1.78-fold: FDR<0.001), miR-543 (2.62-fold: FDR<0.001), miR-760-
3p (1.72-fold: FDR=0.017), miR-2318 (1.85-fold: FDR=0.022) and miR-2344 (1.82-fold: 
FDR=0.030); miRs that were significantly decreased in response to a 7MPa load included: 
miR-425-5p (1.60-fold: FDR=0.010) and miR-451 (2.08-fold: FDR=0.002, Figure 4.8B). 
When directly comparing expression levels between the 2.5MPa and 7MPa loads, there 
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was significant up-regulation of miRs such as: miR-21-5p (1.72-fold: FDR=0.013),  
miR-27a-5p (2.03-fold: FDR<0.001), miR-221 (2.59-fold: FDR<0.001), miR-222 (4.09-fold: 
FDR<0.001) and miR-543 (1.73-fold: FDR=0.005), concomitant with down-regulation of 
miR-425-5p (1.49-fold: FDR=0.037) and miR-483 (1.79-fold: FDR=0.025, Figure 4.8C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 175 
 
 
 
 
                      
 
Figure 4.6. Differential expression of mechanically regulated miRs in explants subjected 
to either a 2.5MPa (A) or 7MPa (B) load and analysed at 2h post-load. Unloaded explants 
served as controls and the expression of each miR in these unloaded samples is 
presented as 1 (dotted line) (A,B). Analysis of pooled samples that were either unloaded 
(n = 6) or were subjected to 2.5MPa (n = 6) or 7MPa (n = 6) load was conducted by Next 
Generation Sequencing. Results presented are the mean of three independent 
experiments (N = 3). Key: MPa - megapascal, vs - versus, [* FDR≤0.05, ** FDR≤0.01,  
*** FDR≤0.001]. 
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Figure 4.7. Differential expression of mechanically regulated miRs in explants subjected 
to either a 2.5MPa (A) or 7MPa (B) load and analysed at specific periods of 6h post-load. 
Unloaded explants served as controls and the expression of each miR in these unloaded 
samples is presented as 1 (dotted line) (A,B,C), however data were normalised to the 
2.5MPa load when comparing the two loading regimes directly (C). Analysis of pooled 
samples that were either unloaded (n = 6) or were subjected to 2.5MPa (n = 6) or 7MPa 
(n = 6) load was conducted by Next Generation Sequencing. Results presented are the 
mean of three independent experiments (N = 3). Key: MPa - megapascal, vs - versus, 
[* FDR≤0.05, ** FDR≤0.01, *** FDR≤0.001]. 
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Figure 4.8. Differential expression of mechanically regulated miRs in explants subjected 
to either a 2.5MPa (A) or 7MPa (B) load and analysed at specific periods of 24h post-
load. Unloaded explants served as controls and the expression of each miR in these 
unloaded samples is presented as 1 (dotted line) (A,B,C), however data were normalised 
to the 2.5MPa load when comparing the two loading regimes directly (C). Analysis of 
pooled samples that were either unloaded (n = 6) or were subjected to 2.5MPa (n = 6) 
or 7MPa (n = 6) load was conducted by Next Generation Sequencing. Results presented 
are the mean of three independent experiments (N = 3). Key: MPa - megapascal,  
vs - versus, [* FDR≤0.05, ** FDR≤0.01, *** FDR≤0.001]. 
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4.2.3. Validation of putative mechanically regulated miRs in articular cartilage 
Having identified mechanically-regulated miRs using NGS, the results were validated by 
quantitative PCR using TaqMan® technology. The results from the NGS indicated that 
most of the differentially regulated genes were present at 24h post-load (Figure 4.8), 
therefore this time point was focused on. miRs that demonstrated significant differences 
in expression in both comparisons i.e. unloaded vs loaded (2.5MPa or 7MPa) and 
2.5MPa vs 7MPa loads were selected for validation. Validation was performed on three 
independent experiments (n = 6 explants per experiment) to confirm the NGS 
observations.  
miR-21-5p presented a significantly differentiated expression (1.99-fold: p=0.034) in 
response to a 7MPa load, whereas 2.5MPa appeared to slightly increase miR-21-5p 
levels, however the change was not statistically significant (Figure 4.9A).  
A significant increase in miR-27a-5p expression was observed in explants subjected to  
a 7MPa load when compared to the unloaded tissue (2.56-fold: p=0.001). There was also 
a significant response to increasing load with higher levels of miR-27a-5p in response to 
7MPa load when compared to the 2.5MPa loading response (2.39-fold: p<0.001; Figure 
4.9B).  
Validation confirmed the elevated expression of miR-221 in explants subjected to the 
7MPa load when compared to either the unloaded (3.89-fold: p<0.001) or 2.5MPa 
loading regime (2.55-fold: p=0.011; Figure 4.9C). In a similar manner, miR-222 was also 
significantly up-regulated in response to the 7MPa load when compared to either 
unloaded (3.78-fold: p<0.001) or the 2.5MPa regime (2.82-fold: p=0.002, Figure 4.9D). 
Interestingly, the qPCR analysis demonstrated that the lower load of 2.5MPa did not 
significantly affect the expression of either miR-221 or miR-222 when compared to the 
unloaded cartilage (Figure 4.9C and D), suggesting that they are responsive to higher 
loads only. 
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Of the remaining miRs, there was a high degree of variability in expression levels of  
miR-451 as demonstrated by the large error bars (Figure 4.10A). The observed reduction 
in miR-483, as detected by NGS, was confirmed when comparing the response of 
explants to 7MPa load versus unloaded (1.98-fold: p=0.047; Figure 4.10B). 
Expression of miR-543 was found to be significantly elevated in response to the 7MPa 
load, as detected by NGS (Figure 4.8B), however this differential regulation was not 
validated using qPCR (Figure 4.10C). 
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Figure 4.9. Validation of significant mechanically regulated mature miRs that were 
selected on the basis of NGS data. Analysis of samples that were either unloaded (n = 6) 
or were subjected to 2.5MPa (n = 6) or 7MPa (n = 6) (1Hz, 15 minutes load) and 
processed 24h post-load was conducted using qPCR with TaqMan™ Fast Advance 
technology. miR levels were normalised to the geometric mean of 2 reference genes 
(SDHA, YWHAZ) and further normalised relative to the unloaded controls. Data are 
presented as mean ±SD (n = 6 explants) and is representative of 3 independent 
experiments for each miR: miR-21-5p (A), miR-27a-5p (B), miR-221 (C), miR-222 (D). 
Statistical analysis was performed using a 1-way ANOVA with Tukey’s post hoc test. Key: 
unloaded (control), 2.5MPa, 7MPa (loaded) [*p≤0.05, ** p≤0.01, ***p≤0.001].         
 
 181 
 
 
Figure 4.10. Validation of significant mechanically regulated mature miRs that were 
selected on the basis of NGS data. Analysis of samples that were either unloaded (n = 6) 
or were subjected to 2.5MPa (n = 6) or 7MPa (n = 6) (1 Hz, 15 minutes load) and 
processed 24h post-load was conducted using qPCR with TaqMan™ Fast Advance 
technology. miR levels were normalised to the geometric mean of 2 reference genes 
(SDHA, YWHAZ) and further normalised relative to the unloaded controls. Data are 
presented as mean ±SD (n = 6 explants) and is representative of 3 independent 
experiments for each miR: miR-451 (A) miR-483 (B) and miR-543 (C). Statistical analysis 
was performed using a 1-way ANOVA with Tukey’s post hoc test. Key: unloaded 
(control), 2.5MPa, 7MPa (loaded) [*p≤0.05].        
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4.3. Discussion 
Since 1993 when the miR molecule was initially discovered, the importance of these 
small non-coding RNA molecules has been widely reported. During this time, the role of 
miRs in articular cartilage has also been studied, and they are believed to have great 
significance in cartilage development, homeostasis and degradation (Mirzamohammadi 
et al., 2014). Of the many important factors that influence cartilage homeostasis, 
mechanical load is essential for the regulation of cartilage metabolism in order to keep 
cartilage in a healthy condition. Interestingly, there have only been a few studies that 
have investigated the mechano-sensitive character of miRs in articular chondrocytes 
including miR-146a (Jin et al., 2014), miR-221/-222 (Dunn et al., 2009) and miR-365 
(Guan et al., 2011). With the knowledge that (i) some miRs are regulated by mechanical 
force in cartilage chondrocytes and (ii) expression of several miRs differ between healthy 
and OA cartilage the purpose of this experimental chapter was: 
 To identify cartilage miRs that respond to increasing mechanical load 
that may be potential regulators of genes involved in cartilage 
degeneration and OA development. 
 
Cartilage explants were subjected to 2.5MPa and 7MPa loads and were processed  
2, 6 or 24h post-cessation of load. The same time points for analysis were applied to the 
unloaded explants that were used as controls. The time points chosen for this 
experiment were selected on the basis of the results from our previous studies, whereby 
the period of time post-cessation of load required to notice differential expression of 
mechano-regulated matrix genes was optimised (Chapter 3). In our preliminary, optimal 
timeframe identification experiment, periods of 4h, 8h and 24h post-cessation of load 
were appropriate to observe changes at the gene level of anabolic and catabolic 
molecules. As miRs are upstream of the target genes it was decided to select 2h, 6h and 
24h as time points, as the miRs regulating anabolic and catabolic gene responses 
occurring in cartilage are likely to react more quickly to mechanical stimulation than 
matrix gene transcription.  
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4.3.1. Preliminary examination of mechano-sensitive miRs 
Before establishing the global expression of miRs in the loaded explants by NGS,  
a preliminary experiment was performed to determine whether the previously reported 
mechano-sensitive miR-221 and miR-222 (Dunn et al. 2009) were regulated in my 
experimental mechanical loading system. In addition to miR-221 and miR-222, the 
expression levels of miR-140 was also quantified as it is reported to be one of the most 
important miRs in cartilage homeostasis (Miyaki et al., 2010). The qPCR data 
demonstrated the mechano-responsiveness of miR-221 and miR-222 confirming 
previously published studies (Dunn et al., 2009, Mohamed et al., 2010, Mendias et al., 
2012). Interestingly, our preliminary results also indicated that the expression of  
miR-221 and miR-222 was only significantly increased when higher loads (7MPa) were 
applied, as they did not appear to be differentially regulated by the lower (2.5MPa) load 
in comparison to the unloaded. Surprisingly, miR-140 was also sensitive to mechanical 
stimulation and was significantly decreased in explants subjected to a 7MPa load 
compared to the unloaded explants when analysed after 24h. The mechano-sensitivity 
of miR-140 has been previously demonstrated in tendons (Mendias et al., 2012) and 
smooth muscle cells (Mohamed et al., 2010) but not in chondrocytes. In these studies, 
expression levels of miR-140 were significantly decreased in rat achilles tendons which 
were running for 30 minutes on an uphill treadmill with increasing elevation every  
10 minutes (Mendias et al., 2012), and elevated in primary human airway smooth 
muscle cells subjected to 1h of cyclic stretch (1Hz, 0.5 seconds deformation/0.5 seconds 
relaxation)  (Mohamed et al., 2010). These findings suggest that miR-140 expression is 
mechano-sensitive.  
4.3.2. Which miRs are the most abundant in articular cartilage? 
The NGS data was processed by Andrew Skelton (bioinformatician from Newcastle 
University) who performed all of the analyses. By using a combination of RSamTools 
(Morgan, 2011) and ShortRead (Morgan et al., 2009) bioconductor packages, the miRs 
present in the experimental material were detected and quantified which was the first 
necessary step prior to further analysis to determine whether the applied loading 
regimes affected the expression levels of cartilage miRs.  
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Of the top 50 most abundant miRs in articular cartilage (comparing data from loaded 
and unloaded tissue at all of the time points analysed) miR-140 and miR-148a were 
consistently present in the top two. This data are consistent with a previous study which 
demonstrated that one of the most highly expressed chondrocyte miRs is miR-140 
(McAlinden et al., 2013). McAlinden et al. compared miR levels during the process of 
chondrogenesis and demonstrated that miR-140 is the most highly expressed miR in all 
three stages of the chondrocyte phenotype examined (precursor, differentiated and 
hypertrophic). Surprisingly, miR-148a that is known to play an important role in cartilage 
homeostasis by promoting the synthesis of collagen type II and inhibiting the mRNA 
levels of collagen type X, MMP-13 and ADAMTS-5 in the ECM (Vonk et al., 2014) was not 
present on the list of the top 30 most abundant miRs in any of the chondrocyte 
developmental stages examined (McAlinden et al., 2013). This was unexpected, 
especially because the results presented in this chapter demonstrate similar expression 
levels of miR-148a and miR-140 with some rotation in the top two places depending on 
the experimental condition.  
4.3.3. Identification of mechanically regulated miRs in articular cartilage 
NGS is widely used as a tool in both the clinical and research arena, and has 
revolutionised the field of genomics and molecular biology. It gives the opportunity to 
analyse the entire human genome within a few days (Ulahannan et al., 2013) and is 
characterised by a high sensitivity and reproducibility of data. Unfortunately, NGS and 
analysis of deep sequencing reads is not perfect and there are some risk factors that 
may affect the interpretation of data from deep sequencing, e.g. ligation bias of small 
RNAs during library preparation (Sorefan et al., 2012, Raabe et al., 2014) and incorrect 
mapping of genes to the  reference genome (Ulahannan et al., 2013). To avoid false 
positive/negative results, miRs that are found to be significantly altered according to 
NGS data require validation.  Three different periods post-cessation of load were 
examined to find the optimal timeframe to monitor the greatest number of significantly 
altered miRs in response to applied loads. The 2.5MPa loading regime, as was expected, 
altered expression of less miRs than the 7MPa load in all tested time points giving 2, 1 
and 1 altered miRs at 2, 6 and 24h post-load, respectively, whereas the non-physiological 
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(7MPa) magnitude of load induced significant changes in expression levels in 8, 2 and 16 
miRs at 2, 6 and 24h periods post-cessation of load, respectively. Levels of expression of 
only 3 and 7 miRs were changed respectively at 6 and 24h after the 7MPa load when 
normalised to 2.5MPa loading regimes, whereas no changes were observed at the 
earliest (2h) time point (Figure 4.6, 4.7, 4.8). The panel of miRs that were chosen for 
further validation were selected based on two criteria: (i) at least a 2-fold change in 
expression between loaded and unloaded explants or (ii) potential significance in OA 
development reported in the literature. As indicated, because most of the effects were 
observed at 24h post-cessation of load, the selected miRs were predominantly identified 
from this data set for validation. Normalisation of the qPCR data was performed against 
the geometric mean of the specific reference genes: SDHA and YWHAZ which had 
previously been established to be most stable in expression under the experimental 
system utilised. Most published studies analysing miRs expression level have used U6 
spliceosomal RNA (U6) as a reference gene, however in my experimental system this 
gene was found to be unstable, therefore it was not used in my study. 
Of the miRs identified by NGS and validated by qPCR, the most robustly altered miRs 
regulated by mechanical load (7MPa) are miR-221 and miR-222; these miRs were  
up-regulated by almost 4-fold in comparison to unloaded controls and approximately 
2.5-fold when compared to 2.5MPa load. These results corroborate the mechano-
sensitive nature of miR-221 and miR-222 as demonstrated in our preliminary 
experiments and in previously published studies (Dunn et al., 2009, Mendias et al., 
2012). Dunn et al. (2009) demonstrated that the level of these miRs is increased in the 
superficial zone of anterior weight-bearing cartilage when compared to either the 
posterior non-weight bearing superficial zone or middle zone of anterior weight-bearing 
tissue in bovine stifle joint (Dunn et al., 2009).   
Another mechano-responsive miR was miR-21-5p that presented increased expression 
in response to high load (7MPa). These novel results in chondrocytes are consistent with 
several other studies that have reported on the mechano-regulation of miR-21 (Song et 
al., 2012, Weber et al., 2010, Zhou et al., 2011). Song et al. (2012) exposed human aortic 
smooth muscle cells to elevated tensile strain (16%, 1Hz, 12h) which induced increased 
expression of miR-21 (tao Song et al., 2012). Other groups have shown that steady 
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laminar shear stress (LSS; 15 dynes/cm2) (Weber et al., 2010) and oscillatory shear stress 
(OSS; 0.5 ± 4 dynes/cm2)(Zhou et al., 2011) applied to human umbilical vein endothelial 
cells elevated miR-21 expression, whereas pulsatile shear stress (PSS; 12 ± 4 dynes/cm2) 
inhibited the expression of miR-21 at the transcriptional level (Zhou et al., 2011). 
However, to date, there are no published reports on the response of miR-21 to 
mechanical load in cartilage chondrocytes making this a novel finding. 
Another NGS-identified miR which was found to be significantly elevated in response to 
high loads (7MPa) was miR-27a-5p. The human genome contains two miR-27 genes: 
miR-27a and miR-27b, but the mature product of these miRs differ by only one 
nucleotide in the 3’ UTR region leaving the seed region unchanged (Demolli et al., 2013). 
The novel finding that miR-27a is mechanically regulated in chondrocytes, corroborates 
the findings of other groups who demonstrated that both miR-27a and miR-27b were 
up-regulated in endothelial cells subjected to 18h and 24h laminar flow (15 dynes/cm2) 
(Urbich et al., 2012).  
The results of the NGS and qPCR validation indicated that miR-483 levels were 
significantly reduced in response to high loads (7MPa), but interestingly, to date there 
is no published data referring to the mechano-responsiveness of this miR in any cell 
type, again reflecting the novelty of this finding.  
The role of these validated miRs in cartilage homeostasis and/or OA development will 
be described in further depth in Chapter 5.  
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4.3.4. Summary: 
 The most abundantly expressed miRs in articular cartilage are: miR-140 and miR-
148 and their expression remains constant irrespective of the magnitude of 
compressive load or period post-cessation of load 
 Differential expression of miRs in articular cartilage were most evident at 24h 
post-cessation of load and were magnitude-dependent i.e. most miRs were 
affected by the higher 7MPa load only 
 miR-221 and miR-222 were confirmed as being mechano-sensitive in cartilage 
chondrocytes as previously reported (Dunn et al., 2009) 
 Novel findings that miR-21-5p, miR-27a-5p and miR-483 are mechanically 
regulated in cartilage chondrocytes  
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            Chapter 5  
            Identification of direct targets of  
                 mechanically-regulated miRs 
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5.1. Background 
NGS and qPCR validation performed in Chapter 4 identified a number of mechanically-
regulated miRs in articular cartilage: miR-21-5p, miR-27a-5p, miR-221 and miR-222. 
Although the identification of mechano-sensitive miRs in articular cartilage was one of 
the objectives of this PhD, an awareness of the existence of these differentially-
regulated miRs and knowledge of their reported functions is not enough to have an input 
into understanding the correlation between miRs, mechanical load and OA 
pathogenesis.  
Although the function of miRs is clear i.e. controlling the level of target molecule 
expression in cells by regulation of their genes at the post-transcriptional level,  
a working mechanism of gene target recognition is still not completely understood. The 
target genes are recognised by miRs based on the miR:mRNA base pairing that does not 
have to be perfectly matched. The target sites (allocated on mRNA) that allow miRs to 
control mRNA expression can be classified into four groups: (i) 5’- dominant canonical, 
(ii) 5’- dominant seed only, (iii) 3’-compensatory (Brennecke et al., 2005) and (iv) centred 
(Shin et al., 2010) as described below.  
The canonical site is well paired at both the 5’ and 3’ ends. The dominant seed only site 
has perfect base pairing at the most evolutionary conserved miR sequence called the 
“seed region”  (Lewis et al., 2003) positioned at the miR 5’ end, with little or no 3’ miR 
pairing (Brennecke et al., 2005). The 3’ compensatory site depends on strong pairing to 
the miR 3’ end, to compensate for mismatches or short base pairing to the seed region 
(Brennecke et al., 2005). The centred site is a sequence of at least 11 base pairs that 
perfectly match to the miR at the following nucleotide positions: 4-14 or 5-15 and lack 
the seed region and 3’-compensatory complementarity (Shin et al., 2010). As the 
abundance of both 3’-compensatory and centred sites is relatively low compared to 
seed-matched sites (Shin et al., 2010), the seed region at the miR 5’ end is commonly 
acknowledged as the most important sequence in mRNA targeting (Thomson et al., 
2011). 
Focusing on the seed region that is the main area of binding, it must be paired to  
a seed-matched site that is mostly allocated at the 3’ UTR target mRNA, however a small 
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subset of miRs are also able to control expression of some genes by targeting the 5’UTR 
(Lee et al., 2009) or coding region of mRNA (Brümmer and Hausser, 2014). Although 
targeting mRNA can occur in three different locations (3’UTR, 5’UTR and coding regions) 
that usually contains at least one type of seed-matched site (6mer, 7mer-m8, 7mermA1, 
8mer), the most effective protein reduction occurs as a result of miR binding to the 
3’UTR (Baek et al., 2008, Fang and Rajewsky, 2011, Bartel, 2009) with a minimum of one 
7mer-m8 seed-matched site in the mRNA (Baek et al., 2008, Grimson et al., 2007).  
To explore the functional role of a specific miR and determine their influence on target 
genes, precise target prediction is essential. To identify miR target molecules, 
bioinformatic approaches are commonly used and these are the most popular 
prediction programmes: TargetScan (Lewis et al., 2003), miRanda (Betel et al., 2008) and 
PicTar (Krek et al., 2005). Each programme uses its own algorithm to identify target 
genes of a selected miR, therefore unfortunately,  the results when compared between 
different online prediction systems are not always the same (Sethupathy et al., 2006).  
Computational prediction of target mRNA is the first step in the identification of specific 
miR:mRNA interactions, but unfortunately it is not good enough to use it as the only way 
of identifying target genes. One of the biggest problems with using prediction algorithms 
to identify target genes is that these programmes are focused on searching mRNAs 
containing target sites in their 3’UTR, ignoring 5’UTR and coding regions (Thomson et 
al., 2011, Moqadam et al., 2013). In addition, the algorithms select target genes based 
on the exact seed site complementarity, paying no attention to other groups of target 
sites that can still result in gene repression (described at the beginning of this chapter) 
(Moqadam et al., 2013). In addition, one mRNA might be regulated by more than one 
miR and multiple miRs may have to act together to affect individual protein expression 
(Thomson et al., 2011). This means that apart from bioinformatic analysis, all biological 
outcomes of a miR:mRNA interaction must be examined experimentally to observe the 
real influence of a miR on potential target molecules.  
 
 
 191 
 
Summary of the aims of this experimental chapter: 
 Establish whether the identified mechano-sensitive miRs control the 
expression of ECM molecules that have an involvement in cartilage 
homeostasis and/or OA development   
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5.2. Results  
NGS analysis of miR levels in articular cartilage explants subjected to different loading 
regimes identified several miRs as being mechanically-regulated, which were 
subsequently confirmed by qPCR validation (Chapter 4). The next step was to identify 
the downstream target genes of the miRs selected for further exploration which 
included miR-21-5p, miR-27a-5p, miR-221 and miR-222. The choice of miR-21-5p,  
miR-27a-5p, miR-221 and miR-222 over the other differentially-regulated miRs was 
made based on their: (i) mRNA level in loaded explants compared to unloaded tissue 
and (ii) published reports of their differential expression levels in OA cartilage compared 
to healthy tissue. In addition to using a computational algorithm for prediction of 
putative target genes (http://www.targetscan.org/), these targets were also validated 
experimentally to confirm the TargetScan results. To examine experimentally the direct 
regulation of predicted downstream target genes by the miRs, manipulation of the 
expression levels of selected miRs was required.  
5.2.1. Evaluation of cellular uptake of siRNA 
Before manipulation of miR-21-5p, -27a-5p, -221 and -222 expression levels was 
performed in primary bovine chondrocytes, the ability of the cells to take up the siRNA 
was examined using the same experimental conditions planned for miR-21-5p, -27a-5p, 
-221 and -222 manipulation. Isolated primary chondrocytes were transfected as  
a monolayer for 48h, and the extent of cellular uptake of Cy3™- anti-miR™ negative 
control #1 was visualised by fluorescence microscopy. The transfection efficiency was 
found to be almost 100% for the delivery of siRNA into chondrocytes (Figure 5.1).   
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Figure 5.1. Cellular uptake of siRNA over a 48h transfection period. The efficiency of 
chondrocyte transfection was assessed by Cy3™- anti-miR™ negative control #1 (red) 
counterstained with DAPI to locate the nuclei (blue) and visualised using fluorescence 
microscopy. Purple represents transfected cells. Low (A) and high (B) power images of 
representative cells [Scale bars = 200µm and 50µm respectively]. 
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5.2.2. Transfection efficiency of miR inhibitors/mimics 
Having assessed the transfection efficiency of primary chondrocytes using an anti-miR™ 
negative control #1 oligo, the next step was to determine whether the transfection 
conditions were equally conducive to transfecting a high number of cells using the 
functional siRNAs to examine the downstream influence on their target genes. The 
effectiveness of the transfection process on the expression levels of the specific miRs 
were assessed prior to investigating the direct targets of the selected miRs. qPCR was 
conducted on cells transfected with inhibitors/mimics of miRs of interest to evaluate the 
relative expression levels compared to their respective non-targeting controls.  
In addition, as well as assessing miR inhibitor/mimic transfection experiments, the 
response of cells to the process of transfection itself was examined.  
Transfection reagent effect: Primary chondrocytes were transfected with:  
(i) DharmaFECT1™ transfection reagent only (referred to herein as Mock),  
(ii) DharmaFECT1™ and Negative Control #1 (non-targeting inhibitor control) or  
(iii) DharmaFECT1™ and AllStars negative control siRNA (non-targeting mimic control). 
The levels of miR-21-5p, miR-27a-5p, miR-221 and miR-222 were evaluated in 
transfected cells using cells treated with non-targeting controls as the baseline control 
level. The expression levels of miR-21-5p (Figure 5.2A), miR-221 (Figure 5.4A) and  
miR-222 (Figure 5.5A) did not alter appreciably in either the mock cells or the non-
targeting inhibitor/mimic controls compared to untreated controls. Also, miR-27a-5p 
(Figure5.3A) did not show statistically significant changes between non-targeting 
inhibitor control and untreated cells. 
Transfection efficiency of functional miRs was assessed by comparison of their 
expression in cells transfected with their modulators: inhibitors/mimics and cells 
transfected with non-targeting inhibitor/mimic, respectively.  
miR-21-5p: Both miR-21-5p inhibitor and mimic affected miR-21-5p expression levels. 
Although, the knock-down activity of miR-21-5p inhibitor was small, the alteration in 
miR-21-5p expression in inhibited cells was still significant (1.39-fold: p=0.02; Figure 
5.2B). In contrast to miR-21-5p inhibitor, miR-21-5p mimic significantly increased miR-
21-5p levels (142.32-fold: p<0.001; Figure 5.2C).  
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miR-27a-5p: The response of miR-27a-5p expression in primary chondrocytes to  
miR-27a-5p inhibitor transfection was surprising as the level of miR-27a-5p was slightly 
down-regulated in one experiment but the change did not reach statistical significance 
(1.52-fold: p=0.39; Figure 5.3B), whereas the second experiment showed a statistically 
significant up-regulation (3.59-fold: p=0.002; Figure 5.3B) of this miR. Due to these 
unexpected results potential target genes of miR-27a-5p were not examined in the 
current study. 
miR-221: miR-221 expression was significantly altered in response to transfection with 
either the miR-221 inhibitor or miR-221 mimic. As with the miR-21-5p experiment, the 
effect of miR-221 inhibitor was subtle and resulted in a 2.48-fold decrease in miR-221 
expression (p=0.01; Figure 5.4B), whereas the specific mimic significantly increased  
miR-221 levels (289.5-fold: p<0.001; Figure 5.4C).  
miR-222: Delivery of either miR-222 inhibitor or miR-222 mimic to cells also influenced 
the level of miR-222. Interestingly, miR-222 inhibitor acted more effectively than  
miR-21-5p or miR-221 on their target sequences, knocking down miR-222 expression by 
9.08-fold (p<0.001; Figure 5.5B). A significant increase in miR-222 levels was also 
observed in the presence of the miR-222 mimic (82.45-fold: p<0.001; Figure 5.5C). 
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5.2.3. Impact of transfection on cell morphology and viability 
To confirm that variations in gene expression was a specific effect of manipulating miR 
levels and not a specific effect on cell differentiation/metabolism, the cell phenotype 
was examined. Morphology of cells incubated for 48h in transfection reagent with 50nM 
final concentration of siRNA was assessed by light microscopy. As expected, the 
morphology of all cells remained unchanged (circular) in comparison to untreated cells 
that were used as a control (Figure 5.6). The results indicate that the transfection 
reagents do not affect cell phenotype and that changes in target mRNA levels are 
attributed to the effects of manipulating miR expression directly. 
As it is quite common that too high concentration of transfection reagents may have a 
toxic influence on cells, cell death was assessed using a viability assay. The Live/Dead® 
Assay, in conjunction with confocal microscopy, was used to assess the effect on 
chondrocyte viability of a 48h period of transfection, in the presence or absence of 50nM 
miR inhibitors/mimics (Figure 5.7). Although representative images showed higher 
levels of cell death as evidenced by increased ethidium homodimer-1 labelling in cells 
subjected to miR-221 mimic (Figure 5.7I) and miR-222 mimic (Figure 5.7J), the average 
percentage of live (Figure 5.8A) or dead (Figure 5.8B) cells calculated from 6 individual 
regions of each transfection treatment or untransfected cells showed no statistically 
significant changes in cell viability/death in any of the treatments when compared to 
untreated cells indicating that the transfection and concentrations of miR 
inhibitors/mimics were non-toxic.   
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Figure 5.6. Morphology of untreated or transfected primary chondrocytes. Monolayers 
of transfected or untreated cells were incubated at 37°C for 48h. Untreated primary 
chondrocytes (A) were used as a control for healthy cell morphology. Transfected cells 
were treated either with transfection reagent only (mock) (B), or 50nM 
inhibitors/mimics:  mirVana® miR Inhibitors: Negative Control #1 (C), miR-21-5p (D),  
miR-221 (E), miR-222 (F), miScript® miR Mimics: 50nM AllStars negative control siRNA 
(G), miR-21-5p (H), miR-221 (I), miR-222 (J). Images were taken using a light microscope. 
Scale bar = 100µm. 
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Figure 5.7. Representative images of Live/Dead® assay to monitor cell viability in 
chondrocytes either left as untreated (A), cells transfected with transfection reagent 
only (B), 50nM mirVana®miR Inhibitor Negative Control #1 (C), 50nM mirVana® miR 
Inhibitors: miR-21 (D), miR-221 (E), miR-222 (F), 50nM AllStars negative control siRNA 
(G) or 50nM miScript® miR Mimics: miR-21-5p (H), miR-221 (I), miR-222 (J). Confocal 
images of cells labelled with CalceinAM or Ethidium homodimer-1 present abundance 
of live and dead cells respectively. Representative images for each treatment show 
either separate results for live cells (i) and dead cells (ii) or an overlay of both channels 
(iii). Scale bar = 50µm. 
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Figure 5.8. Calculation of cell viability (A) and death (B) expressed as a % of live 
(CalceinAM) and dead (Ethidium homodimer-1) cells compared to % of total cell number 
(CalceinAM and Ethidium homodimer-1) of untreated and transfected primary 
chondrocytes, as assessed by Live/Dead® assay. Cell viability was determined 48h  
post-transfection and was visualised by confocal microscopy (Figure 5.5). Number of 
live/dead cells was calculated using Image J. Data are presented as mean ±SD  
(n = 6 individual images) and analysed using a 1-way ANOVA. 
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5.2.4. Differential expression of Wnt signalling components in response to inhibition 
of miR-21-5p, miR-221 and miR-222 
As the manipulation of the miRs by inhibitors/mimics efficiently modified miR levels 
without affecting cell morphology or viability, the next step was to determine the direct 
target genes of miR-21-5p, miR-221 and miR-222.  
A few studies have been reported, in cell types other than chondrocytes, implicating 
these miRs of interest in the regulation of genes involved in Wnt/β-catenin signalling 
pathways (Corr, 2008, Kawakita et al., 2014, Li et al., 2013, Wu et al., 2015, Zheng et al., 
2012). To establish which of the Wnt related molecules are potential target genes of 
these miRs, the transcriptional levels of Wnt/βcatenin signalling components were 
examined in chondrocytes transfected with miR inhibitors using custom-built bovine 
specific Wnt signalling PCR arrays designed by Dr Aisha Al-Sabah (Cardiff University). The 
PCR array contained 84 Wnt related genes including: targets of Wnt signalling, molecules 
of canonical Wnt signalling, Wnt/Ca2+ pathway, planar cell polarity (PCP) pathway and 
inhibitors of Wnt signalling (a complete gene list is shown in the Appendix 1 - 3). Array 
data were normalised to HPRT1 and YWHAZ reference genes that were present on the 
array using the online Qiagen Data Analysis centre software 
(http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).  
Surprisingly, transcript levels of FOSL1, PITX2 and Wnt2B were differentially expressed 
as a result of the transfection procedure itself, as determined by comparing the gene 
profile of the untreated cells to the non-targeting inhibitor control (Figure 5.9); 
therefore, these genes were excluded from the panel of putative target genes. 
Alterations in gene expression in response to inhibition of miR-21-5p, miR-221 or  
miR-222 were normalised to cells treated with the non-targeting inhibitor control and 
the data presented as at least a 2-fold change in gene expression in cells transfected 
with functional inhibitors. 
miR-21-5p targets: miR-21-5p inhibitor increased MMP-7 transcription (2.7-fold). 
Surprisingly, many more genes were down-regulated including DKK1 and DKK3 
(canonical Wnt signalling) and FOXN1 (developmental process) (2.53-fold; Figure 5.10). 
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miR-221 targets: Only one Wnt-related gene was differentially expressed by more than 
2-fold in cells transfected with miR-221 inhibitor and that was Wnt3A (canonical Wnt 
signalling and Wnt/Ca2+ signalling) which was elevated (2.2-fold; Figure 5.11). 
Surprisingly, this inhibitor did not reduce the transcript levels of any of the genes 
measured. 
miR-222 targets: Predictably, as miR-222 has the same seed region as miR-221, Wnt3A 
transcription was increased (2.67-fold) in response to miR-222 inhibition (Figure 5.12). 
In contrast to miR-221, miR-222 down-regulated 13 genes including AXIN2 (3.15-fold, 
canonical Wnt signalling) and GSK3A (2.72-fold, canonical Wnt signalling). 
Although, data from inhibition of miR-21-5p and miR-222 demonstrate a greater 
number of repressed genes than those with increased expression, an interesting 
observation is that some genes are down-regulated in both cases: APC (canonical Wnt 
signalling), AXIN2 (canonical Wnt signalling, Wnt signalling target gene), CTNNB1 
(canonical Wnt signalling, cell growth and proliferation), DKK3 (canonical Wnt 
signalling), FOXN1 (cell growth and proliferation) and FRZB (Wnt binding protein). 
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Figure 5.9. Scatterplots of Qiagen Wnt signalling PCR array data comparing the 
transcriptional profile of Wnt-related genes between untreated and cells transfected 
with non-targeting inhibitor (mirVana®miR Inhibitor Negative Control #1 miR). Cells 
were transfected for 48h with 50nM inhibitor, RNA extracted and PCR arrays 
performed. Data represents a single experiment, in which n = 3 cell culture wells per 
treatment. A single array was performed with representation of each treatment from 
pooled samples. Gene expression was normalised to the geometric mean of reference 
genes (HPRT1, YWHAZ) and relative to the untransfected control. The lines on the 
graph represent a 2-fold change in gene expression, and the fold-change of identified 
targets are listed in the accompanying table.    
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Figure 5.10. Scatterplots of Qiagen Wnt signalling PCR array data comparing the 
transcriptional profile of genes between transfected cells with miR-21-5p inhibitor 
and non-targeting miR inhibitor. Cells were transfected for 48h with 50nM inhibitor, 
RNA extracted and PCR arrays performed. Data represents a single experiment, in 
which n = 3 cell culture wells per treatment. A single array was performed with 
representation of each treatment from pooled samples. Gene expression was 
normalised to the geometric mean of reference genes (HPRT1, YWHAZ) and relative 
to the non-targeting inhibitor control. The lines on the graph represent a 2-fold 
change in gene expression, and the fold-change of identified targets are listed in the 
accompanying table.    
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Figure 5.11. Scatterplots of Qiagen Wnt signalling PCR array data comparing the 
transcriptional profile of genes between transfected cells with miR-221 inhibitor and 
non-targeting miR inhibitor. Cells were transfected for 48h with 50nM inhibitor, RNA 
extracted and PCR arrays performed. Data represents a single experiment, in which  
n = 3 cell culture wells per treatment. A single array was performed with representation 
of each treatment from pooled samples. Gene expression was normalised to the 
geometric mean of reference genes (HPRT1, YWHAZ) and relative to the non-targeting 
inhibitor control. The lines on the graph represent a 2-fold change in gene expression, 
and the fold-change of identified targets are listed in the accompanying table.    
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Figure 5.12. Scatterplots of Qiagen Wnt signalling PCR array data comparing the 
transcriptional profile of genes between transfected cells with miR-222 inhibitor and 
non-targeting miR inhibitor. Cells were transfected for 48h with 50nM inhibitor, RNA 
extracted and PCR arrays performed. Data represents a single experiment, in which  
n = 3 cell culture wells per treatment. A single array was performed with representation 
of each treatment from pooled samples. Gene expression was normalised to the 
geometric mean of reference genes (HPRT1, YWHAZ) and relative to the non-targeting 
inhibitor control. The lines on the graph represent a 2-fold change in gene expression, 
and the fold-change of identified targets are listed in the accompanying table.    
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5.2.5. Quantitative PCR validation of miR-21-5p, miR-221 and miR-222 target 
genes identified from the PCR arrays 
Expression levels of identified genes that were differentially expressed using Wnt 
signalling arrays were validated using SybrGreen® qPCR. Alterations in target gene 
expression in response to manipulation of miR-21-5p, miR-221 or miR-222 levels were 
normalised to cells treated with the respective non-targeting control. The impact of 
transfection itself was assessed by comparing untreated control cells to cells treated 
with: (i) DharmaFECT1™ transfection reagent only (Mock), (ii) DharmaFECT1™ and 
Negative Control #1 (non-targeting inhibitor control) or (iii) DharmaFECT1™ and AllStars 
negative control siRNA (non-targeting mimic control). 
Putative target genes were selected for validation based on the following criteria:  
(i) at least a 2-fold change in transcript levels between cells transfected with functional 
miR inhibitor and non-targeting control, (ii) mRNA level of putative target gene is 
elevated in cells treated with the functional miR inhibitor compared to the non-targeting 
control. The second criteria was crucial as the aim of this chapter was to identify direct 
target genes of mechano-sensitive miR-21-5p, miR-221 and miR-222. Based on these 
criteria, only two genes were selected for validation: MMP-7 and Wnt3A. Although 
neither MMP-7 nor Wnt3A mRNA contain miR-21-5p, miR-221 or miR-222 seed sites 
(according to TargetScan software), the genes were selected for validation as the 
predictive software only searches for target sites in the 3’UTR.    
The transfection process itself did not significantly affect expression of MMP-7 (Figure 
5.13A); furthermore, there was no change in MMP-7 expression in cells transfected with 
either miR-21-5p inhibitor or mimic (Figure 5.13B). Although transfection reagent alone, 
in the presence or absence of the non-targeting inhibitor control, did not affect Wnt3A 
gene expression compared to untransfected cells (Figure 5.14A), interestingly, 
transfection with the non-targeting mimic control increased expression of Wnt3A in 
comparison to both untreated cells (3.98-fold; p=0.024) and non-targeting inhibitor 
control (2.91-fold; p=0.079). However, neither miR-221 inhibitor or miR-221 mimic 
(Figure 5.14B), or miR-222 inhibitor or miR-222 mimic affected Wnt3A transcript levels 
(Figure 5.14C). 
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Figure 5.13. Validation of MMP-7, a component of the Wnt signalling pathway, as  
a putative target gene of miR-21-5p. Expression levels of MMP-7 was assessed by qPCR 
in cells transfected with transfection reagent only or non-targeting inhibitor/mimic (A) 
and miR-21-5p inhibitor/mimic (B). All data were normalised to the geometric mean of 
reference genes HPRT and YWHAZ and to the respective controls, which were either 
untreated (A) or cells transfected with non-targeting miR inhibitor/mimic (B).  Results 
are presented as mean of independent wells ± SD (n = 3 cell culture wells). Statistical 
analysis was performed using a 1-way ANOVA with Tukey’s post hoc test. Key:  
NT - non-targeting. 
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5.2.6. Identification of miR-21-5p, miR-221 and miR-222 target genes using Next 
Generation Sequencing 
As the expression of selected Wnt signalling components present on the custom-built 
PCR array did not identify any candidate target genes from cells transfected with 
functional miR inhibitors, an analysis of global gene changes was conducted using NGS. 
Extracted RNA from untreated cells or cells treated with 50nM non-targeting siRNA or 
miR-21-5p/miR-221/miR-222 inhibitors was analysed via Illumina deep sequencing 
conducted in the School of Biosciences, Cardiff University. The average number of reads 
obtained from sequencing was ~42.9x106 per library and they were analysed by  
Dr Daniel Pass using R Statistical programming software available on Bioconductor.  
All raw reads were aligned to the bovine reference genome (UMD3.1). To observe global 
changes in mRNA levels, expression levels of genes in cells treated with functional miR 
inhibitors was normalised against the non-targeting controls. Genes that were 
significantly altered in cells with non-targeting siRNA compared to untreated cells were 
excluded from the panel of putative target genes as they were identified as being 
sensitive to the transfection procedure itself (data available electronically). As the 
Benjamini-Hochberg adjusted p-values (FDR) at a threshold of ≤0.05 presented a limited 
number of differentially expressed genes, the list of putative target genes was expanded 
by selecting them according to fold change instead of the False Discovery Rate (FDR), 
and genes that were increased by a minimum 1.5-fold were taken into consideration as 
target genes of tested miRs. 
Table 5.1 and 5.2 indicate the top 5 most up-regulated and down-regulated genes, 
respectively, in cells transfected with miR-21-5p inhibitor. Surprisingly, the gene that 
was elevated the most (4.9-fold: FDR=0.51) was U1 (U1 spliceosomal RNA). This gene is 
involved in intron removal and processing of mRNA splicing that occurs in the nucleus. 
The most reduced gene was Insulin Like Growth Factor Binding Protein 2 (IGFBP2)  
(3.31-fold: FDR=0.51) that binds Insulin Like Growth Factors (IGF-1 and IGF-2) which 
seems to be one of the most important growth factors in articular cartilage as IGF-1 
stimulates synthesis of ECM molecules, mostly collagen type II and proteoglycans 
(Starkman et al., 2005). 
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Unexpectedly, the top 5 most significantly up-regulated genes in response to inhibition 
of either miR-221 (Table 5.3) or miR-222 (Table 5.5) are genes involved in mRNA 
processing in the nucleus. U1, as identified in cells treated with miR-21-5p inhibitor, 
exhibited the greatest transcriptional up-regulation in response to inhibition of both 
miR-221 (2,333-fold: FDR<0.001) and miR-222 (1,209-fold: FDR<0.001). Inhibition of 
miR-221 significantly reduced the expression of several genes including a Wnt signalling 
ligand: SFRP2 (Secreted Frizzled-Related Protein 2, 2.94-fold: FDR=1; Table 5.4) which 
was the most reduced. IGFBP2, similar to the cell response observed for miR-21-5p 
inhibition was the most down-regulated gene (2.83-fold: FDR=1) in response to miR-222 
reduction (Table 5.6). 
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Table 5.1. Top 5 most highly elevated genes in response to miR-21-5p knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to the non-targeting inhibitor control, the p value and False Discovery Rate 
(FDR - adjusted p value). 
               
Table 5.2. Top 5 most highly reduced genes in response to miR-21-5p knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to non-targeting inhibitor control, the p value and False Discovery Rate  
(FDR - adjusted p value). 
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Table 5.3. Top 5 most highly elevated genes in response to miR-221 knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to non-targeting inhibitor control, the p value and False Discovery Rate  
(FDR - adjusted p value). 
           
Table 5.4. Top 5 most highly reduced genes in response to miR-221 knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to non-targeting inhibitor control, the p value and False Discovery Rate  
(FDR - adjusted p value). 
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Table 5.5. Top 5 most highly elevated genes in response to miR-222 knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to non-targeting inhibitor control, the p value and False Discovery Rate  
(FDR - adjusted p value).  
             
Table 5.6. Top 5 most highly reduced genes in response to miR-222 knock-down. The 
table presents the greatest fold change of differentially expressed genes that were 
normalised to non-targeting inhibitor control, the p value and False Discovery Rate  
(FDR - adjusted p value). 
 
  
 221 
 
The aim of the work described in this chapter was to identify direct target genes 
regulated by the mechano-sensitive miR-21-5p, miR-221 and miR-222. As the expression 
levels of direct target genes should be inversely proportional to the level of knocked-
down miRs, only up-regulated genes (> 1.5-fold) with p value ≤0.05, despite a FDR=1 
were taken from the lists of putative genes (Tables 5.7-5.9) for validating their 
expression as downstream targets of miR-21-5p, miR-221 and miR-222.  
To inhibit the activity of a gene, the miR must bind either totally or partially to a specific 
site within the mRNA of the direct target. In order to establish which genes contain 
specific target sites (Tables 5.7-5.9), the computational prediction program TargetScan 
was used. The TargetScan algorithm recognises conserved and poorly conserved 6mer, 
7merA1, 7mer-m8 and 8mer seed sites within the examined 3’UTR of the mRNA. 
Using this software in conjunction with the NGS data (Table 5.7), 28 genes were 
identified as putative target genes for miR-21-5p. From the panel of recognised target 
genes, 7 transcripts had conserved seed sites, 18 contained poorly conserved seed sites, 
and 3 included both conserved and poorly conserved sites. Using TargetScan and 
analysis of NGS data from cells transfected with miR-221 inhibitor (Table 5.8), 3 putative 
target genes were identified with conserved and poorly conserved seed sites, 7 with 
conserved sites only and 17 transcripts that contained poorly conserved sites only.  
By a similar process, inhibition of miR-222 elevated the expression of 24 transcripts 
recognised as target genes (Table 5.9). Amongst these 24 mRNA sequences, 5 genes had 
conserved sites only, 16 contained poorly conserved sites, whereas both conserved and 
poorly conserved sites were present in 3 genes.  
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Table 5.7. Up-regulated genes (≥1.5-fold) in cells transfected with miR-21-5p inhibitor 
compared to expression in the non-targeting inhibitor control, as identified using NGS. 
Key: Genes highlighted with green contain conserved seed site(s), yellow contain poorly 
conserved seed site(s), and orange contain conserved seed site(s) and poorly conserved 
seed site(s), FDR - False Discovery Rate (p adjusted).       
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Table 5.8. Up-regulated genes (>1.5-fold) in cells transfected with miR-221 inhibitor 
compared to expression in the non-targeting inhibitor control, as identified using NGS. 
Key: Genes highlighted with green contain conserved seed site(s), yellow contain poorly 
conserved seed site(s), and orange contain conserved seed site(s) and poorly conserved 
seed site(s), FDR - False Discovery Rate (p adjusted).       
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Table 5.9. Up-regulated genes (≥1.5-fold) in cells transfected with miR-222 inhibitor 
compared to expression in the non-targeting inhibitor control, as identified using NGS. 
Key: Genes highlighted with green contain conserved seed site(s), yellow contain poorly 
conserved seed site(s), and orange contain conserved seed site(s) and poorly conserved 
seed site(s), FDR - False Discovery Rate (p adjusted).        
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5.2.7. Quantitative PCR validation of target genes of miR-21-5p, -221 and -222 
identified from the NGS 
A panel of putative target genes has been identified, genes that are differentially 
expressed i.e. mRNA levels increase in cells treated with miR-21-5p, miR-221 or miR-222 
inhibitors, and using TargetScan the 3’UTR sequences are predicted to contain the seed 
sites, suggestive of direct gene targets for further validation. Putative genes were 
chosen for validation based on the following criteria: (i) at least a 1.5-fold increase in 
transcript levels in response to specific miR inhibition, (ii) no effect on gene expression 
between non-targeting control and non-transfected control, (iii) contains at least  
1 conserved seed site for a specific miR, (iv) Fischer’s exact test p-values ≤ 0.05. Although 
a few of the target genes did not meet all of these criteria, they had been previously 
validated, by other groups, using experimental approaches hence their selection.  
Transcript levels of selected genes were assessed on RNA extracted from cells treated 
with miR-21-5p, miR-221 or miR-222 inhibitors or their equivalent mimics. Experimental 
validation should present the appropriate transcriptional response in the cells 
transfected with siRNA, namely being elevated expression with miR inhibitors and 
reduced levels with miR mimics. Validation was conducted using either SybrGreen® or 
TaqMan® quantitative PCR. The impact of transfection reagents on the gene levels was 
evaluated by comparing the relative expression in cells treated with (i) transfection 
reagent only (mock), or (ii) transfection reagent and non-targeting siRNAs (non-targeting 
controls) to untreated control cells. Transcriptional levels of genes of interest were 
normalised to the geometric mean of the reference genes HPRT and YWHAZ (which 
were found to maintain stable expression under the experimental conditions) and 
relative to inhibitor/mimic non-targeting control. 
miR-21-5p: 4 putative targets of miR-21-5p with varying numbers of seed sites were 
selected for validation: (i) mRNA polyadenylation factor: CPEB3, (ii) signalling antagonist: 
SPRY4, (iii) matrix metalloproteinase: MMP‐13 and (iv) metalloproteinase inhibitor: 
TIMP-3 (Table 5.10). 
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Table 5.10. List of putative target genes of miR-21-5p. The list was created based on NGS 
data and computational target gene prediction using TargetScan. 
 
 
CPEB3 transcription was highly reduced by the non-targeting mimic compared to other 
controls: untreated (2.77-fold: p<0.001), mock (2.31-fold: p<0.001) and non-targeting 
inhibitor (2.71-fold: p=0.001; Figure 5.15A). CPEB3 mRNA level was elevated in response 
to miR-21-5p inhibition in a manner approaching significance (1.22-fold: p=0.068), 
confirming the NGS data (Table 5.7), and was significantly decreased when treated with 
miR mimic (1.52-fold: p=0.015) compared to the respective non-targeting controls 
(Figure 5.15B). 
Expression of SPRY4 mRNA did not change in response to mimic control, but surprisingly, 
was significantly increased in both mock cells (4.08-fold: p<0.001) and in response to 
inhibitor control (4.21-fold: p<0.001) when compared to untreated cells (Figure 5.16A). 
SPRY4 mRNA levels were elevated in response to the miR-21-5p mimic (1.5-fold: 
p=0.046) when compared to its respective non-targeting control (Figure 5.16B);  
miR-21-5p inhibitor did not affect SPRY4 transcription.  
The non-targeting miR inhibitor also appeared to affect MMP-13 expression, elevating 
MMP-13 mRNA levels compared to the untreated control (2.06-fold: p=0.026) and 
mimic control (1.99-fold: p=0.036; Figure 5.17A). Although the NGS data did not indicate 
a >1.5-fold increase in MMP-13 expression in response to miR-21-5p inhibition, the qPCR 
data demonstrated a significant 1.99-fold increase (p=0.007) compared to the  
non-targeting control, with no effect of mimic treatment (Figure 5.17B).  
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For TIMP-3 expression, there was reduced mRNA levels in the mimic control when 
compared with mock (2.08-fold: p=0.024) or non-targeting inhibitor (2.07-fold: 
p=0.023), although its expression remained unchanged from untreated control (Figure 
5.18A). Validation of TIMP-3 confirmed the results of NGS (1.61-fold, p=0.074; Table 5.7) 
showing an up-regulation in response to miR-21-5p inhibitor (1.51-fold: p=0.01), and  
a significant reduction in response to miR-21-5p mimic (2.11-fold: p=0.006; Figure 5.18B) 
compared to their respective non-targeting controls.  
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Figure 5.15. Validation of CPEB3 - a putative target gene of miR-21-5p. Expression of 
CPEB3 in cells transfected with: transfection reagent only or non-targeting 
inhibitor/mimic (A) and miR-21-5p inhibitor/mimic (B) was assessed by TaqMan® qPCR. 
All data were normalised to the geometric mean of the reference genes HPRT and 
YWHAZ and to the respective control: either untreated (A) or transfected with non-
targeting miR-inhibitor/mimic (B) cells. Data is presented as mean ± SD (n = 3 cell culture 
wells) and is representative of 3 independent experiments. Statistical analysis was 
performed using a 1-way ANOVA with Tukey’s post hoc test. Key: NT - non-targeting,  
[* p≤0.05, ** p≤0.01, *** p≤0.001].   
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Figure 5.16. Validation of SPRY4 - a putative target gene of miR-21-5p. Expression of 
SPRY4 in in cells transfected with: transfection reagent only or non-targeting 
inhibitor/mimic (A) and miR-21-5p inhibitor/mimic (B) was assessed by SYBRgreen® 
qPCR. All data were normalised to the geometric mean of the reference genes HPRT and 
YWHAZ and to the respective control: either untreated (A) or transfected with non-
targeting miR-inhibitor/mimic (B) cells. Data is presented as mean ± SD (n = 3 cell culture 
wells) and is representative of 3 independent experiments. Statistical analysis was 
performed using a 1-way ANOVA with Tukey’s post hoc test. Key: NT - non-targeting,  
[* p≤0.05, *** p≤0.001].   
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Figure 5.17. Validation of MMP-13 - a putative target gene of miR-21-5p. Expression of 
MMP-13 in cells transfected with: transfection reagent only or non-targeting 
inhibitor/mimic (A) and miR-21-5p inhibitor/mimic (B) was assessed by SYBRgreen® 
qPCR. All data were normalised to the geometric mean of the reference genes HPRT and 
YWHAZ and to the respective control: either untreated (A) or transfected with  
non-targeting miR-inhibitor/mimic (B) cells. Data is presented as mean ± SD (n = 3 cell 
culture wells) and is representative of 3 independent experiments. Statistical analysis 
was performed using a 1-way ANOVA with Tukey’s post hoc test. Key: NT - non-targeting,  
[* p≤0.05, ** p≤0.01].   
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Figure 5.18. Validation of TIMP-3 - a putative target gene of miR-21-5p. Expression of 
TIMP-3 in cells transfected with: transfection reagent only or non-targeting 
inhibitor/mimic (A) and miR-21-5p inhibitor/mimic (B) was assessed by SYBRgreen® 
qPCR. All data were normalised to the geometric mean of the reference genes HPRT and 
YWHAZ and to the respective control: either untreated (A) or transfected with  
non-targeting miR-inhibitor/mimic (B) cells. Data is presented as mean ± SD (n = 3 cell 
culture wells) and is representative of 3 independent experiments. Statistical analysis 
was performed using a 1-way ANOVA with Tukey’s post hoc test. Key: NT - non-targeting,  
[* p≤0.05, ** p≤0.01].   
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miR-221 and miR-222:  As the seed regions of miR-221 and miR-222 are identical, 
expression of selected putative target genes were validated for both. The panel of 
potential targets of these miRs includes transcription factor: Runx2, signalling 
antagonist: SPRY4, mRNA polyadenylation factor: CPEB3, cytokine/type I cytokine 
receptor/immunity protein: LIFR, and the metalloproteinase inhibitor: TIMP-3 (Table 
5.11). MMP-13 and HDAC4, despite not having seed sites in the 3’UTR for miR-221 or 
miR-222, were also validated as they have been identified as target genes controlled by 
miR-222 (Song et al., 2015). 
 
Table 5.11. List of putative target genes of miR-221 and miR-222. The list was created 
based on NGS data and computational target gene prediction using TargetScan. 
        
 
 
The effect of transfection reagents on SPRY4 mRNA expression was as previously 
described for miR-21-5p manipulation. Although SPRY4 was identified from the NGS 
data as one of the significant highly up-regulated genes in response to miR-221 and  
miR-222 inhibition, these changes were not confirmed by qPCR (Figure 5.19B and C). 
SPRY4 mRNA expression is visibly elevated when treated with the functional inhibitors, 
but the changes are not statistically significant. Surprisingly, no significant elevation of 
SPRY4 is observed in response to the miR-222 mimic (Figure 5.19C). 
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Runx2 appears to be sensitive to the transfection process itself showing reduced mRNA 
levels in the mock cells compared to the untreated control (1.43-fold: p=0.047) and  
non-targeting inhibitor (1.55-fold: p=0.011; Figure 5.20A). Runx2 was identified from the 
NGS data as being noticeably but not statistically significantly elevated in response to 
miR-221/-222 inhibition (Table 5.8), and has been experimentally validated as a target 
gene of hsa-miR-222-3p (Yan et al., 2016) which contains an identical nucleotide 
sequence as bta-miR-222. Therefore, the qPCR validation data were totally surprising as 
both miR-221 and miR-222 inhibitors down-regulated Runx2 transcripts relative to the  
non-targeting miR inhibitor control, however the differentially expressed gene was 
statistically significant (2.42-fold: p=0.048) in response to miR-221 inhibitor only (Figure 
5.20B). The expression of Runx2 was not significantly affected by either the miR-221 
mimic (Figure 5.20B) or the miR-222 mimic (Figure 5.20C).   
CPEB3 sensitivity to the transfection process (Figure 5.21A) is as described above for 
miR-21-5p validation. There was a significant decrease in CPEB3 mRNA levels in response 
to the miR-221 mimic (1.51-fold: p=0.016; Figure 5.21B) compared to the non-targeting 
control. However, the miR-221 inhibitor (Figure 5.21B), or either the miR-222 inhibitor 
or mimic did not affect CPEB3 transcription (Figure 5.21C).  
LIFR transcription was unaffected by transfection itself as none of the treatments 
significantly altered its expression (Figure 5.22A). Up-regulation in LIFR mRNA levels was 
observed in the NGS data for both miR-221 (1.51-fold: p=0.07) and miR-222 (1.65-fold: 
p=0.03), and this was confirmed by qPCR in response to the miR-221 inhibitor (1.31-fold: 
p=0.014; Figure 5.22B). In contrast, miR-222 inhibition appeared to slightly elevate LIFR 
mRNA levels but this was not statistically significant, although miR-222 mimic 
significantly reduced LIFR transcription (1.51-fold; p=0.03; Figure 5.22C). 
Differential expression of TIMP-3 transcription was induced by transfection itself  
(Figure 5.23A) as discussed above for miR-21-5p validation. TIMP-3 seems to be a direct 
target of both miR-221/-222 (Table 5.11). It was also up-regulated by inhibition of  
miR-221 (1.76-fold: p=0.03; Table 5.8) and miR-222 (1.45-fold: p=0.16; Table 5.9). 
Increased TIMP-3 transcription in response to knock-down of miR-221 (1.54-fold: 
p=0.003; Figure 5.23B) and miR-222 (1.29-fold: p=0.025; Figure 5.23C) was confirmed. 
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Furthermore, there were significant reductions in TIMP-3 mRNA in cells treated with  
miR-221 mimic (2.11-fold; p=0.006; Figure 5.23B) and miR-222 mimic (2.17-fold; 
p=0.006; Figure 5.23C) when compared to the mimic control.  
Despite HDAC4 and MMP-13 not meeting any of the criteria set for validation of putative 
targets of the selected miRs, their responses to miR-221 and miR-222 siRNAs were 
assessed. The reason why these genes were taken into consideration was that previously 
miR-222 had been identified as regulating MMP-13 expression by targeting HDAC4 
(Song et al., 2015). Results from the NGS experiment did not identify HDAC4 as being 
differentially expressed in response to transfection itself or the miR-221 and miR-222 
inhibitors (data not shown); furthermore, the qPCR validation confirmed these findings 
(Figure 5.24A), and also confirmed that HDAC4 transcription was unaffected by  
over-expression of either miR-221 (Figure 5.24B) or miR-222 (Figure 5.24C). 
MMP-13 sensitivity to transfection reagents (Figure 5.25A) is as previously described 
above for miR-21-5p validation. Although the deep sequencing data indicated no 
significant increase in MMP-13 transcription in response to knock-down of miR-221 
(1.31-fold: p=0.416) and miR-222 (1.39-fold: p=0.309), surprisingly, the qPCR validation 
showed definite up-regulation of MMP-13 mRNA levels in response to both inhibitors: 
miR-221 (2.41-fold: p<0.001; Figure 5.25B) and miR-222 (1.76-fold: p=0.027;  
Figure 5.25C). In contrast, overexpression of either miR-221 (Figure 5.25B) or miR-222 
(Figure 5.25C) did not affect MMP-13 transcript levels. 
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5.3. Discussion 
miRs are small, highly conserved and non-coding molecules having regulatory functions 
in many crucial biological processes i.e. proliferation, differentiation, signal 
transduction, immune responses and carcinogenesis (Bartel, 2009). The importance of 
miRs in living organisms is strengthened by the fact that they are coded by roughly 1% 
of animal genes and they are very often highly conserved across different species 
(Brennecke et al., 2005). Moreover miRs control expression of approximately one third 
of all human genes (Lewis et al., 2003), therefore it is not surprising that alterations in 
miR levels is very often associated with changes in expression of matrix molecules and 
may cause the development of many diseases (Soifer et al., 2007, Ardekani and Naeini, 
2010). One of the diseases that is characterised by altered expression of some miRs 
compared to healthy tissue is OA (Araldi and Schipani, 2010, Crowe et al., 2016, Goldring 
and Marcu, 2012, Le et al., 2016, Pauley and Cha, 2011, Swingler et al., 2012). 
Although miRs biological importance is clear, the mechanism of target gene recognition 
and regulation remains not well explained. Nowadays, it is known that miR control of 
gene expression is based on the miR complementarity to at least one of the target seed 
sites: 6mer, 7mer-m8, 7mermA1, 8mer (Brennecke et al., 2005, Fang and Rajewsky, 
2011). Moreover, there is some evidence that mammalian miRs can regulate expression 
of genes by complementary binding to their 5’UTR mRNA (Lee et al., 2009) or coding 
region mRNA (Brümmer and Hausser, 2014), but base-pairing to 3’UTR mRNA with  
a minimum of one 7mer-m8 seed-matched site in the mRNA is still thought to be the 
dominant manner of target genes regulation (Baek et al., 2008, Fang and Rajewsky, 
2011, Bartel, 2009).  
Based on miR abilities of binding to short complementary sequences of mRNA, it is not 
surprising that a single miR can putatively regulate transcription of hundreds of genes 
and that one mRNA can be targeted by many different miRs (Lewis et al., 2003). 
Knowing that miR-21-5p, -221 and -222 are: (i) responsive to non-physiological (7MPa, 
1Hz, 15 minutes) magnitude of load and (ii) miR-21 alters in expression in OA cartilage 
compared to healthy tissue, the purpose of this experimental chapter was to: 
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 Determine whether mechano-sensitive miR-21-5p, -221 and -222 regulate the 
expression of ECM molecules that have an involvement in cartilage 
homeostasis and/or OA development.   
Unfortunately, computational prediction of target genes of miRs is not good enough, 
because (i) prediction algorithms search for complementarity to seed region sequences 
in the 3’ UTR of mRNA only, (ii) each prediction software uses different algorithms not 
always giving the same results, (iii) most softwares do not contain the database for the 
bovine genome. Therefore, in order to establish which genes are truly controlled by 
specific miRs, experimental evaluation is necessary. Initially, mammalian miRs were 
believed to regulate expression of their target genes mainly via inhibition of mRNA 
translation. However, studies by Baek et al. and Selbach et al. using proteomics and 
microarray methods, suggested that mRNA degradation of target genes of miRs may be 
a major manner of miR activity, as changes in protein expression of target genes were 
associated with variations in mRNA levels of these molecules (Baek et al., 2008, Selbach 
et al., 2008). Based on these studies, identification of direct target genes of  
mechano-sensitive miR-21-5p, -221 and -222 was conducted by assessment of putative 
target gene mRNA levels. 
The functional analysis of mechano-responsive miRs in articular chondrocytes selected 
from chapter 4 was performed by monitoring relative expression of genes in 
chondrocytes subjected to manipulation of miR-21-5p, -221 and -222 levels.  
5.3.1. Transfection, toxicity and quantification of manipulated miRs 
The preliminary transfection of bovine primary articular chondrocytes performed to 
assess the transfection efficiency was taken from published siRNA transfection 
conditions (Crowe et al., 2016) and confirmed a highly efficient delivery system and 
therefore were applied to functional siRNA transfection. The chondrocytes were 
exposed to 50nM miR-21-5p, -221, -222 inhibitors/mimics and miR-27a-5p inhibitor 
transfection for 48h. The analysis performed directly after this transfection period 
corroborated high intracellular uptake showing significant knock-down or 
overexpression of miR in cells treated with specific miR-21-5p, miR-221 and miR-222 
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mimics/inhibitors, respectively when compared to their non-targeting controls. 
However, surprisingly the miR-27a-5p presented statistically significant up- and not 
down-regulation of miR-27a-5p gene level in response to theoretically knock-down 
treatment, therefore searching of miR-27a-5p targets became impossible in this 
circumstance.  
As too high a concentration of transfection reagents may induce cell death (Masotti et 
al., 2009), the effect of the cationic lipid transfection reagent only and with 50nM siRNA 
was assessed following a 48h transfection. Unchanged chondrocyte morphology 
(rounded cells) of transfected cells and similar level (~97.7%) of cell viability and (~2.3%) 
of cell death in treated and untreated cells measured using Live/Dead assay confirmed 
that transfection and concentrations of miR inhibitors/mimics were non-toxic and 
enough to induce changes in miR levels. 
5.3.2. Differential expression of Wnt signalling components in response to inhibition 
of miR-21-5p, miR-221 and miR-222 
Having confirmed that transfection conditions do not affect cell morphology and 
viability of primary articular chondrocytes, identification of direct target genes of  
miR-21-5p, -221 and -222 was the next step and the goal of this chapter.  Based on the 
previously published influence of these miRs on the expression of Wnt/βcatenin 
signalling pathway components (Corr, 2008, Kawakita et al., 2014, Li et al., 2013, Wu et 
al., 2015, Zheng et al., 2012), the profile of Wnt signalling molecules in chondrocytes 
subjected to miR manipulation was assessed. The study was conducted using a  
custom-built bovine specific Wnt signalling PCR array designed by Dr. Aisha Al-Sabah 
(Cardiff University). The array included 84 Wnt signalling related genes that were 
grouped according to their function: targets of Wnt signalling, molecules of canonical 
Wnt signalling, Wnt/Ca2+ pathway, planar cell polarity (PCP) pathway and inhibitors of 
Wnt signalling. To eliminate false results of the chondrocytic response to functional miR 
level reduction, the gene expression profile was firstly compared between cells treated 
with non-targeting siRNA and untransfected cells. The effect of miR-21-5p, -221 and 
 -222 knock-down was assessed by comparison of transcript profile in cells transfected 
with functional siRNA to non-targeting siRNA control. 
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Genes: FOSL1, PITX2 and Wnt2B were excluded from functional siRNA versus  
non-targeting siRNA comparison, as they presented altered expression levels in cells 
treated with non-targeting siRNA compared to untransfected cells, suggesting  
a sensitivity of these genes to transfection itself. As miR inhibitor binds to its 
complementary miR and reduces its activity, the expression of the direct target gene of 
this miR should be elevated. Surprisingly, results of the Wnt signalling PCR array for all 
tested miRs presented a greater number of decreased genes in cells treated with specific 
miR inhibitors than elevated ones. This data suggests that these down-regulated genes 
are down-stream of direct targets of examined miRs. 
miR-21 is upregulated in OA cartilage (Zhang et al., 2014b) and was reported to be an 
upstream gene of some Wnt signalling pathway components (Kawakita et al., 2014, Wu 
et al., 2015). miR-21-5p inhibition reduced expression levels of 13 molecules, whereas 
only 1 gene (MMP-7) was upregulated. Despite MMP-7 not containing a target site in its 
3’UTR and having not been indicated by TargetScan as a target gene of miR-21-5p, it was 
taken for validation. The reason for this decision was that target prediction algorithms 
are focused on the 3’UTR and four target sites ignoring the 5’UTR, protein coding region 
and mismatched sequences (Thomson et al., 2011). Unfortunately, validation data 
corroborated TargetScan results in that MMP-7 is not a direct target of miR-21-5p 
(http://www.targetscan.org/vert_71/).  Although, this experiment did not reach the 
appointed goal to find direct target genes of miR-21-5p, it confirmed a positive 
correlation of miR-21 with β-catenin, a key molecule in the Wnt signalling pathway, 
observed in previous studies performed on human lung cancer cells and Lewis lung 
carcinoma in mice (Wu et al., 2015). Surprisingly, the data presented also demonstrated 
positive regulation with the Wnt antagonist gene: dickkopf 2 (DKK2); this response is 
contradictory with Kawakita’s observation of up-regulation of this gene in a human 
tongue cancer cell line transfected with miR-21 inhibitor (Kawakita et al., 2014). 
Studies performed on human prostate cell lines and glioma cells demonstrated that 
respectively miR-221 (Zheng et al., 2012) and -222 (Li et al., 2013, Corr, 2008) also 
control the Wnt/β-catenin signalling pathway. In my experiment down-regulation of 
miR-221 and -222 slightly elevated expression of a few genes, but only Wnt3A, a gene 
which does not contain a seed site for any of these miRs in its 3’UTR, crossed the cut off 
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of a 2-fold increase. Due to the potential of other seed sites, as was mentioned in the 
case of MMP-7 up-regulation in response to miR-21-5p inhibition, Wnt3A was selected 
for validation, however the validation did not confirm the Wnt signalling array data. 
Zheng et al. reported a negative correlation between miR-221 and dishevelled 2 (DVL2) 
(Zheng et al., 2012) suggesting that, despite the minor up-regulation of this gene  
(1.26-fold) in response to miR-221 knock-down in my experiment, the change in 
expression was real, however this gene was also not validated. Studies by Li et al. 
showed an ability of miR-222 to regulate the expression of β-catenin and other 
downstream genes of the Wnt/β-catenin pathway by inhibition of its direct target DKK2, 
a known Wnt antagonist (Li et al., 2013); however results presented in this chapter did 
not corroborate these findings. Surprisingly, down-regulation of miR-222 expression in 
articular chondrocytes showed a reduction in expression of the following genes: DKK2 
(data not shown), Axis Inhibition Protein 2 (Axin2) and Frizzled Class Receptor 1 (FZD1) 
which contain seed sites for miR-222 thus making these data difficult to rationalize.   
5.3.3. qPCR validation of miR-21-5p, miR-221 and miR-222 target genes identified 
using Next Generation Sequencing  
Although Wnt signalling pathway arrays presented variations in gene expression, the 
results showed mostly positive correlation between altered genes (even those 
containing specific seed sites for examined miRs) and inhibited miRs indicating that 
these genes are not direct targets of tested miRs.  
As the purpose of this chapter was to identify direct target genes of miR-21-5p, -221 and 
-222, the global changes in mRNA levels in cells transfected with functional miR 
inhibitors was assessed via Illumina Next Generation Sequencing. Cells treated with non-
targeting siRNA were used as a control. Untreated cells were used as an additional 
control to assess the influence of transfection itself on gene expression. Genes that were 
significantly altered in cells with non-targeting siRNA compared to untreated cells and 
their FDR was less than 5%, were excluded from the panel of putative target genes as 
they were deemed sensitive to the transfection process. Originally, differentially 
expressed genes were selected based on the Benjamini-Hochberg corrected adjusted  
p-values (FDR≤0.05), however because of the very limited number of significantly 
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altered genes, which were not direct targets as they do not have seed sites for the tested 
miRs, genes with at least a 1.5-fold up-regulation were considered for further studies in 
order to determine direct targets. Although, the FDR suggested extremely high rates of 
false positives for most of the differentially expressed genes, some of these genes were 
selected for further studies using the fold change cut off because expression of selected 
putative target genes was individually validated by qPCR.   
The NGS data without the additional target site prediction analysis presented a number 
of spliceosomal and small nucleolar RNAs located in the nucleus as significantly  
up-regulated genes in response to miR-21-5p, -221 and -222 knock-down, with U1 
spliceosomal RNA as the most elevated gene in cells with miR reduction. Although, there 
is evidence that some miRs i.e. miR-21 (Meister et al., 2004), -206 (Politz et al., 2006) 
and -709 (Tang et al., 2012) are present in the cell nucleus in their mature form, with 
miR-206 even being localised in the nucleolus (Politz et al., 2006), to date there is no 
publication confirming the control function of any miRs in nuclear non-coding RNAs. U1, 
U5 (Wassarman and Steitz, 1992) and U12 (Hall and Padgett, 1996) are involved in intron 
removal and mRNA splicing, whereas small nucleolar RNAs: U3 and U13 are engaged in 
nucleolar processing of pre-18S ribosomal RNA (Tyc and Steitz, 1989). Although, Meister 
et al. (2004) reported that 20% of mature miR-21 was localised in the nucleus of HeLa 
cells (Meister et al., 2004), the U1 gene does not contain a seed site for this miR 
excluding it as a miR-21-5p direct target. None of the spliceosomal or nucleolar RNA, or 
miR, or protein coding genes that were statistically (FDR≤0.05) and significantly up-
regulated in response to miR-221/-222 contain seed sites complementary to seed 
regions of these miRs, nor have they been localised anywhere else than the cytoplasm. 
Therefore, at this stage these up-regulated genes must be considered as either false 
positive results or potential indirect target genes.  
The goal of this chapter was to establish which genes that were differentially detected 
in the NGS data are direct targets of mechano-responsive miR-21-5p, -221 and -222.  
A loss/gain of function theory used for the identification of target genes assumes the 
inversely proportional expression of target genes of up- or down-regulated miRs. 
Although some down-regulated transcripts may be indirect targets of examined 
inhibited miRs, these genes were excluded from the further analysis. Molecules that 
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were at least 1.5-fold up-regulated were considered as putative targets, from which a 
few genes were selected for further studies in order to validate their response to miR-
21-5p, miR-221 and miR-222 manipulation.  
The true direct target mRNA of miR must have at least one complementary seed site. 
Therefore, to eliminate indirect targets or false positive results, TargetScan - the 
computational prediction algorithm was used to search potential gene targets based on 
their conserved and poorly conserved 6mer, 7merA1, 7mer-8m and 8mer seed sites 
within their 3’UTR mRNA. 
Among the genes presenting at least a 1.5-fold change (Tables 5.7 - 5.9), few genes with 
at least 1 conserved seed site for a specific miR were selected for further validation. All 
selected genes based on the above criteria were also validated for other tested miRs if 
they contained any seed site complementary to the miR seed region sequence and was 
up-regulated in response to miR inhibition even if not reaching the 1.5-fold criteria. 
Moreover, additional genes that were experimentally proven by other groups as a target 
gene of miR-21 or miR-221/-222 were also selected for validation.  
Potential direct target gene validation was conducted on original mRNA from cells 
transfected with miR inhibitors sent for NGS and on cells treated with miR mimics as an 
additional control of a true response to miR manipulation. Relative gene expression was 
normalised to non-targeting siRNA controls.  
A number of genes were either up-regulated or down-regulated in response to miR 
inhibitors or miR mimics, respectively, suggesting they are direct targets. Matrix 
metalloproteinase-13 (MMP-13), which was significantly decreased in 2.5MPa (Chapter 
3), is highly expressed by hypertrophic chondrocytes and is involved in cartilage 
degradation by proteolytic cleavage of collagen type II (Billinghurst et al., 1997, Poole et 
al., 2002) and aggrecan (Fosang et al., 1996) was activated by miR-21-5p inhibitor having 
only one poorly conserved 7mer-8m seed site. Also, it was induced by miR-221 and 222 
inhibitors which corroborates the observation that miR-222 knock-down elevates the 
expression of MMP-13 (Song et al., 2015). However, this regulation was indirect and it 
was conducted through positive correlation with HDAC4 which was reported by 
luciferase assay to be a direct target gene of miR-222  (Song et al., 2015). Although, 
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HDAC4 was a proven direct target of miR-222 (Song et al., 2015), qPCR validation of this 
gene in chondrocytes transfected with both miR-222 inhibitor and mimic in this current 
study did not confirm this result which is surprising and difficult to explain. 
One 8mer and one 7mer-m8 conserved seed site for miR-221/222 is present in leukemia 
inhibitory factor receptor alpha (LIFR). This molecule combined with a signal transducer 
gp130 is involved in inducing the Mitogen-Activated Protein Kinase (MAPK) Pathway 
(Schiemann et al., 1995, Thoma et al., 1994) which is required for cartilage formation 
and maturation (Bobick and Kulyk, 2008, Mariani et al., 2014), therefore it was selected 
for validation. Moreover, it has shown mechano-sensitivity in response to 7MPa load 
presenting up-regulation (1.69-fold; FDR=0.01) at 4h post-load (Chapter 3). Although, 
the gene showed statistically significant changes in response only to miR-221 inhibitor 
and miR-222 mimic, noticeable but not statistically important changes were also seen in 
miR-221 mimic and miR-222 inhibitor. Although, there is no evidence in the literature 
that LIFR is targeted by the miRs used in this study, the trend of alteration (up-regulation 
in response to miR inhibitor and down-regulation to miR mimic) in this experiment 
suggests that it would be worth assessing the correlation between miR-221/222 and 
LIFR expression using alternative methods of searching for miR target genes.  
Although, the transcription factor Runx2 is weakly expressed in immature chondrocytes, 
its expression is elevated in pre- and hypertrophic cells (Kim et al., 1999, Komori, 2010). 
Moreover Runx2, which is elevated in OA cartilage, directly regulates MMP-13 which is 
involved in cartilage matrix degradation, efficiently degrading collagen type II 
(Billinghurst et al., 1997, Poole et al., 2002) and aggrecan (Fosang et al., 1996). This 
transcription factor contains one 7mer-A1 conserved and one 7mer-m8 poorly 
conserved site for miR-221/-222, suggesting it is a target of this miR. Yan et al. (2016) 
reported that hsa-miR-222-3p, which contains an identical nucleotide sequence as 
 bta-miR-222 and has the same seed region as bta-miR-221, controls Runx2 at the 
protein level in human bone marrow stromal osteoprogenitor cells (Yan et al., 2016). 
Although, NGS performed on miR-221/-222 knock-down chondrocytes presented Runx2 
as a target gene of miR-221/222, qPCR validation did not confirm previous findings.  
The results of Yan et al. were based on protein levels of Runx2, whereas in my study I 
assessed the quantity of Runx2 transcripts and as miRs can control gene expression via 
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repression of translation without interfering at the mRNA level, it may be a reason for 
these two conflicting results. 
Out of 4 and 7 tested putative target genes for miR-21-5p and miR-221/-222, 
respectively, only TIMP-3 showed a statistically significant elevation and down-
regulation respectively to miR-21-5p, -221 and -222 inhibitors and mimics transfection. 
CPEB3 may be also considered as a real target gene of miR-21-5p, because its statistically 
significant reduction was observed in response to miR-21-5p mimic and up-regulation 
presented in miR-21 knock-down cells was approaching significance (p=0.068). 
TIMP-3 has a wide range of inhibitory capabilities (Murphy, 2011). It represses 
TACE/ADAM-17 (Amour et al., 1998), ADAM-10 (Amour et al., 2000) that are able to 
convert pro-TNFα into the active cytokine TNFα which is involved in chronic 
autoimmune and inflammatory diseases, i.e. rheumatoid arthritis (Amour et al., 1998) 
and ADAM-12 (Loechel et al., 2000) which inhibits chondrocyte proliferation in human 
OA cartilage (Okada et al., 2008). Sahebjam et al. performed histological analysis of 
aggrecan and collagen type II in a knee joint of TIMP-3 knock-out mice and showed 
significant degradation of these two ECM components in knock-out mice compared to 
wild type mice (Sahebjam et al., 2007). This result suggests that TIMP-3 is essential for 
maintaining cartilage homeostasis by regulation of aggrecanase (ADAMTS-4 and -5) and 
collagenase (MMP-1, -8 and -13) activity (Sahebjam et al., 2007). TIMP-3 is known to be 
down-regulated in experimentally induced temporomandibular joint osteoarthritis in 
rats (Li et al., 2014) and in human OA chondrocytes (Dehne et al., 2009); furthermore, it 
appears to be a direct target of miR-21-5p, -221 and -222, however it was up-regulated 
in explants subjected to both 2.5MPa and 7MPa loads which coincided with elevated 
levels of these miRs. These conflicting findings may be explained by different 
experimental systems (cartilage explants for mechanical load/primary chondrocytes for 
identification of miRs targets) used in this study and masking effects of other  
load-induced genes on miR-21-5p, -221 and -222 influence on TIMP-3 expression. The 
level of TIMP-3 transcripts assessed by qPCR was altered according to the rule indicating 
that expression of a real target of a miR must be inversely proportional to the tested 
miR inhibitors and mimics. This result is consistent with already existing data from 
experiments performed on other cells or tissue; e.g. miR-21 has been shown to be a 
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TIMP-3 regulator in glioma cell lines (Gabriely et al., 2008), esophageal carcinoma cell 
line (Wang et al., 2013b) and human renal carcinoma cell line (Zhang et al., 2011). In 
turn miR-221 and -222 regulated TIMP-3 expression in lung and liver cancer tissue and 
cell lines (Garofalo et al., 2009), papillary thyroid carcinoma tissue (Yang et al., 2013) 
and human glioblastoma cells (Zhang et al., 2012). So far, there is no publication 
reporting miR-21, -221 and -222 as regulators of TIMP-3 in articular cartilage. The facts 
that TIMP-3 (i) affects the activity of aggrecanases and collagenases (Nagase et al., 
2006), (ii) is down-regulated in OA cartilage (Li et al., 2014) and (iii) is validated by qPCR 
as a target gene of the overexpressed miR-21 reported to be elevated in OA cartilage 
(Zhang et al., 2014b) and mechano-sensitive miR-221/-222 (Dunn et al., 2009) strongly 
implicates these miRs as having a role in OA development.   
A novel finding is the regulation of CPEB3 by miR-21-5p. CPEB3 has been mainly 
identified in neural tissues as a modifier of post-translational/post-transcriptional 
molecule expression, however due to the function it plays in those tissue, I believe it can 
also affect cartilage integrity. In neurons of CPEB3 knock-out mice an increased 
expression/activity of glutamate NMDA receptor (NMDAR) has been identified resulting 
in induced Ca2+ influx (Chao et al., 2013). NMDAR is a non-selective cation channel and 
was first shown to occur in human chondrocytes in 2004 (Salter et al., 2004). NMDAR is 
implicated in cartilage mechanotransduction and the Ca2+ influx through NMDAR is 
believed to be one of the major activators of many signalling pathways e.g. PI3K/AKT 
and MAPK (Salter and Lee, 2010a). CPEB3 is a nucleocytoplasm-shuttling protein that is 
predominantly localised in the cytoplasm, however the activation of NMDAR 
translocates and accumulates CPEB3 in the nucleus where it binds and suppresses signal 
transducer activated transcription 5b (STAT5b) transcription factor (Peng et al., 2010). 
STAT5b has been identified as a stimulator of EGFR gene transcription, therefore CPEB3 
knock-down elevated EGFR expression through higher activity of STAT5b in neuron 
nuclei (Peng et al., 2010). EGFR is involved in the control of cartilage homeostasis by 
inducing the PI3K/AKT and MAPK signalling pathways (Peng et al., 2010). Moreover, 
induction of OA by destabilisation of the medial meniscus (DMM) in EGFR knock-down 
mice demonstrated higher up-regulation of ADAMTS-5 and MMP-13 and a reduced level 
of aggrecan in comparison to DMM model of wild type mice (Zhang et al., 2014a). In the 
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microarray data (available electronically) of explants loaded with 2.5MPa and 7MPa, 
EGFR was shown to be significantly down-regulated in response to 2.5MPa and 7MPa 
(1.52-fold: FDR=0.033, 1.6-fold: FDR=0.007, respectively) 4h post-load and 24h post-
load with 7MPa load (1.49-fold: FDR=0.021). However, neither CPEB3 nor NMDAR mRNA 
levels were differentially regulated in loaded explants even though miR-21-5p was 
significantly elevated in response to 2.5MPa (3.12-fold: FDR>0.001) and 7MPa (6.95-
fold: FDR>0.001) at 4h post-load and 7MPa load at 24h post-load (2.28-fold: FDR=0.002). 
These findings suggest that even though CPEB3 has been validated as a direct target of 
miR-21-5p in transfected primary chondrocytes, the effect of this miR activity in a more 
complex system i.e. tissue may be weakened by the activity of other molecules. This 
study also confirmed the mechano-sensitive nature of EGFR which has been reported in 
statically (10% elongation, 5 minutes) (Kippenberger et al., 2005) and dynamically (30% 
elongation, 0.5Hz, 10 minutes) (Correa-Meyer et al., 2002) loaded epidermal cells, 
however the current study was the first to show EGFR mechano-responsiveness in 
chondrocytes.   
The work described in this chapter investigated potential direct targets of the  
mechano-sensitive miR-21-5p, -221 and -222. There are a few experimental methods 
that are recommended for use to validate functional target molecules of miRs including: 
qPCR, western-blotting and luciferase reporter assay. Both qPCR and western-blotting 
assess co-expression of miR and putative targets respectively at the gene and protein 
levels, whereas a luciferase reporter assay determines direct interaction between a miR 
and a target gene (Kuhn et al., 2008, Thomson et al., 2011). As one miR is able to control 
many genes and the purpose of this study was to find as many molecules that are 
targeted by selected miRs that potentially play important roles in cartilage 
homeostasis/pathology as possible, the Wnt signalling array and Next Generation 
Sequencing based on mRNA level assessment was used.  The choice of these methods 
was driven by the fact that at least 84% of miRs control the expression of their targets 
through mRNA destabilisation (Guo et al., 2010) and that the majority of alterations at 
the protein level of target molecules are reflected by changes in their transcript 
abundance (Baek et al., 2008, Selbach et al., 2008). Although transcript destabilisation 
based methods can determine direct target genes, the biggest drawback of these 
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methods is that both the direct and indirect targets are identified simultaneously. To 
establish which putative differentially regulated genes identified by NGS data are direct 
targets the combined approach of computational target prediction and gene validation 
is necessary, both NGS and array analysis give more global views on genes and affected 
pathways in response to miR variations. 
This chapter showed that TIMP-3, which contains target sites for the studied miR-21-5p, 
-221 and-222 was regulated by all tested miRs, whereas CPEB3 seems to be targeted by 
miR-21-5p only. Although these genes were up-regulated and down-regulated 
respectively in response to miR overexpression or inhibition, they should be validated 
by at least one more method to confirm them as direct target genes (Kuhn et al., 2008).  
5.3.4. Summary: 
 Transfection conditions (transfection reagent concentration and 48h 
transfection) is non-toxic for primary chondrocytes 
 DharmaFECT1 (cationic lipid transfection reagent) and non-targeting siRNAs 
affect expression of most studied genes 
 miR-21-5p is a regulator of TIMP-3 and CPEB3 
 miR-221 and miR-222 control expression of TIMP-3 
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     Chapter 6  
                        General discussion 
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6.1. Importance of miRs in articular cartilage homeostasis 
miRs are small non-coding molecules with an ability to control the expression of their 
target genes; therefore they play important roles in many biological processes and their 
dysregulation can lead to a large range of diseases (Bartel, 2009). Recent studies have 
demonstrated that miRs are actively involved in maintaining the balance between 
anabolic and catabolic processes occurring in articular cartilage by regulating the  
expression of ECM molecules either directly or by secondary signalling processes  
(Diaz-Prado et al., 2012, Swingler et al., 2012, Tuddenham et al., 2006). Therefore, due 
to the highly important role of miRs in the maintenance of cartilage turnover many 
groups have studied their involvement in degenerative diseases including OA.  
OA is a multi-factorial and prevalent chronic joint disease that leads to cartilage 
degeneration, thickening of subchondral bone and osteophyte formation (Thysen et al., 
2015). Several risk factors that contribute to the development of OA include ageing, 
abnormal mechanical load, joint injury, obesity, inflammation and genetic 
predisposition (Goldring and Marcu, 2009). OA is the most common form of arthritis and 
results in an imbalance of biosynthetic and degenerative activities in chondrocytes, with 
increased expression and activation of proteolytic enzymes that degrade the main 
components of cartilage: namely collagen and proteoglycans (Goldring and Marcu, 
2009). Apart from an increased mRNA level and activity of proteolytic enzymes such as 
the MMPs and ADAMTSs in OA (Goldring and Marcu, 2009), recent studies have 
investigated differences in the expression of miRs in healthy and OA articular cartilage 
tissue. Among significantly down-regulated miRs in OA chondrocytes are: miR-27a/b 
(Akhtar et al., 2010), miR-125b (Matsukawa et al., 2013) and miR-142-3p (Wang et al., 
2016a); in contrast miR-9 (Jones et al., 2009), miR-98 (Jones et al., 2009), miR-22 
(Iliopoulos et al., 2008), miR-23a-3p (Kang et al., 2016), miR-30a (Chang et al., 2016), 
miR-139 (Hu et al., 2016) and miR-455 (Swingler et al., 2012) expression is increased 
with the OA disease. miR-146a whose influence on cartilage homeostasis is described in 
more detail in Section 1.5.1.6.2 is elevated in the early stages of degeneration but is 
decreased in end-stage OA (Yamasaki et al., 2009). Findings concerning the differential 
expression of miR-140 in OA cartilage are conflicting with studies reporting both 
repressed (Miyaki et al., 2009, Miyaki et al., 2010, Tardif et al., 2009) and elevated 
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(Swingler et al., 2012) levels of this miR in diseased cartilage, however both data may be 
right and miR-140 expression similar to miR-146a may be OA-stage dependent as the 
stage of OA cartilage utilised in these studies may have been different (Le et al., 2013). 
This miR is one of the most important in OA development as it is implicated in 
chondrogenesis (Karlsen et al., 2013, Miyaki et al., 2009, Miyaki et al., 2010) and 
cartilage development and homeostasis (Miyaki et al., 2010, Miyaki et al., 2009, 
Nakamura et al., 2011). Therefore, dysregulation of miR-140 expression in chondrocytes 
leads to stimulation of several genes involved in chondrocyte hypertrophy: Runx2 and 
Mef-2 which are regulated by HDAC-4 that is a direct target of this miR  (Swingler et al., 
2012, Tuddenham et al., 2006)  or in cartilage matrix degradation: ADAMTS-5 (Araldi and 
Schipani, 2010, Miyaki et al., 2010, Miyaki et al., 2009), IGFBP-5 (Tardif et al., 2009) 
which was previously discussed (Section 1.5.1.6).       
During every day movement the joints are subjected to different categories of 
mechanical stimuli such as tensile, hydrostatic and shear stress, however a compressive 
load is the dominant stimulus applied on the weight bearing joint. Different types of load 
have different impacts on cartilage integrity; normal “physiological” load helps to 
maintain the functional integrity of articular cartilage and joint homeostasis by balancing 
biosynthetic and degenerative activities in chondrocytes (Goldring and Marcu, 2009). 
 In contrast, abnormal “non-physiological” loads induce elevated gene expression of 
catabolic molecules (e.g. MMPs, ADAMTS) which can lead to cartilage degradation and 
result in OA development (Bader et al., 2011).  
One of the primary risk factors  for the initiation and development of OA is a combination 
of abnormal mechanical load (e.g. excessive or diminished joint contact) and an 
inflammatory response to mechanical stress (e. g. IL-1-induced cellular catabolism) 
(Torzilli et al., 2011). To date, there are limited studies on the mechano-regulation of 
miRs in cartilage, but previous studies in articular cartilage (Section 1.5.1.8) have shown 
that miR-146a (Jin et al., 2014), miR-221/-222 (Dunn et al., 2009) and miR-365 (Guan et 
al., 2011) are sensitive to mechanical load. Moreover, the mechano-responsive nature 
of a number of miRs, for example miR-19a (Qin et al., 2010), miR-663 (Ni et al., 2011), 
miR-24 (Luna et al., 2011b), miR-208a (Wang et al., 2013a), miR-16, -26a and -140 
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(Mohamed et al., 2010), miR-378 and miR-100 (Mendias et al., 2012) was also reported 
in cell types other than chondrocytes (Section 1.5.1.7).   
Therefore, I hypothesised that: (i) mechanical compression applied to cartilage 
explants induces a differential miR response involved in maintaining cartilage 
integrity, (ii) the alteration in expression of mechanically-regulated miRs occurs in  
a load-dependent manner, (iii) differentially expressed miRs in response to a higher 
load may have a potential involvement in cartilage degeneration and development of 
OA.  
To verify the hypothesis, the aims of this PhD project were to: 
1. establish regimes utilising “physiological” and “non-physiological” magnitudes of 
load in vitro, that (i) induce transcription of genes involved in ECM 
turnover/catabolism, and (ii) have the potential to induce biosynthetic and 
degradative changes at the protein level if applied for a suitably prolonged 
period of time 
2. determine which miRs expressed in explant chondrocytes are sensitive to 
mechanical stimuli 
3. establish whether there is any relationship between expression of  
mechanically-sensitive miRs and molecules involved in cartilage pathophysiology  
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6.2. SDHA and YWHAZ are the most appropriate reference genes in mechanically 
loaded cartilage explants 
Minimum Information for Publication of Quantitative Real-Time PCR Experiments 
(MIQE) guidelines advises use of at least three experimentally validated reference genes 
for an individual experimental design for normalisation of qPCR data indicating that 
usage of only one reference gene is unacceptable as it increases the chance of getting 
false results (Bustin et al., 2009, Bustin et al., 2010). Reference genes are used to 
determine the differences in studied gene expression levels stimulated by experimental 
factors (McCulloch et al., 2012), therefore reference gene expression levels must be 
stable and unaffected by the treatment regime being applied e.g. mechanical load 
(McCulloch et al., 2012). Identification of reference genes for the loading regimes 
utilised that were appropriate for use in qPCR normalisation were investigated. Very few 
‘mechanobiology’ groups have analysed the appropriateness of the reference genes 
used for transcript quantification, therefore using a panel of eight reference genes, qPCR 
was utilised to ascertain which of these genes remained constant in their expression in 
response to the different loading regimes to be used in this study. Using RefFinder 
software, SDHA was identified as the most stable reference gene across the loading 
regimes tested with YWHAZ as second; in contrast, GAPDH and HPRT were deemed to 
be the least stable under these experimental conditions. These findings were published 
this year (Al-Sabah et al., 2016), and thus in this thesis gene expression in loaded and 
unloaded explants were normalised to SDHA and YWHAZ, having been identified as the 
most appropriate in this model system. 
6.3. Identification of physiological and non-physiological magnitudes of cyclic 
compressive load 
Before identification of mechano-sensitive miRs that are potentially involved in cartilage 
integrity, optimisation of load magnitudes was necessary to determine loading regimes 
that regulate the expression of ECM genes which have been implicated in cartilage 
homeostasis or OA development. Furthermore, the periods of loading also needed to be 
investigated to identify regimes in which early transcriptional changes induced by short 
periods of cyclic compression could be detected. Although there are many publications 
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reporting on compressive load-induced alterations in the expression of key ECM 
molecules involved in cartilage homeostasis in vivo (Kiviranta et al., 1987, Jortikka et al., 
1997, Otterness et al., 1998, Palmoski and Brandt, 1981, Palmoski et al., 1979) and in 
vitro (Fitzgerald et al., 2008, Kiraly et al., 1998, Kurz et al., 2001, Palmoski and Brandt, 
1984), this first step was necessary as all of the changes reported in these studies 
occurred after hours of mechanical load/immobilisation.  
In my preliminary study, early transcriptional changes that suggests turnover or 
induction of catabolism in response to load was observed after load was applied for 15 
minutes, at a frequency of a fast walking pace (1Hz) (Bader et al., 2011). Having selected 
these parameters for time and frequency, the loading regimes were further optimised 
to take into account the magnitude of load – for this peak stresses of 2.5MPa, 5MPa and 
7MPa were applied to the explants. These peak stresses were selected based on 
previously reported studies. In the literature ≤5MPa magnitude is considered  
as a physiological load (Fehrenbacher et al., 2003, Grodzinsky et al., 2000), whereas 
magnitudes above 5MPa are considered as injurious (Fehrenbacher et al., 2003). The 
loading regimes i.e. applied magnitudes were examined to identify experimental 
regimes capable of inducing changes in the expression of ECM molecules at the 
transcriptional level, with the potential to induce alterations at the protein level if the 
load was applied for longer periods of time. ADAMTS-4 transcription was up-regulated 
both in response to 2.5MPa and 5MPa loads, but significant up-regulation of other 
catabolic molecules such as MMP-1 and -3 was only observed at 5MPa, therefore  
I considered a 2.5MPa to be physiological magnitude. Despite the up-regulation of some 
catabolic molecules with a 5MPa load compared with the 2.5MPa load, I did not consider 
this magnitude as abnormal. The reason this decision was made was that with a 5MPa 
load ADAMTS-5 mRNA levels were not elevated and expression of MMP-9 and -13 were 
down-regulated. The substantially increased expression of catabolic genes in response 
to 7MPa load compared with the lower loads confirmed that the 7MPa load should be 
used as representative of a non-physiological magnitude of load. To summarise,  
a loading magnitude of 2.5MPa was selected to represent a physiological (normal) 
magnitude and 7MPa as a non-physiological magnitude. 
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6.3.1. Time dependent transcriptional response of mechano-sensitive genes 
One of the aims of chapter 3 was to identify, using a global perspective involving 
microarray analysis, mechano-sensitive genes in articular cartilage subjected to the 
selected 2.5MPa and 7MPa loading regimes. In addition, to establish the stability of 
transcriptional changes of mechanically-regulated genes, the analysis of mechano-
sensitive gene expression was performed at 4h and 24h time points post-cessation of 
load. These time points were selected based on the preliminary experiments performed 
in our lab (data not shown) and the literature showing differential expression of 
mechano-sensitive genes such as (i) MMP-3, -13, ADAMTS-4 in primary bovine 
chondrocytes subjected to tensile strain (7.5% elongation, 1Hz, 30 minutes) and 
processed 4h post-load (Thomas et al., 2011), and (ii) MMP-3 reported to be elevated in 
bovine cartilage explants subjected to a single impact load (50% final strain at a velocity 
of 1 mm/second) as early as 2h however the peak of 250-fold elevation occurred at 24 
hours post-load (Lee et al., 2005c).  
As was expected, the microarray results confirmed some previous data presented in the 
load optimisation experiments and demonstrated significantly higher expression of 
MMP-3, ADAMTS-4, TIMP-1 and -3 in explants subjected to 7MPa when compared to 
unloaded tissue at 24h post-load. However, neither the 2.5MPa load at the 24h time 
point, nor the 2.5MPa and 7MPa loads at 4h post-load presented changes in these 
genes. Furthermore, at both time points post-cessation of load the 7MPa loading regime 
stimulated the expression of a greater number of mechano-sensitive genes than 
2.5MPa. The data showed differential expression of (i) 2,848 and 778 genes in response 
to 7MPa and 2.5MPa (1Hz, 15minutes) loads, respectively, at 4h post-load and (ii) 1,995 
and 91 genes in response to 7MPa and 2.5MPa (1Hz, 15minutes) loading regimes, 
respectively, at 24h post-load.  
The microarray data suggest that some genes, for example aggrecan and collagen, 
whose levels were not significantly altered either in load optimisation or microarray data 
may need longer periods of load to modulate their differential expression as has 
previously been reported by Fitzgerald et al. They reported a time-dependent 
transcriptional response to mechanical stimulation showing that bovine explants 
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subjected to a cyclic compression (3% deformation, 0.1Hz) for 24h induced significant 
elevations in aggrecan, collagen type II, MMP3 and ADAMTS-5 expression, whereas the 
same load applied for shorter periods of time (1, 4 or 8h) did not affect their mRNA levels 
(Fitzgerald et al., 2006); these explants were processed directly after application of load.  
The microarray findings indicated that differential transcription of many mechanically-
regulated genes in this study requires different periods post-cessation of load to present 
changes at the mRNA level; moreover, most of the differentially-regulated genes were 
altered in a load dependent manner indicating a transitory effect of mechanical stimuli. 
To these genes belong, for example, FOSB presenting elevated expression at 4h only in 
response to both loading regimes (2.5MPa: 8.89-fold: FDR>0.001, 7MPa: 40.31-fold: 
FDR>0.001) or ESR1 (ERα) which was significantly decreased in response to 7MPa load 
at 24h post-load (2.8-fold, FDR=0.004). Other molecules, for example, FOSL-1 and JUNB 
showed differential expression at both time-points. FOSL-1 was up-regulated in explants 
subjected to 2.5MPa (6.94-fold: FDR>0.001) and 7MPa loads (16.51-fold: FDR>0.001) 
processed at 4h post-load; in turn, explants loaded with 2.5MPa and 7MPa magnitudes 
and processed at 24h post-load showed elevation of this gene in the following manner: 
3.13-fold: FDR>0.001 (2.5MPa) and 8.92-fold: FDR>0.001 (7MPa). JUNB was upregulated 
by 4.11-fold (FDR>0.001) and 5.81-fold (FDR>0.001) at 4h post load in response to 
2.5MPa and 7MPa, respectively, while at 24h post-load JUB was still elevated in 
response to 2.5MPa load (2.15-fold: FDR>0.001) and 7MPa load (2.61-fold: FDR>0.001), 
and had not returned to basal expression levels.  
In my experiments, transcription factors were one of the most abundant protein classes 
of differentially expressed genes in explants subjected to 2.5MPa and 7MPa loads and 
processed 4h post-load. The 24h time point also showed a large group of this type of 
molecule, although not as many as observed at 4h, however this was only in response 
to the 7MPa load.  These results corroborate published data concerning mainly FOS and 
JUN family members suggesting that transcription factors are early-response molecules 
to mechanical stimuli (Bougault et al., 2012, Lee et al., 2005c). This effect can be 
explained by the fact that as they are molecules that regulate the transcription of other 
genes they must be affected first to stimulate transcriptional changes in their down-
stream genes. Bougault et al. reported that FOS and JUN family members were  
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up-regulated directly after 30 minutes of compressive load (range 20-40KPa, 0.5Hz) 
applied on 3D chondrocyte constructs (Bougault et al., 2012). Lee et al. showed that 
injuries static load (50% final strain at a velocity of 1 mm/second) increased the 
expression level of c-FOS (~120-fold) and c-JUN (~40-fold) in bovine articular cartilage 
explants within 1h after load and after 4h post-load their elevated expression decreased 
by 3-fold and remained at this level of expression for 24h (Lee et al., 2005c). In turn, 
Roosa et al. also observed a rapid response in the increased expression of the AP1 
transcription factor components, such as FOSL-1 and JUNB after only 4h from the 
application of the single loading episode (13N, 2Hz, 3 minutes) on rat forelimb bone  
(Mantila Roosa et al., 2011). The early responsiveness of AP1 components was 
confirmed in my mechanical loading model, whereby significant elevations in FOSB, 
FOSL-1, JUNB and JUND transcripts in explants subjected to both utilised loading regimes 
and processed at 4h post-cessation was observed. Results from the current study 
demonstrated sustained up-regulation of FOSL-1 and JUNB showing their increased 
expression at 24h post-load; however, the effect was transitory as the relative fold 
changes of these genes were twice and 4 times lower in FOSL-1 and JUNB in response 
to both loading regimes in comparison to the explants subjected to the same loads but 
processed at 4h post-load. FOSB and JUND were not significantly altered by the 24h time 
point.  
The molecular classification performed using PANTHER software showed that both 
mechanical loads (2.5MPa or 7MPa, 1Hz, 15 minutes) and both times post-cessation of 
load (4h and 24h) induced the expression of similar protein classes in loaded explants 
indicating that these protein groups are the most sensitive to mechanical compression 
in articular cartilage. Although, the sizes of most of these protein groups differed in each 
condition, there were some protein classes demonstrating similar proportions. Explants 
subjected to 7MPa load and processed either at 4h or 24h post-load presented 
comparable proportions of the most abundant protein classes. Interestingly, cartilage 
loaded with 2.5MPa and processed at 4h post-load presented a similar distribution to 
the most abundant protein groups induced in the 7MPa loaded explants processed at 
4h and 24h post-load; whereas, noticeable differences were observed in the top 3 most 
abundant protein classes identified in cartilage loaded with 2.5MPa when comparing 4h 
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versus 24h post-load. These differences may be attributed to (i) the temporary changes 
in gene expression of some mechanically-regulated molecules identified in explants 
subjected to load and (ii) the lower fold-changes of mechanically-regulated molecules in 
explants subjected to 2.5MPa compared to 7MPa. These data suggest that the 
transferase protein group does not contain as many temporary mechano-regulated 
molecules as nucleic acid binding proteins and transcription factors. Transferases were 
identified as the only class out of these most abundant protein groups of mechano-
sensitive molecules that occurred in all loaded explants processed either at 4h or 24h 
post-load. In turn, nucleic acid binding proteins and transcription factor sub-classes were 
similarly regulated in explants subjected to 7MPa load at both time points and in the 
2.5MPa loaded explants processed at 4h post-load; however, these protein classes were 
not amongst the most abundant groups of mechanically-regulated proteins in explants 
subjected to a 2.5MPa load and analysed at the later time-point.  
The microarray results and PANTHER analysis  suggest that the transcript levels of 
mechanically-regulated molecules and associated protein classification is  load- and 
time-dependant indicating that the timeframe to observe early transcriptional effects of 
mechanical stimuli may be very different depending on the gene under investigation  
(Garg et al., 2014). 
 
6.4. 24h time point is the most appropriate to observe differentially expressed miRs  
Experiments presented in Chapter 4 focused on identifying mechanically-regulated miRs 
in articular cartilage that are involved in maintaining cartilage homeostasis. One of the 
aims of this study was to identify early mechano-responsive miRs in articular cartilage 
that control important cartilage homeostasis genes. To date, there is no publication 
suggesting which time point is the most appropriate to observe changes in the 
expression of mechanically-regulated miRs, therefore RNA was extracted from cartilage 
explants 2h, 6h and 24h after being subjected to physiological (2.5MPa) or  
non-physiological (7MPa) magnitude of loads and expression of miRs quantified. Pooled 
samples were sent for NGS followed by analysis by the bioinformatician (Andrew 
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Skelton, Newcastle University). Assessment of miR expression levels using the NGS 
method was chosen over microarray analysis as NGS provides more detailed information 
about the transcriptomes, therefore NGS data may be used for future investigation i.e. 
novel mechano-responsive miRs in cartilage, whereas arrays deliver limited results 
containing only those genes that are present on the array platform. 
Although, all time points (2h, 6h, 24h) analysed using the NGS method initially revealed 
mechano-sensitive miRs, the RNA extracted at 24h post-load presented the greatest 
number of 17 differentially expressed miR genes, therefore this period post-load 
cessation was selected for further analysis. NGS of miRs had been conducted before the 
microarray technique was utilised to compare global changes in mechano-sensitive 
genes in explants processed either at 4h or 24h post-load. From the microarray, it was 
determined that cartilage processed at both 4 and 24h post-load would allow for 
changes in miR expression to be observed. Surprisingly, the microarray data 
demonstrated many more significantly regulated miRs in response to load at 4h post-
load than 24h post-cessation showing 76 and 21 differently expressed miRs at earlier 
and later time points, respectively. RNA from the 4h post-load explants was extracted 
using Qiagen RNeasy mini kits, whereas total RNA isolation from tissue processed at 2h, 
6h and 24h post-load cessation was performed using a mirVana™ miRNA isolation kit 
which may have affected the outcome. If this supposition is real, then these findings 
suggest that either the silica membrane in the Qiagen RNeasy mini kit columns bind 
short sequences of RNA, and not only >200bp as it is designed for, or the findings of the 
microarray performed on the 4h time point are the result of partial RNA degradation. It 
is highly unlikely that it is the latter explanation as the RIN scores for the RNA integrity 
exceeded 8 indicating excellent RNA quality. 
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6.5. Differential regulation of cartilage miRs in response to cyclic compressive load  
According to the number of reads generated from the NGS data, the most abundantly 
expressed miR in cartilage, presenting ~1.2x106 as the average number of reads in all 
explants and time points, is miR-140. It has also been shown to be the most highly 
expressed miR in all three stages of the human chondrocyte phenotype (precursor, 
differentiated and hypertrophic) (McAlinden et al., 2013). Crowe et al. showed that even 
in OA cartilage the most highly expressed miR is miR-140, and further detailed that:  
(i) miR-140-3p is the most abundant miR in cartilage (~4x106 numbers of reads per 
10x106 of reads) and (ii) miR-140-5p is the 3rd most highly expressed miR presenting 
~2x105 numbers of reads per 10x106 of reads (Crowe et al., 2016). miR-140 also 
presented a large difference in expression between articular chondrocytes and 
mesenchymal stem cells (MSC) concomitant with a parallel increase in Sox9 and collagen 
type II transcription during chondrogenesis (Miyaki et al., 2009). This miR was reported 
to play a crucial role in cartilage development and homeostasis (Araldi and Schipani, 
2010, Miyaki et al., 2009, Miyaki et al., 2010, Nakamura et al., 2011, Tardif et al., 2009, 
Tuddenham et al., 2006). Apart from its involvement in decreased proliferation and 
premature chondrocyte differentiation leading to endochondral bone growth defects 
resulting in dwarfism (Miyaki et al., 2010, Nakamura et al., 2011), miR-140 plays a critical 
role in maintaining cartilage homeostasis and integrity by targeting ADAMTS-5 (Miyaki 
et al., 2010, Miyaki et al., 2009, Araldi and Schipani, 2010), HDAC4 (Tuddenham et al., 
2006, Swingler et al., 2012) and IGFBP-5 (Tardif et al., 2009).  
Surprisingly, miR-148a that was expressed in my experimental samples at a similar level 
to miR-140 (~1.2x106 average number of reads) was not on the list of the 30 most 
abundantly expressed miRs in any of the chondrocyte developmental stages  (McAlinden 
et al., 2013). miR-148a is important in maintaining cartilage integrity as it (i) inhibits 
chondrocyte hypertrophy via targeting collagen type X and MMP-13, (ii) reduces 
expression of ADAMTS-5 and (iii) elevates collagen type II mRNA levels (Vonk et al., 
2014).   
Unexpectedly, a significant reduction in miR-140 expression was observed in the 
cartilage explants subjected to a 7MPa load and analysed 24h post-cessation in an initial 
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screening using qPCR; however, this observation was not confirmed by the NGS data 
even though the material used for the NGS analysis was the pooled RNA that had been 
utilised for the qPCR (Chapter 4). Although, qPCR is a more sensitive technique than NGS 
and the mechano-regulation of miR-140 has also been reported in human airway 
smooth muscle cells 12h post-cessation of cyclic stretch (12%, 1Hz, 1h) (Mohamed et al., 
2010), this miR was not selected for further studies as it is already well described in the 
literature. However, miR-140 is imperative for cartilage homeostasis as (i) miR-140 
knock-out mice show growth defects and an abnormal skeletal phenotype as defined by 
shortening of the long bones and craniofacial deformities (Miyaki et al., 2010, Nakamura 
et al., 2011), (ii) ADAMTS-5 is a direct target of miR-140 and was significantly increased 
in miR-140 knock-out mice and significantly decreased in miR-140 transgenic mice 
(Miyaki et al., 2010) and (iii) miR-140 targets HDAC4 (Tuddenham et al., 2006, Swingler 
et al., 2012) which is a corepressor of Runx-2 and Mef-2 that are fundamental for 
chondrocytes hypertrophy and bone formation (Swingler et al., 2012), and IGFBP-5 
(Tardif et al., 2009). Therefore, with additional time it would be worthwhile further 
validating its expression in individual samples to confirm its mechano-responsiveness. 
This knowledge might be beneficial in better understanding how abnormal load might 
modify miR-140 expression and induce cartilage degeneration, especially because miR-
140 has already been shown to regulate genes involved in OA pathology and its 
expression is known to be altered in OA chondrocytes compared to healthy cells, 
probably in an OA stage dependent manner (Gibson and Asahara, 2013).  
NGS analysis identified a total of 17 differentially expressed known miRs in cartilage 
explants when comparing the response of physiological and non-physiological 
magnitudes of load processed at 24h post-load to unloaded tissue. The investigation of 
novel miRs was not conducted as it was not the purpose of this study. Due to time 
constraints, only 7 miRs were selected for validation based on two criteria: (i) at least a 
2-fold change in expression between loaded and unloaded explants or (ii) potential 
significance in OA development reported in the literature. In agreement with previous 
studies in several cell types (not necessarily in chondrocytes), qPCR validation indicated 
the mechano-responsive nature of miR-21-5p, miR-27a-5p, miR-221 and miR-222, and 
also miR-483 that has not previously been reported as being mechanically-regulated. 
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Expression levels of these miRs were reported to be altered in OA cartilage when 
compared to healthy tissue (up-regulation of miR-21 (Zhang et al., 2014b), -483-3p/-5p 
(Gibson and Asahara, 2013, Qi et al., 2013), and down-regulation of miR-27a (Tardif et 
al., 2009) and miR-222 (Song et al., 2015)) indicating that they affect chondrocyte 
metabolic activities and cartilage homeostasis. These miRs have putative and 
experimentally proven targets including: GDF-5 (Zhang et al., 2014b), TIMP-3 (Wang et 
al., 2013b), MMP-13 (http://www.targetscan.org) for miR-21; MMP-13 and insulin-like 
growth factor-binding protein 5 (IGFBP-5) (Tardif et al., 2009) for miR-27a; TIMP-3 
(Zhang et al., 2012) for miR-221/-222; Mdm2 (Kim et al., 2010) for miR-221; HDAC4 
(Song et al., 2015) and DKK2 (Li et al., 2013) for miR-222 separately; collagen type VI, 
GDF-5 and TIMP-3 (http://www.targetscan.org) for miR-483, hence a few of them were 
selected for further studies.  
 
6.6. Functional analysis of mechano-sensitive miRs in transfected primary 
chondrocytes 
Having validated mechano-sensitive miRs, Chapter 5 was focused on determining the 
functional consequences of differential expression of these miRs in chondrocyte 
mechano-transduction. For this purpose, primary cartilage chondrocytes were 
transfected with miR inhibitors or non-targeting siRNA and the level of gene expression 
assessed by: (i) custom designed Wnt signalling arrays and (ii) NGS, where cells treated 
with non-functional siRNA or with transfection reagent only were used as controls.  
The rationale for analysing the profile of Wnt signalling genes in the transfected 
chondrocytes was based on previous studies demonstrating the influence of these miRs 
on the expression of Wnt/βcatenin signalling pathway components (Corr, 2008, 
Kawakita et al., 2014, Li et al., 2013, Wu et al., 2015, Zheng et al., 2012). Furthermore, 
our laboratory has previously demonstrated that components of the Wnt/β-catenin 
signalling pathways are extremely sensitive to these loading conditions (A. Al-Sabah, 
Cardiff University PhD) and regulation of several of the canonical and non-canonical Wnt 
molecules were evident in the microarrays performed (Chapter 3). Unexpectedly,  
the Wnt signalling PCR array demonstrated mostly down-regulated genes in response to 
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treatment with miR inhibitors, hence excluding these genes as direct targets of the 
selected miRs although they could well be regulated indirectly - but this remains to be 
elucidated. Additionally, it was found that in the transfected cells genes that were 
selected for validation based on a >2-fold up-regulation turned out to be false positives. 
Although, the Wnt signalling arrays produced unexpected and contradictory data to the 
published literature, I believe that the positive correlation of miR-21-5p with β-catenin 
detected in this experiment is real and hence has the ability to manipulate Wnt signalling 
in mechanically-stimulated chondrocytes. This hypothesis is based on a previous study  
which demonstrated that although miR-21 knock-down did not alter β-catenin 
expression in a human lung cancer cell line, elevated mRNA and protein levels of  
β-catenin was observed in response to overexpressed miR-21 (Wu et al., 2015). 
Additionally, the same group showed higher expression of both miR-21 and β-catenin in 
Lewis lung carcinoma in mice compared to normal lung cells (Wu et al., 2015). 
Furthermore, the negative correlation between miR-221 and DVL2, which is a key 
intracellular stimulator of the Wnt signalling pathway (Smalley et al., 2005), identified in 
the Wnt qPCR array and previously demonstrated in human prostate carcinoma cell lines 
(Zheng et al., 2012) also adds to this being a real result and should be investigated in 
future studies. Moreover, there is a possibility that the positive correlation between the 
reduced expression level of a miR and its target gene may be an effect of: (i) indirect 
regulation by the miR targeting the upstream genes that do not belong to the Wnt 
signalling pathway or were not present on the array, but affected the expression of Wnt 
components or (ii) influence of transfection itself. Despite the comparison of the  
non-targeting siRNA control vs untreated Wnt arrays not showing many transcriptional 
changes, the gene validation performed in Chapter 5 demonstrated statistically 
significant variations in some of the gene transcripts caused by either cationic lipid 
transfection reagent only or the non-targeting siRNA controls.   
The aim of the final experimental chapter was to identify direct targets of the validated 
mechanically-regulated miR-21-5p, miR-221 and miR-222 to elucidate potential 
involvement in cartilage homeostasis and OA pathogenesis. Therefore, because the 
experiment conducted on the custom-built Wnt signalling array did not identify direct 
target genes of the selected miRs, an analysis of global gene changes in the same set of 
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transfected and untreated cells was conducted using NGS to establish functional effects 
of these miRs on chondrocyte metabolism. Unexpectedly, the sequencing data 
demonstrated no statistically significant genes (FDR≤0.05) for miR-21-5p or only a few 
whose expression was statistically significant and inversely proportional to the level of 
miR-221 (U1, U3, U5, U12, snoU13, CATIP and PLA2G4F) and miR-222 (U1, U3, U5, U12, 
snoU13, PLA2G4F, mir-23a and mir-27a). To wider the panel of putative target genes of 
tested miRs, I selected a few differentially but not statistically significant genes, based 
on the criteria described in Chapter 5, to check their expression in primary chondrocytes 
transfected with inhibitors or mimics of miR-21-5p, miR-221 and miR-222.  
From 4 potential target genes (CPEB3, MMP-13, SPRY4, TIMP-3) of miR-21-5p selected 
for validation, TIMP-3 and CPEB3 were identified as real targets, whereas miR-221/-222 
showed targeting of TIMP-3 out of 7 tested molecules (CPEB3, HDAC4, LIFR, MMP-13, 
RUNX2, SPRY4, TIMP-3). 
 
6.7. Mechano-regulation of miR-21-5p and its potential role in OA pathogenesis 
My finding that miR-21-5p is mechanically regulated in cartilage chondrocytes in 
response to a non-physiological magnitude of load is corroborated by previous 
publications.  Elevated miR-21 expression was previously reported in human aortic 
smooth muscle cells subjected to cyclic tensile strain (16%, 1Hz, 12 hours) (tao Song et 
al., 2012). Moreover, its increased level was also seen in human umbilical vein 
endothelial cells in response to steady laminar shear stress (15 dynes/cm2) (Weber et 
al., 2010) and oscillatory shear stress (0.5 ± 4 dynes/cm2) (Zhou et al., 2011), while 
pulsatile shear stress (12 ± 4 dynes/cm2) decreased miR-21 transcript levels (Zhou et al., 
2011). There is however no published information about the mechano-sensitive nature 
of miR-21 in chondrocytes indicating that the responsiveness of miR-21-5p in cartilage 
to a non-physiological loading magnitude (7MPa) is a novel finding. The fact that  
(i) mechanical induction of miR-21-5p in chondrocytes occurred in explants subjected to 
7MPa load only and (ii) up-regulation of miR-21 is observed in OA pathology (Zhang et 
al., 2014b) indicate that miR-21-5p could be a potential biomarker of OA 
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pathophysiology caused by abnormal mechanical load. miR-21 has been experimentally 
proven to control OA development by direct targeting of growth differentiation factor 5 
(GDF-5), which is known to be reduced in OA cartilage (Zhang et al., 2014b). As GDF-5 
has been reported to increase chondrocyte proliferation in later stages of skeletal 
development (Francis-West et al., 1999), the lower synthesis of this gene may weaken 
the capability of cartilage repair. The fact that GDF-5 expression is inhibited by  
mechano-sensitive miR-21 may suggest that this miR:mRNA correlation is involved in OA 
development induced by abnormal mechanical load.  Although, in my study of direct 
miR targets, GDF-5 was not on the list of differentially expressed genes affected by  
miR-21-5p inhibition (Chapter 5), it would be worth checking this finding in my 
experimental model. In terms of data obtained from my study, the novel findings of 
TIMP-3 and CPEB3 regulation in cartilage by the mechano-sensitive miR-21-5p only 
reinforces the involvement that this miR has in cartilage homeostasis and pathology. 
TIMP-3 regulates the activity of aggrecanases (ADAMTS-4 and -5) and all MMPs 
(Murphy, 2011); therefore it is not surprising that its expression is down-regulated in OA 
cartilage (Dehne et al., 2009, Li et al., 2014) which may be an effect of miR-21-5p activity. 
Furthermore, the inversely proportional co-expression of miR-21 and TIMP-3 has been 
already reported in glioma cell lines (Gabriely et al., 2008), oesophageal (Wang et al., 
2013b) and human renal (Zhang et al., 2011) carcinoma cell lines. In turn, CPEB3 which 
modifies molecule expression at the post-translational (Huang et al., 2014) and post-
transcriptional level (Peng et al., 2010) has mainly been identified in neural tissue and 
has not been reported as a regulator of cartilage homeostasis yet. However, as CPEB3 
knock-down or knock-out murine neurons respectively induce the expression of EGFR 
(Peng et al., 2010) and NMDAR (Chao et al., 2013) which activates anabolic PI3K/AKT 
and catabolic MAPK signalling pathways (Huang et al., 2014, Peng et al., 2010), I assume 
that CPEB3 plays a significant role in maintaining cartilage integrity. This study is the first 
to demonstrate CPEB3 regulation by miR-21-5p and identify the CPEB3 transcript as a 
direct target of this miR. 
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6.8. Is miR-221/-222 sensitivity to non-physiological magnitudes of load involved in 
controlling turnover of cartilage molecules?   
Out of the validated miRs, miR-221 and miR-222 presented the greatest response to 
 a 7MPa load compared to unloaded explants and those subjected to a physiological 
magnitude of load (2.5MPa). These results supported my preliminary qPCR data 
demonstrating the mechano-regulation of miR-221/-222 in cartilage and corroborate  
a previously published study whereby elevated levels of these miRs were observed in 
anterior weight-bearing compared to posterior non-weight-bearing regions of the 
medial femoral condyles of bovine stifle joints (Dunn et al., 2009). Although the role of  
miR-221/-222 in cartilage remains not well understood, there are some publications 
indicating their potentially important function in cartilage biology. miR-221 regulates 
chondrogenesis in mesenchymal cells by inhibition of Mdm2 expression (Kim et al., 
2010). Down-regulation of Mdm2 increased Slug protein activity inhibiting proliferation 
of chondroprogenitor cells (Kim et al., 2010, Lolli et al., 2014). Therefore, these findings 
may indicate that an elevated level of miR-221 expression negatively affects 
chondrocyte differentiation and cartilage development. This hypothesis is supported by 
another study which showed that silencing of miR-221 promoted chondrogenesis in 
hMSC pellet  culture without the addition of the chondrogenic inducer TGF-β (Lolli et al., 
2016). Moreover, this group also reported that miR-221 silenced hMSC, embedded  in 
alginate and inserted into osteochondral defects in osteochondral biopsies that were 
subsequently implanted subcutaneously onto the backs of nude mouse improved 
cartilage repair compared to untransfected hMSCs or no cell alginate controls (Lolli et 
al., 2016). Furthermore, both miR-221 (Wang et al., 2016b) and miR-222 (Li et al., 2013) 
have been reported to affect the Wnt/β-catenin signalling pathway by direct targeting 
of the WNT inhibitor Dickkopf-2 (DKK2). Knock-down of miR-221 in an oesophageal 
cancer cell line reduced Wnt/β-catenin activity via targeting of DKK2 (Wang et al., 
2016b). In turn, overexpression of miR-222 in glioma cell lines led to inhibition of DKK2 
and activation of the Wnt/β-catenin pathway i.e. elevation of β-catenin protein levels, 
whereas down-regulation of miR-222 induced the opposite effect (Li et al., 2013). 
Moreover, miR-222 has been shown to control cartilage destruction via HDAC4 
mediated control of MMP-13 expression in OA cartilage (Song et al., 2015). This  group 
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reported decreased miR-222 expression in OA chondrocytes in which HDAC4, the direct 
target of this miR and regulator of MMP-13 expression, was elevated, whereas 
overexpression of miR-222 in OA chondrocytes significantly reduced the  level of both 
these genes (Song et al., 2015). They also reported that intra-articular injection of 
lentivirus expressing miR-222 into DMM mice joints notably decreased expression of  
MMP-13 and cartilage degradation (Song et al., 2015). Unfortunately, experiments 
conducted in my study cannot confirm this previously published data, because (i) NGS 
data from cells treated with miR-221 inhibitor demonstrated a 1.33-fold up-regulation 
of Mdm2 which did not cross the cut off of a 2-fold increase and therefore was not 
selected for validation, (ii) DKK2 remained unchanged in the Wnt signalling array in 
response to miR-221 knock-down at the time points analysed and (iii) DKK2 was 
observed to be down-regulated in the Wnt signalling array for miR-222 knock-down 
(1.87-fold) which argues against the loss of function theory stating that a real target 
gene must be inversely proportional to the inhibited miR, and (iv) HDAC4 did not 
respond to miR-222 level manipulation indicative of being a direct target. TIMP-3 was 
validated at the gene level as a direct target of both miR-221 and miR-222 corroborating 
previous findings in lung and liver cancer tissue and cell lines (Garofalo et al., 2009), 
papillary thyroid carcinoma tissue (Yang et al., 2013) and human glioblastoma cells 
(Zhang et al., 2012). In my study only TIMP-3 was confirmed to be a genuinely direct 
target gene of miR-221/-222 in chondrocytes. 
 
6.9. Differential regulation of miR-21-5p, miR-221 and miR-222 in loaded cartilage 
explants does not inhibit expression of their direct target TIMP-3 
The findings from this study have demonstrated the (i) elevated expression of  
miR-21-5p, miR-221 and miR-222 in response to non-physiological (7MPa) magnitudes 
of compressive load (Chapter 4) and (ii) validation by qPCR that TIMP-3 is a direct target 
of these miRs (Chapter 5), suggesting that up-regulation of these miRs in response to a 
non-physiological peak load may play an important role in cartilage degradation by 
reduction of TIMP-3 levels. Interestingly, to my surprise TIMP-3 mRNA expression is 
increased in cartilage explants subjected to a 7MPa load (Chapter 3) concomitant with 
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up-regulation of the aforementioned miRs. However, it is unclear how this discrepancy 
in findings has arisen. There is good evidence to believe however that TIMP-3 is a real 
target of miR-21-5p, miR-221 and miR-222 in primary chondrocytes, because it has also 
been experimentally verified in cell types other than chondrocytes (Gabriely et al., 2008, 
Garofalo et al., 2009, Wang et al., 2013b, Yang et al., 2013, Zhang et al., 2012, Zhang et 
al., 2011). It may well be that a more complex system such as in situ cartilage tissue, as 
opposed to primary chondrocytes or cell lines, subjected to exogenous stimulation 
activates the response of so many genes that the strength of the repressive roles of  
miR-21-5p, miR-221 and miR-222 may be masked by other genes and become too weak 
to inhibit TIMP-3 in this explant system. The other possibility that might explain the 
simultaneous elevation of both the tested miRs and TIMP-3 is a regulatory loop i.e. 
elevated TIMP-3 expression induces higher expression of miR-21-5p, miR-221 and  
miR-222 with the purpose of reducing TIMP-3 levels in the cell over time. 
 
6.10. Future directions 
Despite the study providing informative and novel data on the sensitivity of miRs to 
mechanical load which was the main goal of this PhD thesis, there are some aspects that 
could be further explored to gain a better understanding of the effect of mechanical 
load on chondrocyte metabolism and cartilage degradation/OA development.  
In my experiments I used immature bovine cartilage derived from 1-3 weeks old calves, 
however future studies would utilise mature bovine cartilage to investigate whether the 
observations here are evident in skeletally mature tissue. The reasons why I decided to 
use immature cartilage were: 1. Higher chondrocyte number in immature tissue 
facilitating greater yields of extracted total RNA, 2. Less variability in age indicating  
a similar mechanical stimulation history. However, the comparative studies should be 
performed to determine whether the skeletal maturation status of cartilage affects 
expression of mechanically-regulated miRs, especially because some miRs are 
developmental stage dependent. Additionally, it would be interesting to do this study 
also on human cartilage and compare it to differentially expressed miRs in OA cartilage. 
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This kind of comparison would be a better model to identify mechano-sensitive miRs 
involved in OA onset, as the comparison would be made on the same species. All my 
experiments were conducted in an in vitro model, therefore it would be interesting to 
characterise miRs response in an in vivo experimental model. An in vivo model widely 
used in mechano-biology and cartilage degradation studies is the surgical destabilisation 
of the medial meniscus (DMM) in mice and this could be utilised to establish the 
influence of abnormal load on miR expression levels (Gardiner et al., 2015, Glasson et 
al., 2007, O’Conor et al., 2016). Another in vivo model of load-induced cartilage 
degeneration which could be used to assess mechanical effects on miR expression is a 
non-surgical rupture of the murine anterior cruciate ligament (ACL) which induces joint 
instability and subsequent cartilage loss. This ACL rupture model, which represents a 
phenotype akin to that of human post-traumatic OA involves swelling and inflammation 
as an early response to a single episode of mechanical load (12N, 1.4mm/s) and 
extensive cartilage degradation, as well as bone remodelling, by 3 weeks post-rupture 
(Blain et al., unpublished observations). Using this model, the mechanical influences on 
miR regulation could be analysed at defined time points of cartilage degeneration i.e. 
early versus late stage degradation; this is something that is currently being undertaken 
in the lab to inform on mechanically-regulated miRs in disease progression. 
The aim of this study was to find early response mechano-sensitive miRs that are 
involved in cartilage homeostasis and play an important role in cartilage degeneration 
caused by degradative load. For this purpose, based on the literature and optimisation 
studies, two magnitudes of load that can induce “physiological” and “non-physiological” 
responses at the gene level were selected, with the proviso that these magnitudes have 
the potential to activate anabolic/catabolic response at the protein level if applied for 
prolonged periods of time. The loading regimes I chose to determine early events in miR 
regulation was appropriate as miR genes are non-protein coding molecules and do not 
need time for translation. However, it would be interesting to compare the expression 
of miRs that are differentially expressed at the beginning of a potentially physiological 
or non-physiological load and then at the stage where the load becomes biosynthetic or 
degradative respectively, and further compare these miRs with those that are 
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differentially expressed in OA cartilage. This type of comparison would be very helpful 
in identification of early miR biomarkers of degradative load. 
One of the significantly elevated miRs in response to a non-physiological magnitude of 
load (7MPa) was miR-27a-5p (2.56-fold: p=0.001). This novel finding of miR-27a-5p 
mechano-sensitivity in chondrocytes has only been previously demonstrated in 
endothelial cells subjected to 18h, 24h or 72h of laminar shear stress (15 dynes/cm2) 
(Urbich et al., 2012). Moreover, the information that: (i) miR-27a-5p is mechanically 
regulated in chondrocytes and (ii) miR-27a is decreased in human OA chondrocytes and 
indirectly regulates expression of MMP-13 and insulin-like growth factor-binding protein 
5  IGFBP-5 (Tardif et al., 2009) suggest that this miR may have an influence on cartilage 
homeostasis and progression of load dependent OA. In my study, although cells were 
transfected with miR-27a-5p inhibitor under the same experimental conditions as 
chondrocytes treated with the other miR inhibitors, miR-27a-5p presented an unstable 
trend of expression showing both up-regulated and down-regulated miR-27a-5p levels 
in response to this transfection which was completely unexpected. As miR-27a 
expression is reduced in OA chondrocytes (Tardif et al., 2009), it would be worth 
repeating the transfection of chondrocytes using a new batch of miR inhibitor or miR 
mimic to establish the direct targets of this mechanically-regulated miR. 
Although my study is the first to demonstrate the novel mechano-regulation of miR-483, 
which is an equivalent of hsa-miR-483-3p, due to time and cost limitations, I have not 
experimentally searched for its targets although prediction software indicates the 
following targets: collagen type VI, GDF-5 and TIMP-3 (http://www.targetscan.org). 
However it would be worth trying to identify these target genes, especially because  
miR-483-3p/-5p is known to be up-regulated in OA cartilage (Gibson and Asahara, 2013, 
Qi et al., 2013), has been reported to target aggrecan (Iliopoulos et al., 2008) and is 
positively correlated with MMP-13 and IL-1β (Qi et al., 2013).   
It would also be very interesting to confirm the findings of miR-125b and miR-455 whose 
expressions were observed to be elevated (miR-125b-1) or decreased (miR-125b-2, 
 miR-455) from the microarray data (analysis performed on explants 4h post-cessation 
of load), as these miRs are reported to be differentially expressed in OA cartilage 
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(Matsukawa et al., 2013, Swingler et al., 2012).  miR-125b whose direct target is 
ADAMTS-4 has been shown to be down-regulated in OA chondrocytes and was able to 
significantly supress IL-1β induced ADAMTS-4 levels (Matsukawa et al., 2013). These 
findings may suggest that elevated expression of miR-125b-1 controls ADAMTS-4 mRNA 
levels in 4h post-load explants subjected to both 2.5MPa and 7MPa loads, therefore its 
level remained unchanged at this time point, whereas elevated expression of  
ADAMTS-4 in tissue processed 24h after load may be an effect of the unaltered level of 
this miR (microarray data available electronically). In turn, miR-455 was reported to be 
up-regulated in OA chondrocytes and able to control the TGFβ/SMAD2/3 signalling 
pathway, for example: BMP binding protein inhibitor chordin-like 1 (CHRDL1) (Swingler 
et al., 2012) which was down-regulated at 24h post-load in explants subjected to a 7MPa 
load (microarray data available electronically). Therefore, it would be interesting to 
assess their expression in explants processed at 24h post-load, despite the fact that they 
were not identified as being differentially regulated by 24h post-load in microarray and 
NGS analysis. It would also be worth validating miR-21-5p, miR-27a-5p, miR-221 and 
miR-222 in cartilage explants at 4h post-load as the microarray analysis implied their 
differential expression at this earlier time point. If these mechano-sensitive miRs 
present at 24h post-cessation of load are also significantly regulated at this earlier 4h 
time point, it would be worth considering using earlier time points for future miRs 
studies. 
Future studies should also examine TIMP-3 and CPEB3 as target genes of miR-21-5p,  
miR-221/miR-222 and miR-21-5p respectively using techniques other than qPCR to 
confirm that they are real targets of these miRs. Such techniques might include 
performing (i) Western-blotting to establish whether the protein levels of these targets 
is affected by miR expression manipulation, however this method does not distinguish 
direct and secondary targets and (ii) luciferase assay which is commonly used for 
determination of direct interaction of miR:mRNA at the gene level. Based on the fact 
that miR inhibits post-transcriptional process of its target mRNA, the luciferase - 3’UTR 
construct should show less activity than the negative control, if the 3’UTR contains 
specific binding sites for the tested miR. 
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6.11. Conclusion 
The aim of this PhD project was to identify mechano-sensitive miRs in articular cartilage 
that are involved in controlling genes that play key roles in cartilage 
homeostasis/degradation. This study confirms the mechano-regulatory nature of 
miR-221/-222 and demonstrates novel findings of the mechano-regulation of  
miR-21-5p, miR-27a-5p and miR-483 in cartilage explants. Moreover, my work is the first 
to identify TIMP-3 as a target of miR-21-5p, miR-221/-222 and CPEB3 as a direct target 
of miR-21-5p in primary chondrocytes. I believe that my findings provide important 
information in our understanding of cartilage mechanotransduction and that this is only 
the beginning of future studies aimed at identifying biomarkers in cartilage of load-
induced OA which may provide therapeutic potential for OA treatment.  
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Appendix 1 
Table of the genes present on RT2 Profiler Wnt PCR array (Qiagen). 
                            
Position Unigene GenBank Symbol Description
A01 Bt.9945 NM_001128497 AES Amino-terminal enhancer of split
A02 Bt.11086 NM_001075986 APC Adenomatous polyposis coli
A03 Bt.21602 NM_001191398 AXIN1 Axin 1
A04 Bt.4412 NM_001192299 AXIN2 Axin 2
A05 N/A XM_010803098 BCL9 B-cell CLL/lymphoma 9
A06 Bt.25271 NM_001083475 BTRC Beta-transducin repeat containing
A07 Bt.88783 NM_001046273 CCND1 Cyclin D1
A08 Bt.4895 NM_001076372 CCND2 Cyclin D2
A09 Bt.65222 NM_174711 CSNK1A1 Casein kinase 1, alpha 1
A10 Bt.64603 NM_174635 CSNK2A1 Casein kinase 2, alpha 1 polypeptide
A11 Bt.1780 XM_010806373 CTBP1 C-terminal binding protein 1
A12 Bt.33687 NM_001076141 CTNNB1
Catenin (cadherin-associated protein), 
beta 1, 88kDa
B01 Bt.8208 NM_001081588 DAAM1
Dishevelled associated activator of 
morphogenesis 1
B02 Bt.15382 NM_001193246 DAB2
Disabled homolog 2, mitogen-responsive 
phosphoprotein (Drosophila)
B03 N/A XM_002693011 DIXDC1 DIX domain containing 1
B04 Bt.13880 NM_001205544 DKK1 Dickkopf homolog 1 (Xenopus laevis)
B05 Bt.18710 NM_001100306 DKK3 Dickkopf homolog 3 (Xenopus laevis)
B06 Bt.27892 NM_001206601 DVL1 Dishevelled, dsh homolog 1 (Drosophila)
B07 Bt.17972 NM_001191382 DVL2 Dishevelled, dsh homolog 2 (Drosophila)
B08 Bt.30467 XM_002696250 FBXW11
F-box and WD repeat domain containing 
11
B09 Bt.26327 NM_001101985 FBXW4
F-box and WD repeat domain containing 
4
B10 Bt.62944 NM_001040605 FGF4 Fibroblast growth factor 4
B11 Bt.17885 NM_001205985 FOSL1 FOS-like antigen 1
B12 Bt.88317 NM_001192452 FOXN1 Forkhead box N1
C01 N/A XM_002698415 FRAT1
Frequently rearranged in advanced T-cell 
lymphomas
C02 Bt.121 NM_174059 FRZB Frizzled-related protein
C03 Bt.26635 NM_001101048 FZD1 Frizzled family receptor 1
C04 Bt.79602 NM_001192964 FZD3 Frizzled family receptor 3
C05 Bt.76547 NM_001206269 FZD4 Frizzled family receptor 4
C06 N/A XM_005197510 FZD5 Frizzled family receptor 5
C07 Bt.104004 XM_863880 FZD6 Frizzled homolog 6 (Drosophila)
C08 Bt.105583 NM_001144091 FZD7 Frizzled family receptor 7
C09 N/A XM_005214320 FZD8 Frizzled family receptor 8
C10 N/A XM_002698189 FZD9 Frizzled family receptor 9
C11 Bt.33944 NM_001102192 GSK3A Glycogen synthase kinase 3 alpha
C12 Bt.48740 NM_001101310 GSK3B Glycogen synthase kinase 3 beta
D01 Bt.11159 NM_001077827 JUN Jun proto-oncogene
D02 N/A XM_010814133 KREMEN1
Kringle containing transmembrane 
protein 1
D03 Bt.18467 NM_001192856 LEF1 Lymphoid enhancer-binding factor 1
D04 Bt.45360 XM_010821189 LRP5
Low density lipoprotein receptor-related 
protein 5
D05 Bt.60913 XM_002687783 LRP6
Low density lipoprotein receptor-related 
protein 6
D06 Bt.14050 NM_001192974 MAPK8 Mitogen-activated protein kinase 8
D07 Bt.13092 NM_001075130 MMP7
Matrix metallopeptidase 7 (matrilysin, 
uterine)
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Table of the genes present on RT2 Profiler Wnt PCR array (Qiagen) contd. 
                          
Table of the genes present on RT2 Profiler Wnt PCR array (Qiagen) contd. 
D08 Bt.21164 NM_001046074 MYC
V-myc myelocytomatosis viral oncogene 
homolog (avian)
D09 Bt.45162 NM_001166615 NFATC1
Nuclear factor of activated T-cells, 
cytoplasmic, calcineurin-dependent 1
D10 Bt.60075 NM_001105453 NKD1 Naked cuticle homolog 1 (Drosophila)
D11 Bt.43996 NM_001193253 NLK Nemo-like kinase
D12 Bt.18496 NM_001097991 PITX2 Paired-like homeodomain 2
E01 Bt.38004 NM_001101208 PORCN Porcupine homolog (Drosophila)
E02 Bt.13264 NM_001083636 PPARD
Peroxisome proliferator-activated 
receptor delta
E03 Bt.57449 NM_001102534 PRICKLE1 Prickle homolog 1 (Drosophila)
E04 N/A XM_002690892 PYGO1 Pygopus homolog 1 (Drosophila)
E05 Bt.49678 NM_176645 RHOA Ras homolog gene family, member A
E06 Bt.2846 NM_001098147 RHOU Ras homolog gene family, member U
E07 Bt.41723 NM_001101076 RUVBL1 RuvB-like 1 (E. coli)
E08 Bt.5226 NM_174460 SFRP1 Secreted frizzled-related protein 1
E09 Bt.3540 NM_001075764 SFRP4 Secreted frizzled-related protein 4
E10 Bt.112292 NM_001206251 SOX17 SRY (sex determining region Y)-box 17
E11 Bt.44634 NM_001099186 TCF7
Transcription factor 7 (T-cell specific, 
HMG-box)
E12 N/A XM_002691408 TCF7L1
Transcription factor 7-like 1 (T-cell 
specific, HMG-box)
F01 Bt.3589 NM_001098020 TLE1
Transducin-like enhancer of split 1 
(E(sp1) homolog, Drosophila)
F02 Bt.87234 NM_001205875 VANGL2 Vang-like 2 (van gogh, Drosophila)
F03 Bt.63013 NM_001075996 WIF1 WNT inhibitory factor 1
F04 N/A XM_005215320 WISP1
WNT1 inducible signaling pathway 
protein 1
F05 Bt.101628 NM_001114191 WNT1
Wingless-type MMTV integration site 
family, member 1
F06 Bt.61102 NM_001099078 WNT10A
Wingless-type MMTV integration site 
family, member 10A
F07 Bt.21876 NM_001082456 WNT11
Wingless-type MMTV integration site 
family, member 11
F08 Bt.37171 NM_001014949 WNT16
Wingless-type MMTV integration site 
family, member 16
F09 Bt.37360 NM_001013001 WNT2
Wingless-type MMTV integration site 
family member 2
F10 Bt.27254 NM_001099363 WNT2B
Wingless-type MMTV integration site 
family, member 2B
F11 Bt.112395 NM_001206024 WNT3
Wingless-type MMTV integration site 
family, member 3
F12 N/A XM_010806514 WNT3A
Wingless-type MMTV integration site 
family, member 3A
G01 Bt.88484 NM_001205971 WNT5A
Wingless-type MMTV integration site 
family, member 5A
G02 Bt.6367 NM_001205628 WNT5B
Wingless-type MMTV integration site 
family, member 5B
G03 Bt.27385 NM_001205563 WNT6
Wingless-type MMTV integration site 
family, member 6
G04 Bt.69615 NM_001192788 WNT7A
Wingless-type MMTV integration site 
family, member 7A
G05 N/A XM_603482
LOC52513
5
Wingless-type MMTV integration site 
family, member 7B
G06 Bt.106446 NM_001192370 WNT8A
Wingless-type MMTV integration site 
family, member 8A
G07 N/A XM_002688510 WNT9A
Wingless-type MMTV integration site 
family, member 9A
G08 Bt.17918 NM_174739 CBY1 Chibby homolog 1 (Drosophila)
G09 Bt.24868 NM_001082615 DKK2 Dickkopf homolog 2 (Xenopus laevis)
G10 N/A XM_010820369 DKK4 Dickkopf homolog 4 (Xenopus laevis)
G11 Bt.9084 XM_010819270 KREMEN2
Kringle containing transmembrane 
protein 2
G12 N/A XM_001254723 MAP2K7
Mitogen-activated protein kinase kinase 
7
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H01 Bt.14186 NM_173979 ACTB Actin, beta
H02 Bt.87389 NM_001034034 GAPDH
Glyceraldehyde-3-phosphate 
dehydrogenase
H03 Bt.49238 NM_001034035 HPRT1
Hypoxanthine 
phosphoribosyltransferase 1
H04 Bt.22662 NM_001075742 TBP TATA box binding protein
H05 Bt.111451 NM_174814 YWHAZ
Tyrosine 3-monooxygenase/tryptophan 
5-monooxygenase activation protein, 
zeta polypeptide
H06 N/A SA_00137 BGDC Cow Genomic DNA Contamination
H07 N/A SA_00104 RTC Reverse Transcription Control
H08 N/A SA_00104 RTC Reverse Transcription Control
H09 N/A SA_00104 RTC Reverse Transcription Control
H10 N/A SA_00103 PPC Positive PCR Control
H11 N/A SA_00103 PPC Positive PCR Control
H12 N/A SA_00103 PPC Positive PCR Control
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